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ABSTRACT 
Persistent Organic Pollutants is a group of structurally diverse man-made chemicals 
characterized by a high bio-persistence and the ability to travel a long distance on the 
planetary scale. This class of chemicals includes polychlorinated biphenyls, 
organochlorinated pesticides such as DDT and its metabolites and other chemicals such 
as polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans. These 
chemicals are widely distributed in the environment as some of them have long been 
employed in agriculture and in public health as pesticides, others as industrial chemicals 
and others are unavoidable by-products of industrial processes. These chemicals can be 
a source of health risk to human. 
Despite extensive use of OCPs such DDT in Italy in the 1940s to 1970s especially for 
public health control of malaria mosquitoes and PCBs in industry, in energy production 
and in industrial commodities, information on their exposure levels among the general 
population is limited. This study aims at determining the levels of OCPs and of PCB 
congeners among the residents from Italians living in three different places: Novafeltria 
(a village in Central Italy), Pavia (a mid-sized town) and Milan (the second-largest city 
in Italy) and at exploring the relationship with places of residence, gender, age and 
individual body size of their accumulation in the population. 
To measure PCBs concentrations, blood samples were collected from 372 consented 
subjects whereas to measure OCPs blood samples were collected from 137 subjects. 
Thirty six PCB congeners and eight OCPs were measured in blood serum by gas-
chromatography-mass spectrometry. To normalize PCBs and OCPs concentrations to 
total blood lipid concentrations (a commonly employed technique to take into account 
the lipophilic character of the compounds), serum concentrations of triglycerides and 
total cholesterol were measured by standard clinical chemistry techniques. Personal 
information such as gender, age, height and weight, dietary habits, education, residence 
and occupation information were collected through a questionnaire. 
Statistical analyses were employed to highlight variation in analytes levels with respects 
to residence, age, gender and body mass index. The analytes concentrations were 
summarized for the overall population of three sites and separately for the individual 
sites, for gender, for age groups and for BMI categories. 
viii 
The PCB congeners 138, 153 and 180 were the most frequently detected in overall 
population sample and were the major contributors of total PCB burden. PCB 153 had 
the highest median level in each site. Total PCB level differed significantly between the 
study sites (p < 0.0001) with median concentrations of 837, 1355 and 2062 pmol/g lipid, 
respectively in Novafeltria, Pavia and Milan. No evidence was found for the difference 
in distribution of total PCB levels by genders. Total DL–PCB differed significantly (p < 
0.0001) between the sites (median 110, 51 and 167 pmol/g lipid, respectively) and 
genders of Novafeltria and Pavia (p = 0.011 and 0.009, respectively). PCB 138, 153, 
170 and 180 differed significantly between the sites (p < 0.0001) with higher values in 
Milan population. In overall population total PCB, PCB 138, 153, 156, 170 and 180 
correlated positively with age (r for linear correlations range between 0.320–0.569, p < 
0.0001). In Novafeltria the r correlations range between 0.545–0.670 and 0.516–0.666 
in Pavia. In Milan, r correlations with age range between 0.327–0.417 for total PCB, 
congener 138, 153 and 180. With exception of PCB 170 there was no evidence of 
significant difference in distribution of most abundant PCB congeners and total PCB 
across the BMI categories. 
Among the OCPs, p,p'-DDE and HCB were the most abundant and major contributors 
of total OCP concentration. Their levels differed significantly between the three towns 
with a trend Milan > Novafeltria > Pavia (p < 0.0001). Females had significantly higher 
concentrations of HCB and p,p'-DDE than males in overall population sample. HCB 
concentrations were significantly higher in females than in males of Milan (p = 0.029). 
We observed positive correlations of p,p'-DDE and HCB with age in Novafeltria 
subjects (r = 0.468, p = 0.004). Total OCP concentrations differed significantly across 
BMI categories (p = 0.018) in overall population. 
We have demonstrated a pattern of distribution of the levels of the main PCB congeners 
and OCPs in a fairly large population in Italy. Generally our study provides information 
on PCBs and OCPs exposure among the Italian general population and provides 
indications for further investigations. 
Keywords: Persistent organic pollutants; human exposure; serum; DDT; DDE; DDD; HCB; 
HCH; PCBs; DL–PCBs; total PCBs. 
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RIASSUNTO 
I contaminanti organici persistenti costituiscono un gruppo di sostanze chimiche 
artificiali strutturalmente tra loro diverse e caratterizzate, quale elemento comune, da 
un’elevata bio-persistenza e dalla capacità di essere trasportate per lunghe distanze su 
scala planetaria, lontano dal luogo originario di emissione nell’ambiente. A questa 
classe di sostanze chimiche appartengono, tra gli altri, i bifenili poli-clorurati, i pesticidi 
organo-clorurati, tra cui il DDT e i suoi metaboliti, e altri prodotti chimici come le 
dibenzo-p-diossine e i dibenzo-furani policlorurati. Queste sostanze chimiche sono 
ormai ampiamente distribuite nell'ambiente, in quanto alcuni di loro sono stati a lungo 
impiegati in agricoltura e nella sanità pubblica come pesticidi (il DDT e gli altri 
insetticidi clorurati), altri come prodotti chimici industriali (i bifenili poli–clorurati) e 
altri sono inevitabili sottoprodotti di processi industriali (le dibenzo-p-diossine e i 
dibenzo–furani policlorurati). Per le loro caratteristiche tossicologiche, queste sostanze 
chimiche possono essere fonte di rischio per la salute umana. 
In Italia si è fatto largo uso di insetticidi della famiglia organo clorurata (DDT e prodotti 
simili) dagli anni ‘40 agli anni ‘70 del 1900, soprattutto per fini di salute pubblica, per 
l’eradicazione di vettori (zanzare) della malaria e dei PCB, prodotti in Italia per il 
settore manifatturiero (produzione di dispositivi elettrici e termici), nella produzione di 
energia (uso di trasformatori e condensatori) e come materiali industriali in diversi 
comparti. Ciò nonostante, le informazioni sui livelli di esposizione della popolazione 
generale rimangono limitate. Questo studio si è proposto di misurare i livelli di alcuni 
insetticidi organo-clorurati e dei PCB nella popolazione generale italiana in tre luoghi 
diversi: Novafeltria (un paese del Centro Italia), Pavia (una città di medie dimensioni) e 
Milano (la seconda città più grande in Italia) e ad esplorare la relazione del loro 
accumulo nella popolazione con i luoghi di residenza, il sesso, l’età e la costituzione 
individuale. 
Per misurare le concentrazioni di PCB, i campioni di sangue sono stati raccolti 
campioni di sangue da 372 soggetti che hanno fornito il consenso informato e per 
misurare gli insetticidi organo-clorurati sono stati raccolti i campioni da 137 soggetti. 
Nel siero sono stati misurati 36 congeneri dei PCB e 8 insetticidi organo-clorurati 
mediante gas-cromatografia-spettrometria di massa. Per normalizzare le concentrazioni 
dei PCB e degli insetticidi organo-clorurati alle concentrazioni totali di lipidi nel sangue 
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(una tecnica comunemente impiegata per tener conto del carattere lipofilico dei 
composti), sono stati misurate le concentrazioni sieriche di trigliceridi e colesterolo 
totale mediante tecniche standard di chimica clinica. Le informazioni personali quali il 
sesso, l'età, l'altezza e il peso, le abitudini alimentari, l'istruzione, la residenza e 
l'occupazione le informazioni sono state raccolte attraverso un questionario. 
Sono state impiegate analisi statistiche per evidenziare eventuali relazioni dei livelli 
degli analiti con caratteristiche dei soggetti indagati quali la residenza, l’età, il sesso e 
l’indice di massa corporea. Le concentrazioni degli analiti sono state indagate in termini 
sintetici per la popolazione complessiva dei 3 siti, e separatamente per i singoli siti, per 
sesso, per età e per le categorie di BMI. 
I PCB congeneri 138, 153 e 180 sono stati quelli più frequentemente rilevati nei 
campioni e sono risultati quelli maggioritari nel concorrere alla dose totale di PCB. Il 
PCB 153 ha il più alto livello medio in ciascun sito. Il livello totale di PCB differisce in 
modo significativo tra questi siti (p < 0,0001) con concentrazioni mediane di 837, 1355 
e 2062 pmol/g di lipidi, rispettivamente a Novafeltria, a Pavia e in Milano. Non sono 
state dimostrate differenze nella distribuzione dei livelli di PCB totali tra i due sessi. La 
somma dei PCB diossino-simili differiva in modo significativo (p < 0,0001) tra i siti 
(media 111 e 167 pmol/g di lipidi, rispettivamente) e tra i due sessi a Novafeltria e a 
Pavia (p = 0,011 e 0,009, rispettivamente). I PCB 138, 153, 170 e 180 differivano in 
modo significativo tra i luoghi di residenza (p < 0,0001), con valori più elevati nella 
popolazione di Milano. In generale, nella popolazione totale esaminata i livelli dei PCB 
totali e dei congeneri 138, 153, 156, 170 e 180 correlano positivamente con l'età 
(coefficienti r di correlazione compresi tra 0,320 e 0,569, p < 0,0001). A Novafeltria i 
coefficienti r risultano compresi tra 0,545 e 0,670 e tra 0,516 e 0,666 a Pavia. A Milano, 
i coefficienti r per le correlazioni con età sono risultati compresi tra 0,327 e 0,417 per i 
PCB totali e per i congeneri 138, 153 e 180. Ad eccezione del PCB 170 non è stata 
osservata alcuna differenza significativa nella distribuzione dei più abbondanti 
congeneri di PCB e PCB totali tra le diverse categorie di BMI (individui ‘più o meno 
grassi’). 
Tra gli insetticidi organo-clorurati, il p,p'-DDE e l’HCB contribuiscono in misura 
magiore al carico corporeo totale per la classe di composti. I loro livelli differiscono in 
modo significativo tra le tre città, con un trend di Milano > Novafeltria > Pavia (p < 
xi 
0,0001). Considerando l’intero campione, le femmine hanno concentrazioni 
significativamente più alte di HCB e p,p'-DDE rispetto ai maschi. Le concentrazioni di 
HCB sono significativamente più alte nelle femmine rispetto ai maschi di Milano (p = 
0,029). Abbiamo osservato correlazioni positive tra la concentrazione di p,p'-DDE e 
HCB e l’età solo nei soggetti di Novafeltria (r = 0,468, p = 0,004). Considerando 
l’intera popolazione studiata, le concentrazioni dell’insetticida organo clorurati totali 
differiscono in modo significativo tra le categorie di BMI (p = 0,018). 
Abbiamo misurato il pattern dei principali congeneri dei PCB e degli insetticidi organo-
clorurati in una campione abbastanza esteso della popolazione italiana. In generale il 
nostro studio fornisce informazioni sui livelli di esposizione a PCB e ad insetticidi 
organo-clorurati e fornisce indicazioni per ulteriori indagini. 
Parole chiave: Contaminanti organici persistenti; esposizione; siero; DDT; DDE; 
DDD; HCB; HCH; PCB; PCB diossino–simili; PCB totali. 
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CHAPTER ONE 
INTRODUCTION 
1.1 General Introduction 
1.1.1 Characteristics of Persistent Organic Pollutants 
Persistent Organic Pollutants (POPs) represent a group of structurally diverse man-
made and naturally chemicals characterized by environmental persistence and ability to 
accumulate in the food chain. According to UNEP POPs are defined as “chemical 
substances that persist in the environment, bio-accumulate through the food web, and 
pose a risk of causing adverse effects to human health and the environment (UNEP 
1995). Once released in the environment, they break down very slowly in air, water, soil 
and in living organisms. These chemicals are thus difficult to be degraded in the 
environment by chemical, biological and photolysis processes. 
POPs are subject to long range trans-boundary air pollution (LRTAP) transport where 
they are carried over long distances via the atmospheric transport. They migrate from 
warmer regions to the colder polar ones where they condense, precipitate and deposited 
again on earth surface as dry or wet deposit. POPs can also be transported for long 
distance by river, ocean currents and as contaminants in wildlife. DDT for example has 
been found to have this ability to cross international border and travel long distances in 
air and water. As a result DDT and its metabolite are found in Arctic air, sediment and 
snow with substantial accumulations in food chain, mammals and human in these 
regions. Even the body burden of the flocks of migratory birds is a sizeable contribution 
to LRTAP (WHO, 2003). Hexachlorobenzene is widely distributed in the environment 
due to long range transport via atmospheric or oceanic system. It has been detected in 
air, water, sediment, soil and biota from around the world. Its bioaccumulation and 
biomagnification through food chain has been reported. Polychlorinated biphenyls 
(PCBs) are semi volatile and resistance to degradation. These characteristics predispose 
them to long range transport. They are found in many parts of the world including those 
with no PCB production or use have even been reported, such as in Arctic regions. 
Analyses of food and breast milk show that PCBs are still present in those regions. 
Many POPs have been employed in agriculture and public health as pesticides (DDT, 
lindane, hexachlorobenzene), others were used in industry as raw materials 
(polychlorinated biphenyls) or as by-products of production processes (dioxins and 
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furans). In particular, the introduction of synthetic organic chemicals in the second half 
of the 20th century boosted the capability to counter crop- and food-spoiling organisms 
and eradicate or control parasite-borne diseases such as malaria, both improving the 
quality of life of large populations in temperate and semi-tropical areas and allowing 
better utilization of agricultural areas. Because of their persistence they are widely 
distributed in the environment and human exposure to them is unavoidable. This is 
evidenced as they are detected in human tissues such as such as blood (whole blood, 
cord blood, serum and plasma), adipose tissues (from autopsies and biopsies), breast 
milk, muscles and hair (Appenzeller and Tsatsakis, 2012; Covaci et al., 2002; Dewailly 
et al., 1999; Jakszyn et al., 2009; Mrema et al., 2011; Rappolt and Hale, 1968; Tsang et 
al., 2011; Tsatsakis and Tutudaki, 2004; Tsatsakis et al., 1998, 2008; Tutudaki et al., 
2003). 
Human exposure begins during early prenatal and continues during the breast-feeding 
neonatal periods, which are critical stages for the development and differentiation of 
sensitive body organs and systems. In fact, these chemicals cross the placenta to the 
foetus and are secreted into breast milk (Perera et al., 2005). In adults the dietary 
exposure route accounts for more than 90% of total organochlorine compounds (OCs) 
burden for the general population, whilst workers are exposed mainly through 
inhalation and skin contact. 
Many POPs are highly toxic and can turn up in the food chain where bioaccumulation 
occurs in fatty tissues of animals and human as they are soluble in these tissues. Low 
environmental levels of POPs can lead to high levels in the body tissues as their 
concentration can become magnified up to 70,000 times higher than the background 
levels. Exposure to these persistent chemicals has been associated with health effects 
including cancer (Aronson et al., 2000; Cohn et al., 2007; Mathur et al., 2002; 
Recio‐Vega et al., 2011), reproductive defects (Nicolopoulou and Stamanti, 2001) and 
behavioral changes (Zala and Penn, 2004). These effects are believed to be related to 
POPs’ ability to disrupt the functions of certain hormones, enzymes, growth factors, 
neurotransmitters and to interfere with the expression of some key genes involved in 
metabolism of steroids and xenobiotics (Gourounti et al., 2008). Early ecological and 
human health concern led to intensive campaign against their use, leading to a gradual 
ban or restriction of their production and use in most countries starting in the early 
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1970s and finally ending with the Stockholm Protocol in 2001 (UNEP, 2001; 
http://www.pops.int).
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1.1.2 Classes of Persistent Organic Pollutants 
It was since the publication of Rachel Carson’s book ‘Silent Spring’ (Carson, 1962) 
when ecological and health concerns of uncontrolled application of pesticides quickly 
rose especially when highly populated regions of developed countries started to suffer 
the effects of widespread contamination as a threat to their own food sources. 
Industrialized countries started to limit application of pesticides, to ban their production 
and to enforce limits to their presence as ubiquitous contaminants of water and food. 
In May 1995, United Nations Environmental Programme (UNEP) Governing Council 
initiated a global action to reduce and eliminate the release of POPs. Following this, the 
Intergovernmental Forum on Chemical Safety (IFCS) and the International Programme 
on Chemical Safety (IPCS) produced the initial list of 12 POPs for assessment based on 
their properties and the urgency for action. These compounds were named as “the dirty 
dozen” or “poisons without passports” and were listed in Annex A, B and C (Table 
1.1). Of the more ecological and human health concerns compounds are OCPs such as 
DDT (IPCS, 1990) and lindane (IPCS, 1991). Others are industrial chemicals such as 
polychlorinated biphenyls (IPCS, 2003) and hexachlorobenzene (IPCS, 1997). 
Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans are also of more 
concern (IPCS, 1989) with no known uses but unintentionally produced via several 
technological processes (Ritter et al., 1995) such as photochemical and thermal 
processes or as byproducts in municipal waste incineration (Abad et al., 2000), pesticide 
manufacturing (Masunaga et al., 2001) and in chlorine bleaching of pulp and paper 
(Swanson et al., 1988). 
After a long elaboration and negotiations, an international environmental treaty, the 
Stockholm Convention, was signed in 23 May 2001 to eliminate or restrict the 
production and use of some priority persistent organic pollutants (POPs). It entered into 
force on 17 May 2004 with ratification by initial 128 parties and 151 signatories. As of 
April, 2011, there are 173 parties to the Convention and by October 2011 three more 
parties were added (http://chm.pops.int/). Parties to the Convention agreed to 
periodically reviewing the list to add more compounds or classes of compounds, when 
they meet criteria for persistence and trans-boundary threat. As a result a second set of 
nine new POPs was added to the list during its 4th meeting held in Geneva on 8 May 
2009. Of these, four are pesticides, three isomers of hexachlorocyclohexane (HCH) and 
chlordecone (also known as kepone). Others are brominated flame retardants and 
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perfluorinated organic acids. In May 2011 technical endosulfan and its related isomers 
were added to the list (UNEP, 2011). 
Due to the efficacy of some organochlorinated pesticides, such as DDT and lindane, in 
fighting parasite-borne diseases such as malaria and scabies, respectively, exemptions 
allowing to continue production from registered parties and use for specific purposes are 
embedded in Annex B, the enforcement of which is however a task of the individual 
countries. 
Table 1.1. An extended list of POPs banned or restricted by the Stockholm 
Convention. 
Chemical Pesticides Industrial Chemicals Byproduct Annex 
Aldrina +   A 
Chlordanea +   A 
Chlordeconeb +   A 
DDTa +   B 
Dieldrina +   A 
Endrina +   A 
Heptachlora +   A 
Lindaneb +   A 
Mirexa +   A 
Technical endosulfan and its related 
isomersc +   A 
Toxaphenea +   A 
Hexabromobiphenylb 
 +  A 
Hexabromodiphenyl ether and 
heptabromodiphenyl ether 
(commercial octabromodiphenyl 
ether)b 
 +  A 
Perfluorooctane sulfonic acid, its salts 
and perfluorooctane sulfonyl fluorideb  +  B 
Tetrabromodiphenyl ether and 
pentabromodiphenyl ether 
(commercial pentabromodiphenyl 
ether)b 
 +  A 
Chlorinated dioxinsa 
  + A 
Chlorinated furansa 
  + A 
Alpha hexachlorocyclohexaneb + +  A 
Beta hexachlorocyclohexaneb + +  A 
Pentachlorobenzeneb + +  A & C 
Polychlorinated biphenylsa 
 + + A 
Hexachlorobenzenea + + + A 
a Present in the initial “Dirty Dozen” list produced in 2001; bAdded by the Fourth Conference of 
Parties, May 2009; cAdded by Fifth Conference of Parties, May 2011; Annex A – Intentionally 
produced chemicals that need to be eliminated; Annex B – Intentionally produced chemicals with 
restrictions, Annex C – Unintentionally produced chemicals. 
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Some of the categories listed in Table 1.1 above overlap. For example mirex which was 
produced primarily for use as a pesticide has also been used as a fire retardant; PCBs 
which were produced as industrial chemicals are also generated as unwanted by-
products whereas hexachlorobenzene fits into all three categories i.e. as pesticide, 
industrial chemical and by-product. 
Among the several existing POPs, in this study only polychlorinated biphenyls (PCBs) 
and organochlorinated pesticides (OCPs) have been addressed. 
1.1.3 Polychlorinated biphenyls 
Polychlorinated biphenyls (PCBs) constitute a group of 209 chemically related 
compounds which were used extensively in industrial applications and in commercial 
products. Their chemical formula is C12H10-xClx with 1 to 10 chlorine atoms substituting 
hydrogen atoms in the nucleus of biphenyl ring (Table 1.2). In terms of structure-
toxicity relationship, PCB congeners are categorized as coplanar and non-coplanar 
congeners. The former contain one or no chlorine attached to ortho position while the 
latter has one or more than two chlorine atoms attached to ortho position of biphenyl 
ring as illustrated in Figure 1.1. The coplanar groups have a fairly rigid structure with 
the two phenyl rings in the same plane. This gives the molecule a similar structure to 
polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans 
(PCDFs) and allows it to interact in the same way with biological targets at the 
molecular level. For this reason coplanar congeners are referred to as dioxin–like (DL) 
PCBs while the non-coplanar are non–dioxin like (NDL) PCBs. 
Table 1.2. The general schematic structure of 209 polychlorinated biphenyl (PCB) 
congeners 
Polychlorobiphenyls PCB Homologues Formula Mwt N° of Congeners 
 
 
 
biphenyl C12H10Cl0 154.21 1 
monochlorobiphenyl C12H9Cl1 188.66 3 
dichlorobiphenyl C12H8Cl2 223.10 12 
trichlorobiphenyl C12H7Cl3 257.55 24 
tetrachlorobiphenyl C12H6Cl4 291.99 42 
pentachlorobiphenyl C12H5Cl5 326.44 46 
hexachlorobiphenyl C12H4Cl6 360.88 42 
heptachlorobiphenyl C12H3Cl7 395,33 24 
octachlorobiphenyl C12H2Cl8 429.77 12 
nonachlorobiphenyl C12H1Cl9 464.22 3 
pentachlorobiphenyl C12H0Cl10 498.66 1 
Note: Biphenyl is not PCB congener due to its lack of chlorine atom but it is still included in the list. 
7 
The DL–PCBs act similarly like the most toxic dioxin 2,3,7,8-tetrachloro-dibenzo-p-
dioxin (2,3,7,8-TCDD), since their planar configuration allows binding to the 
recognition site of the aromatic hydrocarbon receptor (AhR), thus causing biological 
effects similar to those of dioxins (Safe, 1993). The bound AhR dissociates from the 
inactive dimeric form to the ‘activated’ monomeric agonist-bound form which 
translocates from the citosol to the cell nucleus. The monomeric form binds specific 
DNA-binding proteins causing them to dissociate from the gene sequence and causing 
transcription or inhibition of the transcription of downstream gene elements, among 
which are catalytic or signaling proteins with a biological role in challenging such 
biological phenomena as exposure to xenobiotics (by enhancing the transcription of 
phase I and II metabolizing enzymes) or endogenous oxidative stress (by enhancing 
transcription of antioxidant enzymes). 
As a consequence, substances such as PCBs with limited if any potential to be 
biotransformed into reactive intermediates can enhance biotransformation of other 
xenobiotics, such as PAH, into reactive potentially genotoxic and carcinogenic 
metabolites. Moreover, the action of some PCBs as structural mimics of natural 
estrogen receptor-binding agonists (endocrine disruption) can enhance cell proliferation 
and thus increase risk of estrogen-dependant cancer. 
 
Figure 1.1. Illustration of the generalized structure of the two classes of PCB congeners. 
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Complex mixtures of PCBs (branded as Aroclor in the USA and as Apirolio or Fenclor 
in Italy) found large industrial applications mainly as dielectric fluids in high voltage 
appliances such as capacitors and transformers and as non flammable heat-transport 
fluids in heat exchangers. Globally total PCBs production was ~1.3 million tonnes 
between 1930 and 1993. In Italy it is estimated at around 150,000 metric tonnes from 
1938 to 1984, with production in the 1970s between 2,500 and 5,000 metric tonnes per 
year from Caffaro the main producing plant in Northern Italy (Ruzzenenti, 2001). 
Another estimate gives figures of 31,092 metric tonnes being produced between 1958 
and 1983 (Breivik et al., 2002). In 1977 production and use of PCBs was banned by 
USA and in 2001 by the Stockholm Convention on Persistent Organic Pollutants 
(UNEP, 1999). 
Since environmental exposure to PCBs is always due to complex and variable mixtures, 
toxic equivalent (TEQ) concept was developed to assist health risk assessment due to 
PCBs exposure by using toxic equivalent factors (TEFs). TEF indicates the degree of 
toxicity compared to 2,3,7,8–TCDD, the most toxic POP which is given a reference 
value of 1 (Ahlborg et al., 1994; Safe, 1990). Other dioxin–like compounds such as 
PCDDs, PCDFs and some PCB congeners have TEFs which span from 1 (i.e., a 
compound as toxic as 2,3,7,8–TCDD) to 5 x 10-6 (i.e., a compound which is approx. a 
million times less toxic than 2,3,7,8–TCDD). 
It has to be noted that not all PCB congeners have TEFs. Some criteria have been set to 
qualify a compound to the TEF concept (Van den Berg et al., 1998, 2006) as outlined 
below: 
a. It must have a structural relationship with PCDDs and PCDFs 
b. It must bind to aromatic hydrocarbon receptor (AhR) 
c. It has to elicit AhR-mediated biochemical and toxic responses 
d. It has to persist and accumulate in the food chain. 
Thus DL–PCBs fulfil these criteria and have been assigned TEFs. These include four 
non-ortho PCBs (nPCB 77, 81, 126, 169) and eight mono-ortho PCBs (mPCB 101, 114, 
118, 123, 156, 157, 167 and 187). In 1994 Ahlborg et al. assigned TEFs also to two di-
ortho PCBs (PCB 170 and 180) where in the revisions by Van den Berg et al. (1998, 
2006) they were not considered. 
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A TEF weighted sum of lipid adjusted concentrations is calculated to obtain TEQ as 
shown in the equation 1 below: 
 TEQDL-PCB = ∑(nPCBi x TEFi) + ∑(mPCBi x TEFi) (1) 
The toxicity of specific PCB congeners depends on its planarity, the number of chlorine 
atoms attached to biphenyl rings and biotransformation rate. Majority of their adverse 
effects are thought to be mediated through aryl hydrocarbon receptor (AhR) activation. 
For instance the coplanar non-ortho-substituted PCBs activate AhR and AhR dependent 
signal transduction pathways (van den Berg et al., 1998) and elicit dioxin-like effects 
such as anti estrogenic activity (Buchanan et al., 2000, 2002; Oenga et al., 2004; Safe 
and Wormke, 2003). The modes of these anti estrogenic activities may include 
repression of 17β-estradiol (E2)-dependent gene expression by interactions of activated 
AhR with DNA regions of E2 responsive gene promoters (Oenga et al., 2004; Safe and 
Wormke, 2003), inhibition of E2-induced cell cycle proteins and uterine epithelial 
mitogenesis (Buchanan et al., 2002; Wang et al., 1998) or effects of PCBs on E2 
metabolism (Pang et al., 1999; van Duursen et al., 2003). Non coplanar ortho-
substituted PCBs have been shown to elicit AhR-independent effects such as 
neurotoxicity, (anti) estrogenicity and tumour promotion in MCF–7 cells (Brouwer et 
al., 1999; Hansen 1998; Machala et al., 2003; Robertson and Hansen, 2001; Safe, 1992; 
Wolff and Toniolo, 1995). However their modes of action are not clear. 
Low molecular-weight PCBs have been found to elicit estrogenic activity both in vitro 
and in vivo as observed in several studies (Arcaro et al., 1999; Nesaretnam and Darbre, 
1997; Rogers and Denison, 2000; Rose et al., 2002) but with exception of DL-PCB 77, 
which elicited anti estrogenicity in vivo and also in some in vitro models (Ramamoorthy 
et al., 1999). On the other hand, some highly substituted PCBs such as the most 
prevalent di-ortho substituted PCBs (PCB 138, 153 and 180) have been reported to be 
antiestrogenic (Bonenfeld-Jorgensen et al., 2001; Plísková et al., 2005). 
Like other organochlorines, PCBs are strong inducers of key genes involved in 
metabolism of steroids and xenobiotics. PCB congeners that are sterically similar to 
dioxin induce CYP1A1 and CYP1A2 activities by binding with the aryl hydrocarbon 
receptor while congeners with at least two para and two ortho substitutions exhibit 
phenobarbital-like effects that induce CYP2B1 and CYP2B2 activities. Due to this 
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complex array of potential PCB effects, congener specific analysis is recommended to 
capture all potential effects which could be missed by evaluating only total PCB. 
The most health-threatening PCBs congeners include those which are coded as 77, 126, 
169, 105, 118, 128, 138,156, 170, 87, 99, 101, 153,180, 183, 194, 18, 44, 49, 52, 70, 74, 
151, 177, 187, 201, 37, 81, 114, 119, 123, 157, 158, 167, 168 and 189 classified based 
on their environmental occurrence, abundance and potential toxicity (McFarland and 
Clarke, 1989). International Agency for Research on Cancer (IARC) classified PCBs as 
probably carcinogenic to human under group 2A. Agency for Toxic Substances and 
Disease Registry (ATSDR) concluded that PCBs which contain 60% Cl by weight are 
clearly carcinogenic. A non-ortho PCB 126 which has a high contribution to PCB TEQ 
(TEF = 0.1) has recently been established as a carcinogenic to humans (Consonni et al., 
2012). 
1.1.4 Organochlorinated Pesticides 
Organo-chlorinated pesticides (OCPs) are a structurally heterogeneous class of 
chlorinated organic compounds (OCs) which contain several chlorine atoms per 
molecule. Among OCPs of prominent concern are dichlorodiphenyltrichloroethane 
(DDT) and its metabolites, chlordane, dieldrin, aldrin, endosulfan, hexachlorobenzene 
(HCB) and hexachlorocyclohexane (HCH) isomers such as lindane (Figure 1.2). These 
chemicals are widely distributed in the environment. They were used since the mid-
1940s as insecticides in agriculture and in public health for the control of parasite-borne 
diseases. Some compounds such as DDT is still used in tropical countries, to control 
malaria vectors through indoor residual spraying (Bouwman et al., 2011) and lindane 
for treatment of lice and scabies (Engeler, 2009). 
Their high content of chlorine in a mostly rigid carbon atom scaffold makes the 
molecules highly soluble in the lipid compartment of living organisms and poorly 
degradable in the environment by physical, chemical and biological processes (Mrema 
et al., 2012a). The consequence of both properties, together with widespread and high-
intensity use as pesticides for at least 30 years led to exposure to these chemicals of 
virtually every person and living organism on earth at different magnitude (Carson, 
1962; Mrema et al., 2012a). Due to their long environmental and biological half-lives, 
most banned OCPs are still present at trace levels in several foods, and thus represent a 
source of exposure for the general population in all the corners of the world, with 
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significant geographically based differences (Darnerud et al., 2006; Wang et al., 2007; 
UNEP, 2003; WHO, 2003). Main sources of exposure are some sea foods, milk and 
dairy products, meat and poultry, fats and oils. 
The insecticide DDT is produced as a technical mixture of 3 isomeric forms, the most 
prevalent form being the para,para (p,p')-isomer; ortho,ortho (o,o')- and ortho,para 
(o,p')- isomers being present in minor and variable amounts. Its main by- and bio-
transformation products are dichlorodiphenyldichloroethylene (DDE) and 
dichlorodiphenyldichloroethane (DDD). DDT was initially used in public health control 
of lice and malaria mosquitoes during the Second World War and afterwards it was used 
as pesticide in agriculture. Globally DDT production was ~1.8 million tonnes since 
1940s (ATSDR, 2002) and more than 40,000 tonnes were used in agriculture annually 
(Geisz et al., 2008). It is estimated that 600,000 tonnes of DDT were used domestically 
in USA 30 years prior to its ban. Over 80% of the quantity of the pesticide used in 
1970–72 was applied to cotton crops and the remainder was used on peanut and 
soybean crops. The global production was reported to drop to 3,314 tonnes in 2009; the 
production is meant for use in control of malaria and leishmaniasis (UNEP, 2010a). 
Complex and variable mixtures of hexachlorocyclohexane (HCH) products are 
produced by photochemical chlorination of benzene. HCH exists in 9 stereoisomeric 
forms, which include (+)- and (–)-alpha- (α), beta- (β), gamma- (γ), delta- (δ), epsilon-
(ε), zeta-(ζ), eta- (η) and theta- (θ) isomers. Technical-grade HCH is comprised of 60-
70% α-HCH, 5–12% β-HCH, 10–15% γ-HCH, 6–10% δ-HCH, and 3–4% ε-HCH. 
Purified HCH isomers, as well as technical-grade HCH are used either as fungicides or 
in the synthesis of other chemicals. 
Lindane (γ-isomer) was used as seed treatment for barley, corn, oats, rye, sorghum and 
wheat to protect seeds for sowing from moulds and ants during storage before sowing 
and in the ground before sprouting. The estimation of global production between 1950 
and 2000 was 600,000 tonnes and the majority was used in agriculture. In the past, γ-
HCH was also used in veterinary products to control mites, lice and other pests, but 
recent data suggest that no products are currently registered, at least in the United States 
for this use. It was also used as an insecticide to treat fruit, vegetables, forest crops, 
animals and animal premises. It is also currently used in treatment of scabies and lice in 
humans in form of lotion, cream or shampoo, especially in tropical countries. β-HCH 
was widely used on cotton plants during 1960s and 1970s. 
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Hexachlorobenzene, a fully chlorinated aromatic hydrocarbon, was widely used as 
fungicide. Some amounts of HCB are formed as a by-product during the manufacture of 
solvents and other pesticides. The chemical was also used to make fireworks, 
ammunition and synthetic rubber. Small amounts can be produced by burning of city 
wastes. Its environmental half-life in soil and in air is of approx. 3–6 years and 0.63–
6.28 years, respectively (ATSDR, 2002). In human the half-life of HCB is thought to be 
extremely long in the range of 6 years (To-Figueras et al., 2000). 
Endosulfan is synthesized via Diels-Alder addition of hexachloro-cyclopentadiene and 
cis-butene-1,4-diol in xylene. The annual production is estimated to range between 
18,000 and 20,000 tonnes worldwide (UNEP, 2010b). In USA, 400 tonnes are estimated 
to be used annually for domestic purpose. The main uses include control of pests in 
vegetables, fruits, cereal grains and cotton, ornamental shrubs, trees, vines and 
ornamental plants. It was also used to control ectoparasite on beef and lactating cattle. 
In Africa it is commonly used in cotton production at a dose rate between 1,000 to 
2,000 g/ha while in India it is used to control pests on cashew plantations at the dose 
rate of 1,200 g/ha. The estimated annual production in India is 9,500 tonnes, of which 
4,500 to 5,000 tonnes are consumed domestically. 
These OCPs can constitute a source of health risk (ATSDR, 2005; Mrema et al., 2012b; 
Porta et al., 2008; UNEP, 2003; WHO, 2003). In experimental models, DDT isomers 
are capable of inducing alterations on reproduction and development due to their 
hormone-altering actions. o,p'-DDT has the strongest estrogen-like properties, p,p'-DDE 
has anti-androgenic properties. The hormone disrupting properties of o,p'-DDD 
(mitotane) lead to be used as anticancer drug for adrenocortical carcinoma. All HCH 
isomers can produce liver and kidney effects (ATSDR, 2005). In humans the most 
sensitive target organs of HCB are the liver, the ovary and the central nervous system 
(ATSDR, 2002). 
The International Agency for Research on Cancer (IARC) has classified DDT, all HCH 
isomers and HCB as possibly carcinogenic to humans under group 2B (IARC, 1987, 
1991). Apart from cancer risk, or possibly as one causal mechanism of OCP-triggered 
cancer, the endocrine disruption activity of these substances deserves attention. In 
particular, DDT isomers are capable of inducing alterations on human reproduction and 
development due to their hormone-altering actions. For instance, o,p'-DDT isomer has 
the strongest estrogen-like properties (ATSDR, 2002) whereas p,p'-DDE has anti-
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androgenic properties which has been shown to alter the development of reproductive 
organs when administered perinatally to rats (Gray et al., 2001). 
Ubiquitous presence of DDT in human tissues has been demonstrated in hundreds of 
studies, most of which are collected and reviewed in monographs by United Nations 
(UN) agencies (IARC, 1991; ATSDR, 2002). The human specimens most commonly 
used for OCPs measurement are blood (serum), but also visceral and female breast 
adipose tissue from autopsies and from living subjects. 
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Figure 1.2. Molecular structure of phenobarbital (a prototypic CYP2B inducer) and the OCPs listed 
in the annexes of the Stockholm Convention. 
14 
1.2 Literature Review 
1.2.1 Food as a Main Source of Exposure to POPs 
People are exposed to POPs in several ways including inhalation, ingestion and skin 
contact. Inhalation and skin contact are the main routes of exposure in occupation 
settings. Other exposures occur through accidents like the explosion which occurred at a 
pesticide manufacturing plant in Seveso, Northern Italy in 1976 which exposed people 
to a large amount of dioxin (Mori and Todaka, 2011). Accidental exposure to PCBs and 
PCDFs was reported in Japan in 1968 and Taiwan in 1979 due to consumption of rice 
bran oil contaminated with PCBs that was used as a heat transfer medium in the 
manufacture of the oil. This led to the disease conditions known as Yusho, in Japan, and 
Yu-Cheng, in Taiwan (Aoki, 2001; Kuratsune et al., 1987; Rogan et al., 1988). 
In people of general population, diet accounts for at least 90% of the total exposure to 
OCs (Duarte-Davidson and Jones, 1994; De Felip and Ingelido, 2008; Bilau et al., 2008; 
Turci et al., 2010b). As a consequence of widespread environmental contamination and 
biomagnification along the food chain, OCs are present in foods at levels which show 
significant variability among world countries and among different areas within 
individual countries, in particular in areas previously or currently used for intense 
agricultural activities and high levels of pesticide application. The dietary intake thus 
varies between countries and between populations groups within countries, as 
exemplified by the – data reported in Tables 1.3 and 1.4. 
Table 1.3. Estimated dietary intake in nanograms per day (ng/day) of some POPs through 
seafood consumption by the general population of different countries (data 
adopted from Moon et al. (2009) and references therein). 
Country PCBs DDTs CHLs HCHs HCB Authors 
Indonesia 810 1100 10.0 18.0 10.0 Sudaryanto et al. (2007) 
China 110 882 14.4 28.2 11.4 Yang et al. (2006) 
Sweden 349 256 87.0 35.0 36.0 Darnerud et al. (2006) 
Italy – 197 – 13.0 4.6 Stefanelli et al. (2004) 
Spain – – – – 12.4 Falcó et al. (2008) 
South Korea – 270 13.0 2.1 11.0 Moon et al. (2009) 
Keys: Total PCBs, ∑PCB 8, 18, 28, 29, 44, 52, 87, 101, 105, 110, 118, 128, 138, 153, 170, 180,187, 194, 195, 
200, 205, 206; Total DDTs, ∑p,p′-DDE, p,p′-DDD, p,p′-DDT, o,p′-DDD; CHLs, ∑oxy-chlordane, trans-
chlordane, cis-chlordane, trans-nonachlor, cis-nonachlor; Total HCHs, ∑α-, β-, γ-HCH. 
WHO reported the highest dietary intake of DDT in developing countries whereas 
Codex Alimentarius reported the highest estimation of lindane intake via food in Europe 
with a theoretical maximum daily intake of 0.742 mg, or 12 times the ADI. It has been 
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noted that due to the globalization of food trade almost all countries in the world may be 
subject to the impacts of POPs (Kaloyanova-Simeonova). 
Table 1.4. Total DDT intake compared with the PTDI (Source: WHO, 
2003). 
Country Year Daily intake (ng/kg b.wt) % of PTDI 
Australia 1980 0.390 3.9 
 1987 0.026 0.26 
Egypt 1988 13.700 137.0 
Finland 1984 0.041 0.42 
 1986 0.026 0.26 
Guatemala 1982 0.260 2.6 
 1984 0.200 2.0 
 1985 0.065 0.66 
 1988 0.031 0.32 
India 1981 3.900 39.0 
 1983 3.600 36.0 
Japan 1980 0.056 0.56 
 1982 0.070 0.74 
 1984 0.030 0.3 
 1986 0.020 0.2 
 1988 0.020 0.2 
Netherlands 1984 0.004  
 1985 0.004 0.04 
New Zealand 1982 0.003 0.03 
Switzerland 1983 0.03 0.3 
Thailand 1980 1.600 16.0 
 1987 0.0008 0.008 
United Kingdom 1980 0.050 0.5 
 1981 0.035 0.36 
 1985 0.05 0.5 
United States 1980 0.360 3.6 
 1982 0.033 0.34 
 1985 0.036 0.36 
 1986 0.019 0.2 
Abbreviations: ADI, acceptable daily intake (0–0.02 mg/kg b.wt) (FAO/WHO 
1984); PTDI, provisional tolerable daily intake (0–0.01 mg/kg b.wt) (FAO/WHO 
2000). 
Most food contamination occurs in meat and meat products, fish, milk and dairy 
products (Zuccato et al., 1999). Deposition of airborne OCs on pasture is considered the 
primary pathway from which these pollutants enter the food chain, although in regions 
with highly contaminated soil, green vegetables may significantly contribute to human 
exposure. Food-producing animals accumulate OCs into the adipose tissue through 
ingestion of contaminated pasture or the feed derived from contaminated fatty materials. 
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OCs are thus transferred to animal milk and enter into human diet through milk and 
dairy products. 
In the past phenoxyacetates, widely used herbicides were found to be contaminated by 
dioxin. In particular the formulation containing 2,4,5–trichlorophenoxy acid (2,4,5–T) 
was found to be contaminated by 2,3,7,8–tetrachlorodibenzo-p-dioxin (2,3,7,8–TCDD). 
This caused episodes of significant environmental contamination where the highest 
levels were observed in 1970s, when phenoxy herbicides found high levels of use in rice 
crops. Deliberate dispersion of unwillingly contaminated phenoxy herbicides had also 
occurred e.g. Agent Orange in South–Eastern Asia which was used by the U.S. military 
as part of its chemical warfare program. 
Although fish and sea food is a small fraction of human diet, it is a major route of 
exposure for arctic populations who live on marine mammals, which are at the top of 
the marine trophic network (Bonde et al., 2008). Low level of PCB intake from nine 
fish meals per month has been shown to exceed the tolerable monthly intake and thus 
can pose risk for human health (Carubelli et al., 2007). Fish and other seafood have 
shown to represent principal means of contamination (Binelli and Provini, 2003). A 
significant association between levels of PCBs, DDT and DDE in human plasma and 
fish consumption was demonstrated and thus it was suggested that fish were the major 
source of exposure to these compounds among Swedish population (Asplund et al., 
1994; Svensson et al., 1991). The study conducted by Fitzgerald et al. (2006) showed 
that a mono-ortho congener PCB 74 was related to rates of fish consumption among 
Native American population. In Sweden consumption of fatty fish from Baltic Sea 
represent a major source of PCBs, DDT and its metabolite p,p'-DDE. PCDDs/Fs and 
PCBs have been detected in home-produced eggs in Begium where they presented at 
levels of health concern for the consumers. Soil was the source of contamination by 
these chemicals (Van Overmeire et al., 2009). 
Intensive harvesting of Manila Clam and fishing in lagoon of Venice, Italy, was shown 
to present a risk to human health which was evidenced by presence of POPs in mother 
milk and blood serum of Venetians with different work exposure and food habits. This 
lagoon was reported to receive discharges of POPs such as polychlorinated biphenyls 
(Raccanelli et al., 2009). In 2008 Fattore et al. estimated the dietary intake of NDL–
PCBs among Italian general population to be 24.6, 16.1 and 10.9 ng/kg-b.wt/day for 
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toddlers, children and adults, respectively. Fish and fishery products, milk and milk 
products were the major contributors. 
Unlike other studies, Abballe et al. (2008) failed to establish correlation between NDL–
PCB in human milk with fish-rich diet. The author thought that the inconsistency could 
be due to inverse correlation between consumption of fish and dairy products. However, 
the study showed the increase in PBDE 153 concentration with increase in fish 
consumption. 
 
Figure 1.3. Sources and pathways of persistent organic pollutants to human exposures. 
Human exposure of POPs can be well reflected in their presence in biological 
compartments such as human breast milk, hair, adipose tissue, breast fatty tissue and 
blood. Hence measuring the levels of POPs in these compartments provides a direct 
measure of the internal dose of these chemicals, to establish the relationship between 
these exposures and their health effects. Human breast milk analysis is limited only to 
lactating women. Measurement is usually performed in blood serum or in body fat, 
which are the transport and storage compartments of highly lipophilic compounds, 
respectively. 
Blood is the least invasive and is the most easily accessible human specimen for such 
measurements. Adipose tissue specimens can only be obtained at autopsy (where 
detailed information can seldom be obtained) and from major surgery, for which ethical 
issues are highly prioritized. Stellman et al. (1998) showed that analysis of PCBs in 
either serum or adipose tissue provides comparable information on body burden. In their 
study they observed significant positive serum to adipose correlation for most analyzed 
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PCB congeners. Human hair is currently evaluated as an attractive matrix for 
measurement of inorganic and organic persistent pollutants since it is not invasive, 
easily available and inexpensive (Schramm, 2008). However, there are still limitations 
which prevent to use it as a valid monitoring tool for risk assessment. For these reasons 
in our study we measured the level of these pollutants in blood serum. 
1.2.2 Relevant ADME Characteristics 
Absorption. When organochlorine-contaminated food is consumed, OCs contaminants 
are rapidly absorbed since most of the OC pool is contained in the fatty fraction of food. 
When fat tissue is disrupted during cooking and by the digestion process of food, the 
OCs are readily absorbed from the small intestine and distributed by the blood 
circulation throughout the body. In vegetable crops, most of the very little content of 
OCs is embedded in the non-soluble fibre and lignin compartment and is only made bio-
available if such component of vegetable food is disrupted by probiotic gut microbioma. 
Since even highly degraded vegetable fibre still retains a high absorptive activity for 
small lipophilic organics, it is generally considered that OCs embedded in the ligneous 
edible fraction of crop vegetables is eliminated with the stools. 
Distribution. Since OCs are strongly soluble in body lipids, they accumulate in body 
tissues with high lipid contents such as the adipose tissue, the brain, the liver, the kidney 
and the myocardium. Although they are excreted to some extent from the liver into the 
bile, most are reabsorbed in the entero-hepatic recirculation. Thus most POPs have long 
elimination half-lives and body burden can be detected in fat years after the last 
exposure. Thereafter a continuous exchange between blood and tissues takes place, 
especially when strong remodeling of fatty tissue takes place as, for instance, in fast 
leaning and starving conditions, in severe disease states and in breastfeeding. In 
pregnant women these chemicals cross the placenta to the foetus. In lactating women 
OCs are secreted into breast milk thus transferring the mother’s burden to the young 
through breastfeeding (Perera et al., 2005). 
Metabolism or bio-transformation. In humans and other ‘upper’ organisms, most of 
the minimal bio-transformation of POPs and elimination from the body takes place 
slowly through the liver-kidney axis and, although they are excreted to some extent in 
the bile and most are reabsorbed in the entero-hepatic recirculation, especially PCBs can 
undergo anaerobic biotransformation by the gut microbioma. 
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DDT has a half-life of approximately 3.4 years in adipose tissue (Maroni et al., 2000; 
Tordoir and van Sittert, 1994). DDE, a principal DDT metabolite, is more stable than 
DDT and is rarely excreted from the body but both are excreted in breast milk. Further 
hydroxylation of the chloro-phenyl ring system occurs in the positions ortho- to the 
chlorine atom (possibly by HO+ electrophilic substitution) and meta- to the chlorine 
atom (possibly by HO. radical mechanisms). Elaboration of the gem- dichloride (=CCl2) 
function of DDE leads to stepwise ipso-substitution of the chlorine atoms and finally to 
the dichlorophenyl-acetic metabolites (Figure 1.4). 
 
Figure 1.4. Proposed metabolic scheme of DDT in mammals (Source: Maroni et al., 2000). 
Dieldrin has a half-life of about 267 days in blood which is suspected to be shorter than 
those of heptachlor epoxide and α-, γ- and β- isomers of HCH (Maroni et al., 2000; 
Tordoir and van Sittert, 1994). Comparing these three HCH isomers, β-HCH is 
eliminated very slowly from the body and thus has a significant contribution to the total 
HCH body burden. Its half-life in human blood is estimated to be about 7.2 years (Jung 
et al., 1997). Half-life of HCB is thought to be extremely long in the range of 6 years 
(To-Figueras et al., 2000). 
PCB congeners have a half-life estimated between 4.6 to 41 years (Seegal et al., 2011). 
In aerobic organisms, such as humans, PCBs are metabolized by mono-oxygenation 
through the arene-oxide pathway catalyzed by P450 isoenzymes (Figure 1.5). Highly 
chlorinated PCB congeners are relatively poorly metabolized and thus can remain in the 
20 
body for long periods of time. Less chlorinated PCBs are more easily metabolized and 
excreted faster from the body (ATSDR, 2000). Some hydroxylated metabolites of PCBs 
were found to be 10 times as estrogenic as its parent PCB, and equal to natural estrogen 
in potency, as observed by Arcaro et al. (1999). 
 
Figure 1.5. Proposed metabolic scheme of PCBs (Source: Safe, 1993 with some modifications). 
Prolonged half-lives in the body have some exceptions: for example, estimated half-life 
of endrin is 24 hours while that of lindane and chlordane is between 10–20 days. Aldrin 
is readily metabolized to dieldrin so that residues are rarely found in food and animals 
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(Maroni et al., 2000; Tordoir and van Sittert, 1994). Thus accumulation degree depends 
on metabolic rate where slowly metabolized OCs exhibits the highest accumulation rate 
and persists in the tissues for long periods of time. 
Elimination. The major route of excretion of unmodified PCBs is through faeces, while 
the minor fraction of hydroxylated and conjugated metabolites is eliminated with the 
urine (ATSDR, 2000). Excretion of PCBs via the milk in humans is generally minor in 
comparison to faecal and urinary excretion (Shibamoto and Bjeldanes, 2009). 
1.2.3 POPs concentrations in various body compartments 
Organochlorine compounds are routinely detected as they are widely distributed in the 
environment and they accumulate in food chain. As stated in Section 1.1 some 
organochlorine compounds such as DDT are still being used for agriculture and public 
health programs especially in developing countries. As a result people in these regions 
are still heavily exposed to these chemicals. Due to Long-Range Transboundary Air 
Pollution (LRTAP) effects and globalization of food trade, people in regions where 
these chemicals are not used are also exposed. The relative high levels have been found 
in human tissues and diet has been considered to be a major route of exposure as 
pointed out in Sub-section 1.2.1. In the subsequent sub-sections brief review of some 
studies is provided on the levels of POPs as measured in different body matrices and 
results are summarized in Table 1.5–1.7. 
Levels of POPs in Breast Milk 
Table 1.5 summarizes results of some studies which report the levels of OCs as 
detected in human breast milk in various countries. As pointed out earlier POPs are 
stored mainly in the adipose tissue; as such they can be easily excreted from mother to 
her new born via maternal milk. Zhao et al. (2007) measured levels of PCBs and OCPs 
in human milk from primiparous women residing in two regions with different 
exposure. In the exposed region the maternal milk were highly contaminated with the 
measured PCB as compared to unexposed region. OCPs levels were comparable for 
both milk and food samples in the two regions suggesting different sources of these 
pollutants. The PCBs level in foods collected from these regions could therefore reflect 
the mothers’ exposure to these contaminants. Beta HCH and DDE are highly persistent 
thus account for their highest concentration observed in the milk. 
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The levels of PCBs detected among Iranian women were very high as compared to 
those from China. HCH was the major contributor to the total OCs burden in the human 
milk. There was a significant difference in DDT level between mothers who consumed 
one fish meal per week and those who consume more than one (Behrooz et al., 2009). 
Among Polish women DDT and DDE concentrations were slightly higher than in other 
European countries. Çok et al. (2009) showed lower level of PCB among Turkish 
women as compared to Eastern Europe and German women while Bake et al. (2007) 
found similar levels of PCBs and OCPs as observed in other European countries like 
Finland, Germany, Sweden, Denmark and Norway. 
Level of POPs in Adipose Tissue 
Adipose tissue levels of POPs are considered to be the best indicator for life time 
environmental exposure in human due to lipophilic characteristic of POPs. Adipose 
tissue levels of POPs are expected to be much higher than in other matrix such as 
serum. The accumulation in human adipose tissue and excretion via lactation 
emphasizes the presence of these chemicals in the breast tissue. Tan et al. (2008) 
reported a level which showed that food consumption has the most significant role to 
account for level of POPs in adipose tissue. Fish and poultry were the routes of PCBs in 
mothers in Singapore while beta HCH came mainly from vegetables. An age dependent 
accumulation of POPs was found for beta HCH and PCB congeners. Lactation and 
gestation function as decontamination process for PCBs in the adipose tissue. 
Shen et al. (2008) detected all twelve DL–PCBs and six PCBs indicators with total 
mean concentration of 32.2 and 154 ng/g lipids, respectively. PCB 105, 118 and 156 
were dominant among DL–PCBs whereas PCB 153 concentration was the highest of all 
indicator PCBs. No correlation was observation between age and the levels of 
contaminants. 
La Rocca et al. (2008) conducted a study to measure PCDDs/Fs and DL–PCBs among 
Italian obese subjects who underwent bariatric surgery to achieve weight loss. 
Abdominal adipose tissues were collected for analysis of these pollutants. The obese 
body burden was found to vary from 6 to 11 ng TEQkg-1 b.wt exceeding the estimated 
steady state body burden 5 ng TEQkg-1. The mean total DL–PCB was found to be 
32161 pg/g lipid. Linear regression revealed a positive correlation between total TEQ 
level and age (r2 = 0.83). In addition to OCPs and PCBs, Schiavone et al. (2010) 
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determined the levels of polybrominated diphenyl ethers (PBDEs), a new class of 
emerging POPs, which were found to range between 3.2 and 35.6 ng/g lipids in Italian 
adipose tissue. 
Levels of POPs in Blood Serum/Plasma 
Turci et al. (2006) determined the reference value of coplanar and non coplanar PCBs in 
blood serum collected from residents of two Italian cities; Novafeltria and Pavia. The 
mean values obtained for total PCB from these two cities were 2.48 and 3.93 µg/L 
respectively. Eight DL–PCBs were detected and the most abundant congeners were 
PCB 153, 138, 170 and 180. Age was shown to be a significant determinant of PCB 
concentration. Apostoli et al. (2005) assessed the reference values for PCBs level in 
serum of general population living in non-polluted areas in Brescia and found the mean 
total PCB of 5.15 ng/mL (~897 ng/g serum lipid). De Felip et al. (2008) observed an 
increased serum NDL–PCB body burden (430–470 ng/g lipid) among the two 55+ year 
age groups living in the vicinity of two incineration plants in Italy. These results are in 
agreement with the expected age-dependent increase. 
Fourteen PCB congeners and 13 OCPs were analyzed from the blood samples of 
mothers from eight circumpolar countries. Significant differences among the groups 
were observed which can be accounted by dietary preferences and different 
contaminants deposition pattern across Arctic (Van Oostdam et al., 2004). 
Jakszyn et al. (2009) determined serum levels of p,p′-DDT, p,p′-DDE, β-HCH and HCB 
among health adults in Spain. The concentrations of all OCPs were positively associated 
with age and body mass index. No association was found between OCPs levels and 
dietary factors. The concentrations of p,p′-DDE and β-HCH were higher in southern 
regions while HCB levels were highs in the northern regions. These higher levels in the 
two regions were thought to be due to intensive past use of pesticides related to 
agricultural practices or industrial use, respectively. 
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Table 1.5. The mean concentration (ng/g fat) breast milk organochlorine compounds (OCs) in various countries. 
Country  Region Year of Sampling PCBs DDT HCHs HCB Reference 
Italy Venice  1998–2001 6.87
d,n
 304n,e – 38n Abballe et al. (2008) 
Rome 1998–2001 6.81d,n 484n,e – 51n Abballe et al. (2008) 
Latvia Olaine 2004 141.85a 194h 53.5k 25.5 Bake et al. (2007) 
Poland Wielkopolska 2003 114.8c 1195f 20.0i 22.5 Szyrwiǹska and Lulek (2007) 
China  
Pingqiao 2003–2005 207.62l 1087.59h 256.93j 33.5 Zhao et al. (2007) 
Luqiao 2003–2005 377.8l 1448.43h 267.59j 46.53 Zhao et al. (2007) 
Seoul and Ichon 1997 6.70l,m – – – Yang et al. (2002) 
Turkey 
Instanbul 2007 19462b,n – – – Çok et al. (2009) 
Afyon 2007 12947b,n – – – Çok et al. (2009) 
K.Maraş 2007 10698b,n – – – Çok et al. (2009) 
Antalya 2007 25038b,n – – – Çok et al. (2009) 
Ankara 2007 18659b,n – – – Çok et al. (2009) 
Iran 
Nour 2006 1818b 2680g 3005i 629 Behrooz et al. (2009) 
Nour (countryside) 2006 992b 1571g 2588i 690 Behrooz et al. (2009) 
Noushahr 2006 1306b 3563g 5742i 1078 Behrooz et al. (2009) 
Noushahr (countryside) 2006 1888b 2322g 4548i 1493 Behrooz et al. (2009) 
Czech Republic 
Prague 1999–2001 848c 792e 35.7k 256 Černá et al. (2010) 
Kolín 1999–2001 877c 636e 25.4k 263 Černá et al. (2010) 
Kladno 1999–2001 432c 386e – 119 Černá et al. (2010) 
Keys: a, ∑PCB 28, 101, 138, 153,180; b, ∑PCBs 28, 52, 101, 138, 153, 180; c, ∑PCB 28, 52, 101, 118, 138, 153, 180; d, ∑PCB 105 ,114 ,118 ,123 ,156 ,157 ,167,189, 194; e, ∑p,p'-DDT, 
p,p'-DDE; f, ∑p,p'-DDT, p,p'-DDE, p,p'-DDD; g, ∑p,p'-DDT, p,p'-DDE, p,p'-DDD, o,p'-DDE; h, p,p'-DDE; i, ∑α-HCH, β-HCH, γ-HCH; ; j, ∑α-HCH, β-HCH, γ-HCH, δ-HCH; k, β-HCH; 
l, primiparae; m, TEQ pg/g fat; n, pg/g. 
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Table 1.6. The mean concentration of adipose tissue OCs in various countries. 
Country Region Year of Sampling PCBs DDT HCHs HCB Reference 
Italy 
Northern Italy, Brescia 2006 374.4z,o 202.0z,x – 26.0z Bergonzi et al. (2009) 
Central Italy, Siena 2005–2006 1550z, 617z,r 2040z,t 73.9z,x 152z Schiavone et al. (2010) 
Italian obese population – 32161b,p – – 
– 
La Rocca et al. (2008) 
Singapore  2004–2006 67.8z,q  641.19z,u 188.19z,x 19.6z Tan et al. (2008) 
Japan Akita and Okinawa 1986–1988 – 2.4w,y 0.84a,y 
– 
Sasaki et al. (1991) 
USA Calfonia – – 20.9z,v –  Rappolt and Hale (1968) 
China Zhejiang Province 2006 154z,s, 32.8z,q – –  Shen et al. (2008) 
Keys: o, ∑PCB PCB 28, 31, 52, 74, 99, 101, 105, 114, 118, 123, 128, 138, 146, 153, 156, 157, 167, 170, 172, 177, 180, 183, 187, 189, 194, 196, 201, 203, 206, 209; p, ∑DL-PCB 77, 81, 105, 
114, 118, 123, 126, 156, 157, 167, 169, 189; q, ∑PCB 28, 31, 74, 99, 118, 132, 138, 153, 158, 180, 183, 187; r, ∑PCB 28, 52, 101, 118, 138, 153, 180; s, ∑PCB 28, 52, 101, 138, 153, 180; t, 
∑p,p'-DDE, o,p'-DDE, o,p'-DDT, p,p'-DDT o,p'-DDD, p,p'-DDD; u, ∑p,p'-DDT, p,p'-DDD, p,p'-DDE; v, ∑p,p'-DDE, DDT; w, p,p'-DDE; x, ∑α-HCH, β-HCH, γ-HCH, δ-HCH; y, β-HCH; z, 
ng/g fat; a, ppm; b, pg/g. 
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Table 1.7. The mean concentration of serum OCs in various countries. 
Country Region Year of Sampling PCBs DDT HCHs HCB Reference 
Italy 
Northern Italy, Brescia – 897j,c – – – Apostoli et al. (2005) 
Tuscany, Follonica 2005–2006 240j,e – – – De Felip et al. (2008) 
Novafeltria – 2.48k    Turci et al. (2006) 
Pavia – 3.93k – – – Turci et al. (2006) 
Spain North and South 1992–1996 – 934j,g 167.4h,j 379j Jakszyn et al. (2009) 
Canada Nunavik 1994–1997 262
d
 262f,i 5.1h,i 36j Van Oostdam et al (2004) 
Kitikmeot 1994–1997 181d 145f,i 9.6h,i 57j Van Oostdam et al. (2004) 
Finland Lapland 1994–1997 152d 63f,i 7.2h,i 20j Van Oostdam et al. (2004) 
Greenland Disco Bay 1994–1997 472d 436f,i 18h,i 80j Van Oostdam et al. (2004) 
Iceland Reykjavik 1994–1997 233d 118f,i 32h,i 41j Van Oostdam et al (2004) 
Norway Hummerfest, Kirkenes 1994–1997 175d 83f,i 8.1h,i 23j Van Oostdam et al. (2004) 
Russia Nikel, Kola Penninsulla 1994–1997 235d 464f,i 223h,i 63j Van Oostdam et al (2004) 
Sweden Kiruna Region, Lapland 1994–1997 225d 87f,i 9.2h,i 16j Van Oostdam et al. (2004) 
USA Alaska Barrow/North Slope 1994–1997 66d 122f,i 7.9h,i 28j Van Oostdam et al. (2004) 
Keys: c, ∑PCB 28, 31, 52, 77, 81, 101, 105, 114, 118, 123, 126, 128, 167, 138, 153, 156, 157, 169, 170, 180, 189, 194, 206, 209; d, ∑PCB 28, 52, 99, 101, 105, 118, 128, 138, 153, 156, 
170, 180, 183, 187; e, ∑PCB 28, 52, 101, 138, 153, 180; f, ∑p,p'-DDE, DDT; g, p,p'-DDE; h, β-HCH; i, µg/kg lipid; j, ng/g fat; k, ug/L. 
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1.2.4 Public Health Concerns regarding Persistent Organic Pollutants 
Due to their environmental persistence, the ability to travel long distances in the 
atmosphere and the tendency to accumulate in the food chain, especially in the fat 
component of foods of animal origin, POPs can constitute a source of health risk. 
Because most of them bioaccumulate and remain preferentially in fat, their long-term 
effects are still a matter of public health concern. They are condemned for adverse 
health effects as stated in Subsection 1.1.1. These effects can be elicited via a number 
of mechanisms among others include disruption of endocrine system, oxidation stress 
and epigenetic. However most of the mechanisms are not clear thus a number of studies 
are ongoing trying to elucidate them. 
1.2.5 Persistent organochlorinated pesticides and mechanisms of their toxicity 
In this section we report an overview on available information of possible mechanisms 
of toxicity of some selected OCPs, which is taken from our recently published review 
article (Toxicology 2012. doi:pii: S0300-483X(12)00412 
X.m10.1016/j.tox.2012.11.015). 
1.0 Introduction 
As pointed out earlier in Section 1.1 above, human exposure to persistent organic 
pollutants has been associated with various health effects. These effects can be elicited 
via a number of mechanisms among others include disruption of endocrine system, 
oxidation stress and epigenetic. The mechanism of action involves toxicokinetic and 
toxicodynamic processes, at several levels between chemical exposure and the 
endpoints at individual level. Variation within humans can affect the endpoint at any 
toxicodynamic and/ or toxicokinetic steps (Mortensen and Euling, in press). Direct, 
non/genomic mechanisms of toxicity involve perturbation of the homeostatic redox 
level(s) of biological compartments (oxidative stress) and consequent cellular death 
through apoptosis. Indirect, genomic mechanisms of toxicity involve permanent 
modification of the transcription of gene elements by interference at the epigenetic level 
of DNA functioning. 
Since little is known on the relationship among events that result in OCPs’ toxicity in 
humans (Mortensen and Euling, in press), a number of studies are currently ongoing to 
investigate mechanisms responsible for OCPs’ toxicity. A better knowledge on how 
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these compounds influence the development and progression of diseases is a crucial 
step towards addressing the emerging diseases and hence improving public health. In 
this review, we provide an overview on available information of possible mechanisms 
of toxicity of some selected OCPs and where possible a linkage is made to 
epidemiological data. We summarize findings of epidemiological studies and both in 
vitro and in vivo experimental studies (Tables 1.1R–1.3R). 
The main OCPs for which we review available information are dichlorodiphenyl-
trichloroethane (DDT) and its metabolites, hexachlorobenzene (HCB), beta-
hexachlorohexacyclohexane (β–HCH) and endosulfan. These chemicals have been 
employed in agriculture and in public health as insecticides and biocides for several 
decades as detailed previously. 
Table 1.1R. Summary for selected epidemiological studies showing the relationship 
between DDT/DDE exposure and related health effects. 
Author Effects 
assessed 
OCP 
measured 
OCP level 
(µg/L serum) 
OCP level (µg/g 
lipid serum) Results Ptrend 
Cohn et al. 
(2007) 
Breast cancer DDT Tertiles Tertiles OR, 95% CL  
<8.09 <1.1 1.00 0.01 
8.09–13.9 1.1–1.8  2.8 (1.1–6.8)  
>13.9 >1.8 5.4 (1.7–17.1)  
McGlynn et 
al. (2006) 
Liver cancer DDT – Quintiles OR, 95% CL  
<0.265 1.00 0.049 
0.265–0.382 1.3 (0.7–25)  
0.383–0.521 1.4 (0.7–2.6)  
0.522–0.787 1.4 (0.7–2.7)  
>0.787 2.0 (1.1–3.9)  
McGlynn et 
al. (2006) 
Liver cancer DDT 
adjusted 
for DDE 
level 
– Quintiles OR, 95% CL  
<0.265 1.00 0.0024 
0.265–0.382 1.5 (0.8–2.7)  
0.383–0.521 1.7 (0.9–3.3)  
0.522–0.787 1.4 (1.0–4.3)  
>0.787 3.8 (1.7–8.6)  
McGlynn et 
al. (2008) 
Testicular 
germ 
tumours 
DDE – Quartiles RR, 95% CI  
≤0.157 1.00 0.0002 
0.158–0250 1.01 (0.75–1.36)  
0.251–0390 1.00 (0.73–1.38)  
>0.390 1.71 (1.23–2.38)  
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2.0 Mechanisms of OCPs toxicity 
2.1 Endocrine activity 
The endocrine system controls, balances and produces hormones and modulates their 
actions in the body through a network of activation and repression pathways at multiple 
levels of synthesis, secretion, transport, binding, action or elimination of natural 
hormones. Steroid hormones are involved in cell development, metabolism, protein 
synthesis, behaviour, reproduction and development. These responses are elicited 
through binding of hormones to their specific receptors such as nuclear receptors (NRs). 
Among the members of NRs are estrogen receptors (ERs), androgen receptor (AR), 
progesterone receptor (PR), glucocorticoid receptor (GR), constitutive androstane 
receptor (CAR), rodent pregname X receptor (PXR), mineralocorticoid receptor and 
thyroid hormone receptors (TRs). Aromatic hydrocarbon receptor (AhR) is a key 
regulator of the cellular response to xenobiotic exposure (Swedenborg et al., 2009). 
NRs and AhR are involved in the induction of xenobiotic metabolizing enzymes. 
In the absence of ligands NRs and AhR stay in the cytoplasm or in the cell nucleus in a 
complex form (Picard, 2006). In the presence of ligands, receptor-ligand binding occurs, 
followed by translocation of NRs/AhR to the nucleus. In the nucleus, a complex of aryl 
receptor nuclear translocator (ARNT) protein and co-activators is formed. The complex 
binds to the specific AhR-DNA recognition site and finally induces transcription of 
target genes. The ligand binding triggers conformational changes that lead to 
dissociation of the repressive complex, the recruitment of transcriptional co-activators 
and receptor dimerization (Hankinson, 2005). NRs homodimerize or heterodimerize 
with retinoid X receptor and AhR dimerizes with ARNT leading to gene transcription of 
NR or AhR target genes (Claessens and Gewirth, 2004; Swanson, 2002). NRs control 
transcription through binding to promoter regions of DNA. 
Several chlorine atoms in the molecular structures of OCPs impart their highly 
lipophilic character and fairly rigid conformation. The chlorine atoms are poorly 
reactive towards nucleophilic displacement and elimination reactions and thus their 
biotransformation and biodegradation reactions are limited and are mostly confined, 
albeit to poor yield, only to anaerobic environment of sludges, but seldom in 
mammalian organisms. As a consequence, their interaction with biological systems is 
mostly limited to agonistic or antagonistic binding to the intracellular receptors for 
which natural hydrophobic substances, such as steroid derivatives, are the endogenous 
30 
ligands. Agonistic binding leads to recruitment of coactivators and thus increases 
transcriptional activity while antagonistic binding prevents coactivator recruitment 
and/or attracts corepressors, leading to decreased transcriptional activity of the 
receptors. 
Many POPs including OCPs are known or suspected to be endocrine active. When 
present in the body they may interfere at several control points in the hormone signaling 
pathways. As a result, the response cascade of natural hormones can either be inhibited 
or excessively enhanced, at the wrong time, in the wrong tissue (Swedenborg et al., 
2009). Endocrine activity of OCPs can be due to direct binding with hormone receptors 
due to their conformational similarity with the receptor-binding portions of natural 
hormones, mainly of the steroid and diphenylether (thyroxine) structural groups. This is 
the case of aromatic polychlorinated substances such as DDT and its structural 
cognates, endosulfan and lindane. Other compounds indirectly alter hormonal pathway 
by directly inhibiting enzyme activities responsible for biosynthesis of the precursors of 
steroid hormones. In particular, the DDT analogue, mitotane, a pharmaceutical drug 
which is used to suppress cortisol production also causes a sharp raise in plasma 
cholesterol levels. 
2.1.1 Interference of OCPs in estrogen hormone metabolism 
17β-Estradiol is the main estrogen hormone, responsible for development of female sex 
characteristics such as growth of the breasts and suppression of body hair growth. 
Biotransformation of 17β–estradiol proceeds via two common metabolic pathways 
yielding catechol estrogen 2–hydroxyestrone (2–OHE), a weak estrogen; and 16α-
hydroxyestrone (16α–OHE), a fully potent estrogen. Enzymes CYP1A1, CYP1B1, 
CYP1A2 and catechol-O-methyltransferase (COMT) are responsible for this 
metabolism. 16α–OHE, but not 2–OHE increases unscheduled DNA synthesis, 
uncontrolled cell division and increased anchorage-independent growth. Interrupting 
these pathways might lead to formation of more potent products as exemplified by some 
xenoestrogens. Exposure of cell cultures of MCF-7 to concentrations as low as 10-5M of 
various OCPs such as DDT, lindane, chlordecone and endosulfan blocked the 2–OHE 
pathway and increase levels of 16α–OHE in estrogen positive (ER+) cells (Bradlow et 
al., 1995). This interference in estrogen biotransformation led to increasing 16α–
OHE/2–OHE ratio relative to the ratio in the untreated control cell cultures. This 
increasing ratio has been associated with breast and other cancers of animals (Telang et 
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al., 1992) (Figure 1.1R); possibly because of 16α-OHE has a strong estrogenic activity 
(Bradlow et al., 1995). Levels of 16α-hydroxylation have been found increased by about 
50% in human breast cancer as compared to control cases (Schneider et al., 1982). 
 
Figure 1.1R. Bifunctional pathways to breast cancer (BCA). Abbreviations: OHE, hydroxyestrone; ER, 
estrogen receptor; GJI, gap junction inhibition; 17β–HSD, 17 beta-hydroxysteroid dehydrogenase. 17β–
estradiol metabolites affect cell proliferation and BCA development either directly via receptor-
independent mechanisms involving structural/functional alterations in DNA, or indirectly via receptor-
dependent mechanisms involving phenotypic growth regulation. These mechanisms upregulate aberrant 
proliferation and development of BCA. Source: Adapted from Davis et al. (1998) with some 
modifications. 
CYP1A1 metabolizes estradiol and environmental contaminants into the corresponding 
hydroxylated derivatives through the highly reactive intermediates of arene-oxide 
connectivity (Hayes et al., 1996). The expression of CYP1A1 is regulated by the aryl 
hydrocarbon receptor (AhR), a ligand-dependent transcription factor that activates the 
transcription of target genes, such as CYP1A1, CYP1A2, CYP1B1 and oncogenes 
(Androutsopoulos et al., 2009b). DDT and its metabolites are capable of up regulating 
CYP1A activity (Van Tonder, 2011). According to Navas et al. (2004) CYP1A inducers 
have defined structures which make them capable of binding AhR. DDT has two 
aromatic rings linked by sp3 carbon and thus each of the rings can rotate along its single 
bond with the C2 carbon. This allows some degree of conformational mobility and in 
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principle the possibility to bind AhR but the rings cannot lie in the same plane, as in the 
estrogen molecules (Figure 1.2R). Lack of this molecular recognition motif greatly 
limits the affinity of AhR for DDT. In fact, the concentration of DDT employed in the 
Bradlow experiments is 10-5 M (10 µM), while the physiological concentration of 
steroid hormones such as estradiol is of at least four to six orders of magnitude lower 
(low-picomolar). On the other hand DDT and its metabolites as well as many other 
OCPs are known phenobarbital-type cytochrome P450 inducers as they have been 
shown to induce cytochrome P450 2B (CYP 2B) in rat liver or cultured rat hepatocytes 
(Campbell et al., 1983; Li et al., 1995; Lubet et al., 1990, 1992; Yoshioka et al., 1984). 
The enzyme activation upon exposure to these pesticides can thus lead to alterations in 
the endogenous levels of hormones and consequently compromise hormone signaling. 
In addition to xenobiotics metabolism, CYP1A1 has been shown to participate in the 
activation of dietary polyphenols (Androutsopoulos et al., 2008, 2009a) and it is 
inhibited by various polyphenolics (Androutsopoulos et al., 2010, 2011). 
 
Figure 1.2R. The 3D molecular structure of DDT showing diphenyl rings which are not within the same 
plane. 
2.1.2 DDT and its metabolites 
DDT and its metabolite DDE exhibit hormonal activity in various tissues with 
mechanisms involving the steroidogenic pathway, receptor mediated changes in protein 
synthesis or antiandrogenic and estrogenic actions. Most of their endocrine effects result 
from the ability to mimic 17β–estradiol. o,p′-DDT is a well characterized DDT isomer; 
its intracellular mechanism of action is mediated through the ER pathway (Steinmetz et 
al., 1996) described in Sub-section 2.1 of this review. It has been shown to bind and 
activate the ER, to promote the expression of estrogen-dependent genes and to induce 
proliferation of ER-competent cells such as breast cancer cells (MCF-7) in vitro (Soto et 
al., 1995). At 10 µM concentration, o,p′-DDT agonized both ERα– and ERβ–mediated 
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transcription a potency that is approximately 0.1% that of estradiol (Lemaire et al., 
2006). A significant dose-dependent increase in cell number in MCF-7 cell culture was 
observed starting at 10-8 M and maximum response achieved at 10-6 M (Steinmetz et al., 
1996). Enantiomer-specific estrogenic activity has been suggested (Hoekstra et al., 
2001; McBlain, 1987; Wang et al., 2009). At 5.26×10−5 M (S)-(–)-o,p′-DDT produced 
half of the maximum effect (EC50) whereas (R)-(+)-o,p′-DDT had negligible estrogen 
activity (Hoekstra et al., 2001). The (+)-enantiomer exhibited estrogen-like response 
only at an environmentally unrealistic concentration of 10−3 M, and thus estrogenic 
activity of o,p'-DDT is due to the (–)-enantiomer. 
Transient cotransfection assay of monkey kidney CV1 cells with human AR expression 
vector and a mouse mammary tumour virus promoter with a luciferase reporter vector 
revealed that androgen-induced AR transcriptional activity was inhibited by p,p'-DDE 
or by the potent antiandrogen, hydroxyflutamide at 0.2 µM (63.6 ppb) concentration. 
This level of p,p'-DDE is lower than 140 ppb found among residents living in DDT-
treated homes (Bouwman et al., 1991). In utero exposure to DDE has been shown to 
decrease anogenital distance (a morphologic quantitative indicator of feminization of 
male offspring) in male rat offspring, to increase retention of male nipple and to cause 
an alteration in expression of androgen receptor (Kelce et al., 1995) suggesting that 
these abnormalities might be mediated at the level of the androgen receptor. In addition 
to anti-androgen activity, p,p′-DDE can activate the ER and induce cell proliferation 
(Kelce et al., 1995). 17β-estradiol (1×10−8 M), o,p′-DDT (1×10−5 M) and β-HCH 
(1×10−5 M) similar showed gene expression profile of estrogen-responsive genes (i.e. 
TFF1, PR, ER, BRCA1 and CCND1) in MCF-7 cell line, while p,p′-DDE (1×10−5 M) 
was a weak transcriptional inducer (Silva et al., 2010). 
In adult mice p,p'-DDT induced a dose-dependent effect on estrogen receptor activity in 
liver, brain, thymus and prostate of a transgenic mouse strain (ERE-tkLUC). The same 
effect was caused by o,p'-DDT, except in the liver. This study showed that DDT 
isomers modulate ER activity also in nonreproductive organs (Di Lorenzo et al., 2002). 
At a dose known to interfere with animal fertility (50 µg/kg), o,p'-DDT significantly 
affected ER response. Treatment of rats with 50 or 100 mg/kg body weight p,p'-DDT 
(repeated doses for ten successive days) induced decrease in the number and motility of 
epididymal spermatozoa in a dose dependent manner and DDT induction of testosterone 
metabolism causing reduced testosterone levels (Ben Rhouma et al., 2001). The same 
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treatment led to increased thyroid hormones and to a decrease in serum T4 levels and 
hypothyroidism (Tebourbi et al., 2010). Given the very high doses used in the 
experiments, the results of this study are hardly comparable with effects forecasted at 
human environmental exposure levels. In fact, a cross-sectional study conducted among 
781 young men did not find association between DDE levels (median: 2.7 µg/g serum 
lipid; range 0.1–56.1 µg/g serum lipid) and anogenital distance (Longnecker et al., 
2007). Also a nested case-control study by Torres-Sánchez et al. (2008) among 37 
young men showed that higher DDE levels (10th–90th percentile: 0.21–5.89 µg/g serum 
lipid) significantly reduced the anogenital distance. A study by Bornman et al. (2010) 
on urogenital malformations in male newborns suggests increased rates of 
malformations among those whose mothers lived in DDT-treated homes. Although 
these studies do not provide sufficient information for determination of a quantitative 
risk to humans, biological plausibility is strengthened by animal findings (WHO, 2011). 
Cohn et al. (2007) conducted an epidemiological study and showed an association, with 
a dose response relationship, between DDT exposure and development of breast cancer 
when exposure is prepubertal. This was the case for the younger women (<14 years of 
age) in second and third tertile of exposure who had DDT exposure in their childhood 
[2nd tertile: 8.09–13.90 µg/l (~1.1–1.8 µg/g lipid), OR = 2.8, 95% CI, 1.1–6.8; 3rd tertile: 
>13.90 µg/l, OR = 5.4, 95% CI, 1.7–17.1]. McGlynn et al. (2006) found significant 
increasing risk of liver cancer among individuals with values in the highest versus the 
lowest quintile of serum DDT concentration (geometric mean = 0.49 µg/g lipids; OR = 
3.8; 95% CI, 1.7–8.6; p for trend = 0.0024) when analysis was adjusted for age, sex, 
hepatitis B surface antigen status, places of residence and DDE level. The lowest and 
the highest quintile of serum DDT concentrations were <0.265 and >0.787 µg/g lipids, 
respectively. However there was no evidence of significant association between liver 
cancer and serum DDE concentration (p = 0.51). McGlynn et al. (2008) showed an 
association between testicular germ cell carcinomas and DDE exposure (upper quartile: 
> 0.39 µg/g lipid, RR = 1.71; 95% CI, 1.23–2 38; Table 1.1R). 
Several epidemiological data showed an association between DDT exposure and 
miscarriage or preterm birth (Dewailly et al., 1993; Gladen et al., 2003; Karmaus and 
Zhu, 2004). To understand the involvement of the AhR/CYP1A1 pathway in the 
mechanism of action of DDT and DDE, Wójtowicz et al. (2011) used human placenta 
explants cultures originated from normal pregnancy and cotreated them with 3.2 ng/mL 
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TCDD and 1, 10 or 100 ng/mL (approx. 0.18, 1.81, 18.10 µg/g lipid) of p,p'-DDT, o,p'-
DDT, p,p'-DDE or o,p'-DDE for 24, 48 or 72 hours (these concentrations are known to 
occur in serum of pregnant women). Immunoblot analyses showed that the isomers of 
DDT and DDE inhibited the expression of CYP1A1 most effectively at 48 and/or 72 
hours after treatment. In a separate experiment to study the expression of AhR, the 
placenta explants were cultured in presence of these isomers at 100 ng/mL for 1, 3, 6, 
14, 24, 48 and 72 hours. The level of AhR protein decreased gradually with time 
starting after 3h of treatment in all treatment experiments, with exception of that with 
o,p'-DDE, where the decrease was delayed at 24 h after the start of the experiment. The 
author argued that as CYP1A1 is involved in metabolism and detoxification in the 
human placenta, any malfunction of this enzyme will disrupt the placental 
detoxification machinery. This may lead to an increased susceptibility of the foetus to 
environmental toxins and may be a risk factor for recurrent pregnancy loss. A cross 
sectional study conducted by Tsatsakis et al. (2009) among a Greek rural population, 
revealed a significant association between CYP1A1*2A polymorphism and 
miscarriages (p = 0.012). The investigated population had the median concentrations of 
6.3, 2.9, 81.5, 3.1, 7.1, 5.3, 3.2 and 19.7 pg/mg for α-HCH, HCB, lindane, o,p'-DDE, 
p,p'-DDE, o,p'-DDD, p,p'-DDD + o,p'-DDT and p,p'-DDT, respectively. The significant 
associations were also evident for other ailments such as chronic obstructive 
pneumonopathy (p = 0.045), peripheral circulatory problems (trend p = 0.042), arteritis 
(p = 0.022), allergies (trend p = 0.046), hemorrhoids (trend p = 0.026) and allergic 
dermatitis (p = 0.0016). Thus it was suggested that CYP1A1 may play a significant role 
in the incidence of several diseases among the population with long exposure to 
organochlorinated pesticides. 
2.1.3 Endosulfan 
Most studies investigating endosulfan estrogenicity in vitro show that its potency is 105 
to 106 times lower than that of estradiol (Table 1.2R; Arcaro et al., 1998; Soto et al., 
1994, 1995; Wade et al., 1997). Briz et al. (2011) showed that endosulfan directly 
interacts with ERs in primary cultures of cortical neurons (CN) and cerebellar granule 
cells (CGC). It inhibited the binding of [3H]–estradiol to the ER in both CN and CGC 
with a fairly high IC50 of 21.7 ± 4.2 and 35.0 ± 8.3 µM, respectively. These IC50 values 
are very close to that of α-endosulfan with recombinant human steroid receptors 
particularly hPR (20 µM) (Scippo et al., 2004). Exposure of endosulfan at 10 µM for 5 h 
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increased Akt phosphorylation and activated ERK1/2 through a mechanism involving 
GABAA and glutamate receptors in CN. The observed alterations on ER-mediated 
signaling and ER levels in neurons were suggested to contribute to the neurotoxicity of 
endosulfan. 
In vitro assay showed that endosulfan, dieldrin and lindane act as antagonists of 
androgen receptors (Andersen et al., 2002; Li et al., 2008; Nativelle-Serpentini et al., 
2003). Endosulfan and dieldrin were shown to inhibit the aromatase enzyme (CYP19); 
the rate-limiting enzyme of estrogen synthesis from the non-aromatic precursor 
androstenedione. Like other organochlorines, endosulfan and dieldrin alter the estradiol 
metabolism by inducing CYP1 enzymes (Badawi et al., 2000; Bradlow et al., 1995). 
Endosulfan and dieldrin were shown to inhibit androgen response at 20 µM and thus 
acted as very weak antiandrogens. At 50 µM endosulfan reduced the aromatase activity 
in human placenta microsomes to 87% of the control level (i.e.1 µM of 4-Androsten-4-
ol-3, 17-dione) and hence exhibited weak aromatase-inhibiting effect (Andersen et al., 
2002). 
In vitro assay shows that dieldrin (5 µM) and endosulfan (1 µM) significantly increase 
cell proliferation and ER transactivation gene response in MCF–7 cells (Andersen et al., 
2002). The maximum response occurred at 25 µΜ for both dieldrin and endosulfan. 
However, only endosulfan was shown to potentiate the 17β–estradiol induced 
proliferation when tested together with a concentration of 17β–estradiol causing a sub 
maximum response. Other authors have also shown the ability of endosulfan to promote 
MCF–7 cell proliferation in vitro (Grunfeld and Bonefeld-Jorgensen, 2004; Ibarluzea et 
al., 2004; Soto et al., 1994). However, there are no epidemiological studies linking 
exposure to endosulfan and increase of cancer risk in humans. In vitro studies 
examining the effects of endosulfan on androgen-responsive systems showed that 
endosulfan exhibited cytotoxic effects on testicular cells at a concentration of 20 µM or 
greater (Sinha et al., 1999, 2001). These doses are environmentally irrelevant. In vivo 
assays have not demonstrated estrogenic effects (Gellert, 1978; Raizada et al., 1991; 
Endosulfan caused alterations in testicular functions at very high doses. At doses of 2.5, 
5 and 10 mg/kg administered orally to adult Druckrey rats for 5 days per week for 70 
days, endosulfan was shown to increase testicular enzyme activities at all tested doses. 
Sperm count decreased in a dose-dependent manner (Sinha et al., 1995). 
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Table 1.2R. Summary of selected in vitro, in vivo and epidemiology studies on the endocrine effects of endosulfan. 
Author Study type Study sample/materials Effects investigated Observed effects 
Soto et al. (1994) In vitro MCF–7 cell culture Cell proliferation potential of pesticides Endosulfan was 106 times less potent than 17β-estradiol. Effects 
observed at doses of 10 µM endosulfan or greater. 
Soto et al. (1995) In vitro MCF–7 cell culture Relative binding affinity of pesticides Endosulfan hPR receptor binding affinity was 105 less than 17β-
estradiol 
Wade et al. (1997) In vitro MCF–7 cell culture Cell proliferation potential of pesticides Endosulfan was 105 less potent as compared to 17β-estradiol. Effect 
observed at the highest soluble dose. 
Sinha et al. (1999) In vitro Rat testicular cells in culture Cell viability and lactate dehydrogenase 
leakage 
Endosulfan produced cytotoxic change. Effects observed at 20 µM of 
endosulfan at or above. 
Sinha et al. (2001) In vitro Rat testicular cells in culture Activity of polyol pathway enzymes Increased aldose reductase activity and decreased sorbitol 
dehydrogenase activity at or >20 µM of endosulfan. 
Grunfeld and Bonefeld-
Jorgensen (2004) 
In vitro MCF–7 BUS cells Human ERα and ERβ mRNA expression Endosulfan decreased human ERα mRNA levels weakly with no 
effect on human EBβ expression. 
Li et al. (2006) In vitro MCF–7 cell culture Activation of MAPK, PI3-K, PKC, PKA 
and CaMKIV 
At 20–75 µM endosulfan activated P13-K and MAPK. The effect 
observed at 10 nM of 17β-estradiol and DES. 
Sinha et al. (1995) In vivo Adult Druckrey rats administered with repeat 
dose of endosulfan (0, 2.5, 5 or 10 mg/kg, 5 
days per week for 70 days) 
Testicular enzyme activities, sperm count, 
sperm morphology, and intra-testicular 
spermatid count 
Increased testicular enzyme activities at all doses tested; sperm count 
decreased in a dose-dependent manner; decreased spermatid counts 
and reduced daily sperm production at the two highest test doses was 
reported. 
Sinha et al. (1997) In vivo Weanling Druckrey rats administered with 
repeat dose of endosulfan (0, 2.5, 5 or 10 
mg/kg, 5 days per week for 90 days) 
Testicular enzyme activity, testes 
weights, sperm count, sperm abnormality, 
spermatid count and daily sperm 
production 
No observed effects on testes weights; increased levels of testicular 
enzyme activity; sperm count decreased in a dose-dependent manner; 
decreased spermatid count and sperm production rate. 
Raizada et al. (1991) In vivo Ovariectomized Wistar rats administered with 
repeat dose of endosulfan (1.5 mg/kg daily for 
30 days and injected daily with estradiol 1 
µg/rat i.p.) 
Organs weights, glycogen content of 
organs, and histopathological changes in 
organs 
No effects on weights of uterus, cervix, vagina and pituitary; no 
effects on glycogen content of the organs examined; no 
histopathological changes reported. 
Shelby et al. (1996) In vivo Mice administered with repeat dose of 
endosulfan on postnatal days 17–19 at a dose 
of 10 mg/kg 
Competitive binding of endosulfan to 
mouse estrogen receptor and uterine 
growth 
No competitive inhibition of estrogen receptor observed; no increase 
in uterine wet mass; DES and estradiol significantly affected uterine 
growth. 
Wade et al. (1997) In vivo 18 days rats injected with 3 mg/kg/day 
endosulfan daily for 3 days 
Uterine estrogen receptor binding Estradiol binding inhibited at high doses (105 M endosulfan); no 
change in uterine weights, uterine peroxidase activity or numbers of 
uterine estrogen and progesterone receptors. 
Saiyed et al. (2003) Cohort Male children lived in the village sprayed with 
endosulfan and children who lived in 20 km 
away from village 
SMR assessment; serum testosterone, LH, 
and FSH; and endosulfan residues in 
blood 
Sexual maturity delayed in the exposed population; controlled for age, 
only serum LH levels differed between the populations. 
Ibarluzea et al. (2004) Case–control Breast cancer women (cases) and non-cancer 
women (controls) 
Relationship between cancer diagnosis 
and the adipose pesticides. 
Endosulfan residues were not associated with increased risk of breast 
cancer 
Abbreviations: PI3-K, phosphatidylinositol-3-kinase; PKC, protein kinase C; PKA, protein kinase A; CaMKIV, calcium calmodulin-dependent kinase IV; AI, apoptotic index; MCF–7, Michigan Cancer Foundation-7; 
SMR, sexual maturity rating; LH, luteinizing hormone; FSH, follicle stimulating hormone; i.p, intraperitoneal injection; ER, estrogen receptor; hPR, human progesterone; DES, diethylbestrol. 
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Similar study conducted for 90 days using weaning Druckrey rats yielded similar results 
where spermatid count and sperm production rate decreased (Sinha et al., 1997). 
Repeated dose of 3 mg/kg/day of endosulfan administered to immature rats for 3 days 
caused no change in uterine weights, uterine peroxidase activity, or numbers of uterine 
estrogen and progesterone receptors. Only at a high dose (10 µM) endosulfan inhibited 
estradiol binding (Wade et al., 1997) as was in the case for in vitro studies discussed 
above. 
Exposure of adult rats to 2.5, 5 or 10 mg/kg endosulfan for 10 weeks (5 day per week) 
or 3, 6 or 1000 mg/kg b.wt/day endosulfan have shown to cause reduction in 
intratesticular spermatid counts, sperm abnormalities, and changes in the marker 
enzymes of testicular activities, such as lactate dehydrogenase, sorbitol dehydrogenase, 
γ-glutamyl transpeptidase, and glucose-6-phosphate dehydrogenase (Khan and Sinha, 
1996; Sinha et al., 1995). Moreover exposure of pregnant rats to endosulfan at 1 mg/kg/ 
day from day 12 through parturition has shown to decrease spermatogenesis in offspring 
(Sinha et al., 2001). It should be noted that these doses are orders of magnitude higher 
than those to which humans are usually exposed in the living environment and at the 
workplace. 
Limited human data exist on the effect of endosulfan. A cohort study conducted by 
Saiyed et al. (2003) among male school children (10–19 years old) showed that 
endosulfan exposure was associated with delayed male sexual maturity and interfered 
with the male sex-hormone synthesis. Sexual maturity rating (SMR) scoring for 
development of pubic hair, testes, penis and serum testosterone level was positively 
related to age and negatively related to aerial exposure to endosulfan (AEE; p < 0.01). 
Serum LH levels were significantly positively related to AEE after controlling for age 
(p < 0.01). Serum endosulfan levels were significantly higher (p < 0.001) in the exposed 
population (mean 7.47 ± 1.19 ppb) than controls (1.37± 0.40 ppb). Moreover, a big 
proportion of exposed group (78%) had detectable serum endosulfan as compared to 
29% of the controls. Although these findings match those expected on the basis of 
experimental evidences, nevertheless, it was not clear if endosulfan was the only 
chemical that could be linked to the observed associations. 
Several cellular and molecular mechanisms of endosulfan toxicity have been proposed. 
These include mitochondrial dysfunction, induction of oxidative stress, modulation of 
activities of stress-responsive signal transduction pathways, activating protein-1(AP-1) 
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and antioxidant response element (ARE)-mediated transcription. Recently a model has 
been proposed in which endosulfan is shown to increase extracellular signal regulated 
kinases (ERK) 1/2 and p38 activities and, in turn, these proteins activate mitogen-
activated protein kinases (MAPKs) and increase c-Jun phosphorylation. Phosphorylated 
c-Jun, in turn, increases AP-1 activity, which results in activation of ARE-mediated 
transcription (Song et al., 2012). However, at the moment no firm conclusion can be 
drawn on these proposed mechanisms. 
2.1.4 Hexachlorobenzene 
Hexachlorobenzene is well known to induce porphyria through a free-radical generation 
mechanism (Mazzetti et al., 2004), due to its rather unique chemical characteristics of 
lipophilicity and possibly to conversion into the redox-active tetrachloro-1,4-
benzoquinone. HCB is a weak agonist of the AhR protein (Hahn et al., 1989). The most 
sensitive target organs are the liver, the ovary and the central nervous system (ATSDR, 
2002). Unlike estrogen, HCB does not have a significant affinity for the ER thus 
suggesting other intracellular pathways than the one taken by endogenous estrogen in 
mediating these actions. 
HCB can elicit tumorigenic activity through AhR-dependent and independent pathways. 
In vivo administration of HCB has shown to induce alterations in insulin-like growth 
factors (IGFs) signaling pathway in mammary gland and mammary tumors in rat only 
when co-administered with N-nitroso-N-methylurea (Randi et al., 2006). Since the latter 
compound is a strong mutagen, HCB plays the role of a tumor cocarcinogen in rat 
mammary gland, as an inducer of cell proliferation and of c-Src kinase activity in MCF-
7 breast cancer cells. 
Garcia et al. (2010) used ERα (+) MCF-7 and ERα (-) MDA-MB-231 cell lines to 
investigate ability of HCB to promote cell proliferation and alter Insulin/IGF-I signaling 
pathway. At 0.005 and 0.05 µM, HCB significantly increased the proliferation of only 
MCF-7 cell lines, with no effect at 0.5 and 5 µM. In estrogen-depleted medium, HCB 
stimulated proliferation of MCF-7 cells only at the lower concentrations showing that 
the effect of HCB on cell proliferation was not dose responsive. Thus HCB stimulates 
proliferation in estrogen-sensitive cells in an ERα-dependent manner. At 0.005 and 0.05 
µM, HCB increased the level of IGF-IR and IR in ERα (+) MCF–7 cell line. However 
at 0.5 and 5 µM, HCB did not alter the level of these receptors but increased CYP1A1 
gene expression and induced apoptosis in MCF-7 cell lines, suggesting HCB effect on 
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apoptosis is AhR-dependent. At 0.005 and 0.05 µM of HCB did not induce the 
expression of CYP1A1 mRNA. On the other hand 0.005 µM of HCB led to c-Src 
activation signifying this effect is not AhR-dependent. At 0.005, 0.05, 0.5 and 5 µM, 
HCB increased IRS-1 phosphorylation with no effect in IRS-1 protein levels. IGF-I 
receptor is known to regulate proliferation, survival and differentiation in mammary 
gland. Insulin-like growth factor-insulin receptor (IGF-IR) pathway is involved in 
development of breast cancer and IR content is known to increase in human breast 
cancer whereas IRS-1 is the main intracellular substrate activated by IGF-I and insulin 
in human breast cancer cells. c-Src can promote growth of tumor cells, participating in 
or augmenting mitogenic signaling pathways that are initiated by extracellular growth 
factors or intracellular oncogenes (Biscardi et al., 2000). As per authors’ point of view, 
these results give a clue to the molecular mechanism of HCB in breast cancer 
development. 
To investigate the effects of HCB, Pontillo et al. (2011) showed that at 0.05 µM HCB 
produced an early increase of c-Src, human epidermal growth factor receptor (HER1) 
activation, signal transducers and activators of transcription (STAT) 5b, ERK1/2, but 
not Akt, in ERα (-) MDA-MB-231 cell lines in a dose-dependent manner (0.005, 0.05, 
0.5, and 5 µM). 
Young rats (65 days of age) were administered 100 mg/kg b.wt of HCB three times a 
week (total dose of 1800 mg/kg b.wt over 45 day period) (Peña et al., 2012). When the 
test animals reached oestrous phase they were sacrificed. In mammary glands, HCB 
increased c-Src and HER1 activation, c-Src/HER1 association; and STAT5b and 
ERK1/2 phosphorylation. Moreover HCB enhanced ERα phosphorylation and ERα/c-
Src physical interaction. In tumours, HCB induced c-Src and HER1 activation, c-
Src/HER1 association, as well as Akt and STAT5b phosphorylation. Additionally, HCB 
increased ERα protein content and decreased p-ERα levels and ERα/c-Src association. 
HCB increased serum 17-β estradiol and prolactin contents and decreased progesterone, 
FSH and LH levels in rats without tumours. This might be a consequence of a negative 
feedback on the pituitary hormones secretion, by E2. The opposite effect was observed 
in rats with tumors. These results indicate that HCB induces an estrogenic effect in 
mammary gland, increasing c-Src/HER1 and ERα signaling pathways. HCB stimulates 
c-Src/HER1 pathway, but decreases ERα activity in tumors, appearing to shift them 
towards a higher malignancy phenotype. The enhanced c-Src and HER1 activation 
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could be associated to the increase in the hyperplasia found in the mammary gland and 
the higher malignancy observed in tumors (Peña et al., 2012). The synergism between 
c-Src and HER1 serves to upregulate the mitogenic activity of HER1 downstream 
effectors involved in tumorigenesis (Biscardi et al., 2000). However, the very high 
doses tested significantly affect the relevance of this information for human 
environmental and occupational risk assessment. 
2.1.5 β-Hexachlorocyclohexane 
This isomer of HCH has all chlorine atoms in an equatorial position, and thus (a) while 
it lacks aromatic character, its molecular shape is more similar to that of strictly planar 
hexachlorobenzene than those of all other isomers and (b) it lacks any axial chlorine 
atom(s) which can be the site for 1,2-elimination by chemical mechanisms (Figure 
1.3R). This is one reason why this isomer shows a higher bioaccumulation (half-life in 
human body of about 7.2 years) and a higher bioaccumulation factor of 5274 as stated 
earlier. Since this isomer is eliminated very slowly from human body, it makes a 
significant contribution to the total HCH body burden. 
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Figure 1.3R. 3D molecular shapes of: (A) beta-hexachlorocyclohexane (β-HCH or 
1,2,3,4,5,6-HCH [1α,2β,3α,4β,5α,6β]); (B) hexachlorobenzene (HCB) (Plots by 
ACDLabs/3D, Advance Chemistry Development, 2007). 
β-HCH (1µM) has mitogenic activity in MCF–7 cell lines in vitro (Coosen and van 
Velsen, 1989) but not in ERα-MDA-MB231 cell lines which express a non-functional 
ER (Steinmetz et al., 1996). This result indicates that a functional ER is necessary to 
elicit the mitogenic activity. 
In vivo assay with mouse xenograft showed that 10-8 M β-HCH significantly increased 
MCF-7 cell number and at 10-5 M maximal responses were achieved (Steinmetz et al., 
1996). Moreover β-HCH increased pS2 gene mRNA level. Like HCB, β-HCH does not 
compete with estradiol for binding to the ER (Coosen and van Velsen, 1989; 
Hatakeyama et al., 2002; Steinmetz et al., 1996). Its chemical structure characteristics 
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may not allow binding the classical ligand binding domain and thus fail to activate ER 
in the nucleus, but it shows affinity to the alternative pocket and consequently triggers 
the Src/Ras/ERK pathway (Silva et al., 2010). Although unable to bind the ER, β-HCH 
is capable of activating ER target genes and the proliferation of estrogen-responsive cell 
lines (Silva et al., 2007; Steinmetz et al., 1996) by other chemical and biochemical 
mechanisms. 
Treatment of MCF-7 cells with 1×10−5 M β-HCH resulted in strong activation of the Src 
kinase, ERK1 and ERK2. Thus β-HCH has been shown to induce rapid and sustained 
Src/ERK signalling in MCF-7 cell lines lasting for at least 30 min, while this pathway 
was not significantly affected by p,p′-DDE (Silva et al., 2010). Hatakeyama et al. 
(2002) observed similar activation of ERK1/ERK2 by β-HCH. 
In epidemiological study Mussalo-Rauhamaa et al. (1990) found that β-HCH frequently 
occurs in breast fat of breast cancer patients with mean concentration of 0.13 ± 0.06 
mg/kg fat. Controlling for age and parity, β-HCH remained a significant risk factor 
(OR, 10.51; 95% CI, 2.00–55.26). The cutoff point for the residue level in breast 
adipose tissue was > 0.1 mg/kg fat. 
2.2 Oxidative stress, apoptosis and OCPs’ toxicity 
Apoptosis is the mechanism whereby damaged or unnecessary cells are naturally 
eliminated without causing damage to the surrounding tissue (Ameisen, 1996). This 
effect is accomplished by a partial, yet exhaustive digestion of cell structures (DNA, 
structural proteins, enzymes and lipids) prior to rupture of the cell membrane and 
release of products in the extracellular medium for clearance. When apoptosis is 
excessive or inappropriate, incomplete or insufficient, defections trigger pathological-
related condition such as immunodeficiency, autoimmunity diseases, cancer (Alison and 
Sarraf, 1995; Gougeon et al., 1996) and reproductive anomalies, such as those due to 
abnormal spermatogenesis (Allan et al., 1992). 
Oxidative stress, i.e., a shift of the cell redox balance towards a more oxidative (more 
negative) value of the electrochemical potential with respect to that of the relevant cell 
phase, is one main trigger in the induction of apoptosis (Kannan et al., 2000; Pérez-
Maldonado et al., 2005). Many pesticides share as a possible mechanism of toxicity the 
ability to trigger apoptosis through alterations in redox homeostasis generated by a 
decrease of antioxidant defenses and by accumulation of reactive oxygen species 
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(ROS). An over-production of ROS leads to processes such as oxidative modifications 
of redox signaling protein, oxidative DNA damage, endoplasmic reticulum stress and 
alterations in mitochondrial function which in turn trigger the activation of specific 
signaling cascades. Activation of stress-activated protein kinases (SAPKs) such as c-Jun 
N-terminal kinases (JNK) and of transcription-dependent p53 signaling cascades act as 
important sensors of electrophilic (and of oxidized) substances among which xenobiotic 
metabolites and induce apoptotic cell death. Pesticides also induce the activation of 
survival responses such as DNA repair mechanisms, mutagens-activated protein 
kinase/phosphatidylinositol 3-kinase (MAPK/PI3K) signaling cascades and up-
regulation of antioxidant defenses in an attempt to cope with and counteract the 
deleterious effects of higher levels of intracellular reactive species which in turn trigger 
cell death pathways. In most cases apoptotic and survival signaling cascades are 
activated simultaneously in response to exposure to pesticides. Table 1.3R summarizes 
some studies on apoptotic effects of some OCPs. 
DDT derivatives have been shown to induce neural cell death by apoptosis through the 
activation of mitogen-activated protein kinases (MAPKs) which play significant roles in 
controlling cell survival, proliferation, differentiation and cellular responses to various 
harmful signals (Shinomiya, N. and Shinomiya, M., 2003). β–HCH, p,p′-DDE and other 
OCPs can induce elevation of ROS such as O2•-, HO• and •NO (Samanta and Chainy, 
1997; Song et al., 2008; Sujatha et al., 2001). 
Shi et al. (2009) hypothesized the signaling pathways involved in p,p'-DDE-induced 
apoptosis: in their model ROS generation plays critical role in the initiation of Sertoli 
cells apoptosis through two mechanisms. The first one is mitochondria-mediated 
pathway involving elevation of ROS, decrease in mitochondrial transmembrane 
potential along with the cytochrome c release from mitochondria into the cytosol and 
activation of the caspase-9 and -3. Other mechanism involves elevation of ROS, which 
resulted in activation of NF-κB, expression of FasL and triggered FasL-dependent 
pathway (i.e. FasL/caspase-8/-3 signaling module). In their investigation, Song et al. 
(2008) found at levels above 30 µM, p,p'-DDE induced apoptotic cell death of cultured 
rat Sertoli cells in a pro-oxidant and mitochondria dependent manner by activating the 
intrinsic programmed cell death pathway. Moreover p,p'-DDE elevated the apoptotic 
rate of Sertoli cells in vitro (at >30 µM) and germinal cells in vivo (at >20 mg/kg b.wt) 
by mechanism suspected to involve FasL-dependent pathway (Shi et al., 2009, 2010).
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Table 1.3R. Summary of recent studies on the apoptotic effects of OCPs (DDT, DDE, methoxychlor, β-HCH and γ-HCH). 
Author Study type Study sample/material Effect investigated Observed effects 
Shi et al. (2009) In vitro Rat Sertoli cells from testes of 18 
to 20 days old male Sprague-
Dawley rats. The cells were 
incubated with 10, 30, 50 or 70 
µM p,p'-DDE for 24 hours 
Effects of p,p'-DDE on apoptosis, FasL, 
caspase-3, caspase-8 mRNA, 
procaspase-3, procaspase-8 and NF-ƘB 
activation 
Apoptotic cell death observed at >30 µM; FasL mRNA levels 
higher in a 50µM group; caspase-3 mRNA levels higher in 30 and 
50 µM group; caspase-8 mRNA increased in different doses; FasL 
mRNA induced in 50 µM group, NAC attenuated this effect. 
Procaspase-3 and -8 significantly reduced over 30 and 10 µM, 
respectively; NF-ƘB activation enhanced with increase of dosage. 
Shi et al. (2010) In vivo 20-Day old male rats Prepubertal 
rats administered with 0, 20, 60, 
100 mg/kg b. wt of p,p'-DDE for 
10 days of treatment 
Effects of p,p'-DDE on body weights, 
organs weights, apoptosis, GSH-Px 
activity, SOD activity, MDA level, Fas, 
FasL; caspase-3 and -8; procaspase-8, 
NF-ƘB p65 proteins, caspase-3 and -8 
activities in rat testis 
No change in body weights and testis weights; selective 
degeneration of germ cells at the seminiferous tubules observed at 
>20 mg/kg b.wt; all tested doses induced MDA increase and 
decrease SOD and GSH-Px activity; mRNA level of Fas, FasL, 
caspase-3 and -8 elevated in 100mg/kg b.wt group; p,p'-DDE 
induced increase in FasL and reduction of procaspase-8; NF-ƘB 
p65 activated in 60 and 100mg/kg b.wt groups; caspase-3 and 8 
activities increased in 100 mg/kg b.wt group. 
Shi et al. (2011) In vitro Rat Sertoli cells from testes of 
18–20 days old male rats treated 
with 10, 30, 50, 70 µM β-BHC to 
test the viability of cells. 50 µM 
was found to be the maximum 
tolerant dose. Thus 10, 30 and 
50µM β-BHC (β-HCH) were used 
in subsequent experiments 
Effect of β-BHC on apoptosis, ROS 
production, LDH leakage rate, SOD 
activity, MDA level, JNK/p38 MAPK 
protein levels, FasL, procaspase-3 and -
8 protein levels, NF-ƘB activation, NF-
ƘB p65 protein levels 
Apoptotic rate increased in 30 and 50 µM β-BHC group and 
attenuated by NAC; ROS production increased in 30 and 50 µM 
group and neutralized by NAC; LDH leakage rate enhanced in 30 
or 50 µM group, SOD activity lower in all groups, higher MDA 
level in all group; dose dependent phosphorylation of JNK1 and 
JNK2 observed, p38 MAPK phosphorylation not high in all 
groups; FasL increased in 30 and 50 µM group and attenuated by 
NAC; procaspase-3 and -8 reduced significantly at >30-µM; NF-
ƘB activation enhanced with dosage and neutralized with NAC; 
NF-ƘB p65 increased in the 30, 50 µM groups and attenuated by 
NAC. 
Song et al. (2008) In vitro Rat Sertoli cells from testes of 18 
days old male Sprague-Dawley 
rats. The cells were treated with 
10,30, 50 or 70 µM p,p'-DDE 
Effects of p,p'-DDE on LDH leakage, 
ROS production, SOD activity and 
MDA level, ∆Ψm, Bax family, 
cytochrome c translocation, procaspase-
9 and -3 cleavage; effect of NAC on 
p,p'-DDE-induced apoptosis. 
Apoptotic cell death induced at >30 µM, LDH leakage enhanced in 
30 or 50 µM groups; apoptotic characters exhibited in 30 or 50 µM 
treated cells and blocked with NAC; ROS production increased in 
50µM group; lower SOD activity in all groups; higher MDA level 
in 30 or 50 µM groups; loss of ∆Ψm induced with 10, 30 or 50; Bax 
and Bak significantly increased in cells treated with 30 or 50 µM. 
NAC had little effect on these changes; Bcl-w protein level 
declined significantly in 50µM group and neutralized by NAC; 30 
or 50 µM induced cytochrome c translocation to cytosol, NAC 
rescued this translocation effectively. Procaspase-9 and -3 
significantly decreased at over 30 µM. 
45 
Table 1.3R. Summary of recent studies on the apoptotic effects of OCPs (DDT, DDE, methoxychlor, β-HCH and γ-HCH). 
Author Study type Study sample/material Effect investigated Observed effects 
Pérez-Maldonado 
et al. (2004) 
In vitro and 
in vivo 
Human PBMC from volunteers 
(without DDT exposure) for in 
vitro study. DDT exposed and 
unexposed children for in vivo 
Effects of DDT or its metabolites on 
induction of apoptosis in humans both 
in vitro and in vivo. 
o,p'-DDT, p,p'-DDT, p,p'-DDE and p,p'-DDD induced apoptosis of 
human PBMC in vitro at 20 µg/mL; blood level of DDT, DDE and 
DDD blood and the % apoptosis were  higher in the exposed 
children than in the unexposed children. 
Song et al. (2011) In vitro Rat Sertoli cells from testes of 18 
days old male Sprague-Dawley 
rats treated with various 10, 30, 
50 or 70 µM p,p'-DDE 
Effect of NAC on p,p'-DDE-induced 
cellular viability reduction, ROS 
generation, MAPKs phosphorylation; 
effect of p,p'-DDE on mRNA levels of 
cytochrome c, bax, bak and bcl-w; 
effect of NAC, antinomycin D, 
SB202190 or SP600125 on p,p'-DDE-
induced apoptosis. 
Viability of cells reduced with 30, 50 or 70 µM treatments, NAC 
attenuated the cellular viability reduction induced by 50 µM; ROS 
production significantly increased by 50 µM treatment and 
neutralized with NAC; p38 and JNKs phosphorylation elevated 
after10, 30 or 50 µM treatments and inhibited by NAC; 
cytochrome c, bax and bak levels increased in 30 or 50 µM group 
and inhibited by antinomycin D; no significant changes of bcl-w 
observed; apoptotic cell death induced by 50 µM and attenuated 
with NAC or SB202190 or antinomycin D; SP600125 did not have 
any effect. 
Saradha et al. 
(2009) 
In vivo Adult male Wistar rats (80–90 
days old) administered with a 
single dose of lindane (5 mg/kg 
b.wt) 
The effects of lindane: on the levels of 
cytochrome c, caspase-3 and-9, Fas and 
FasL; on localization of caspase-3 and 
Fas; on immunolocalization of FasL; on 
levels of NF-ƘB p65 in the cytoplasmic 
and nuclear extracts of the testis, 
localization of NF-ƘB p65, germ cell in 
the testis of rats by TUNEL assay. 
Cytosolic cytochrome c and procapase-9 elevated as early as 6 h. A 
time-dependent elevation in procaspase-3, Fas, FasL levels 
observed. A time-dependent increase observed in colocalized 
expression of caspase-3 and Fas. This was the case for 
immunoreactivity of FasL. NF-ƘB p65 level in cytoplasmic extract 
and in nuclear extracts decreased and increased, respectively, in a 
time-dependent manner. The TUNEL-positive cells found in the 
peripheral region near the basement membrane of the seminiferous 
tubules. The number of apoptotic cells increased in a time-
dependent manner following exposure to a single dose of lindane. 
Vaithinathan et 
al. (2010) 
In vivo Adult male Wistar rats (80–90 
days old) administered with a 
single dose of methoxychlor (50 
mg/kg b.wt) 
The effects of methoxychlor: on the 
levels of cytochrome c, caspase-3 and-9 
(in adult rat testis), Fas, FasL, NF-ƘB 
(in testis cytoplasmic extract); on 
localization of caspase-3 and Fas; on 
immunolocalization of FasL and NF-
ƘB; on localization of NF-ƘB p65 in the 
rats testis; on germ cell in the testis of 
rats by TUNEL assay. 
Cytosolic cytochrome c and procaspase 9 elevated as early as 6 h. 
A time-dependent elevation in procaspase-3, Fas, FasL observed. 
NF-ƘB decreased in a time-dependent manner. NF-ƘB p65 changed 
from cytoplasm to nucleus of germ cells. A time-dependent 
increase in co-localization of Fas and Caspase 3 and in 
immunoreactivity of FasL observed. TUNEL-labeled germ cells 
increased in the peripheral regions in time-dependent manner after 
a single dose of methoxychlor. The number of TUNEL labeled 
germ cells increased progressively. 
Abbreviations: Caspases, cysteinyl aspartate-specific proteinases; GSH-Px, glutathione peroxidase; SOD, superoxide dismutase; MDA, malondialdehyde; NF-ƘB, nuclear factor kappa 
B; LDH, lactate dehydrogenase; ∆Ψm, mitochondrial membrane potential; MAPKs (s), mitogen-activated protein kinases; NAC, N-acetyl-l-cysteine; JNKs, c-Jun NH2-terminal kinase; 
PBMC, peripheral blood mononuclear; SB202190, p38 inhibitor; SP600125, JNK inhibitor; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; ROS, reactive 
oxygen species; b.wt, body weight. 
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Exposure to p,p'-DDE can enhance ROS production and oxidative stress, and then 
induce activation of NF-κB and expression of Fas-FasL. As a result, an intrinsic 
program of apoptotic death is stimulated in a target cell resulting to the activation of 
caspase 8. Ultimately, apoptosis of Sertoli cells and germinal cells is mediated by 
caspase 3, thereby disturbing the spermatogenesis (Shi et al., 2010). Song et al. (2011) 
reported the induction of Sertoli cell apoptosis by p,p'-DDE at above 30 µM through 
oxidative stress-mediated p38 MAPK and mitochondria-related pathway. 
Methoxychlor, which was intended to replace DDT, has been shown to induce testicular 
apoptosis in rats following oral exposure to single doses of 50 mg/kg b.wt where 
apoptosis was induced through involvement of Fas-FasL and mitochondria-dependent 
pathways (Vaithinathan et al., 2010). It is necessary to remark that the doses tested are 
unrealistically high if compared to those typical of occupational and environmental 
exposures. 
Pérez-Maldonado et al. (2004) showed that o,p'-DDT, p,p'-DDT, p,p'-DDE and p,p'-
DDD can induce apoptosis of human peripheral blood mononuclear cells in vitro at 20 
µg/mL. This level is 400-fold higher than the mean blood total DDT level (0.05 µg/mL) 
observed in children in their pilot study (Pérez-Maldonado et al., 2004). The significant 
level of ROS, as detected by flow cytometry, was induced at 60 and 80 µg/mL (Pérez-
Maldonado et al., 2005). A marginal influence of DDT and DDE on percentage of 
apoptosis was observed (p = 0.06) confirmed by a weak positive association between 
apoptosis and DDT exposure. In the follow-up study Pérez-Maldonado et al. (2006) 
found significant association between the percentage of apoptotic cells and the blood 
levels of only DDE of exposed children recruited in 2003 (p = 0.010) and those 
recruited in 2004 (p = 0.040). The association between DDT or DDE exposure and 
DNA damage was significant (p = 0.004 and p = 0.005 respectively), whereas the 
association between DDT or DDE and oxidative DNA damage and that of oxidative 
damage and apoptosis were not significant. 
An isomer of DDD, o,p'-DDD, marketed under the name Mitotane is used as an 
antineoplastic medication in the treatment of adrenocortical carcinoma. Mitotane alters 
steroid peripheral metabolism, directly suppresses the adrenal cortex through the 
controlled destruction of adrenal tissue, which leads to a decrease in cortisol production 
(Maher et al., 1992; Wu et al., 2006). 
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Exposure of Wistar rats to a single dose of lindane (γ-HCH; 5 mg/kg b.wt) induced 
testicular apoptosis through the involvement of Fas-FasL and mitochondria-dependent 
pathways (Saradha et al., 2009). Shi et al. (2011) showed that concentrations >30 µM of 
β-HCH induced apoptotic cell death in rat Sertoli cells associated with increased 
expression of FasL levels which could lead to the Fas activation. These two genes are 
known to induce apoptosis. Moreover β-HCH treatment induced an increase of nuclear 
factor kappa B (NF-ƘB) p65. The latter can directly stimulate the expression of these 
genes. Oxidative stress has been reported to enhance NF-κB activation (Nakamura and 
Omaye, 2008). β-HCH has been shown to induce activation of caspase-8, that plays the 
role in transduction of death signal (Said et al., 2004) and caspase-3, that initiates cell 
apoptosis (Khan et al., 2000). 
Moreover, Shi et al. (2011) showed that β-HCH induces increase in apoptotic rate of 
Sertoli cells by possible mechanisms of ROS/JNK/ FasL pathway. In vitro exposure to 
β-HCH in rat Sertoli cells can enhance ROS and oxidative stress, and then induce 
activation of JNKs and NF-κB and expression of FasL. Significant increase of FasL 
protein expression was observed with 30–50 µM β-HCH treatment. This increase could 
lead to activate the Fas system. Upon engagement of FasL to Fas, an intrinsic program 
of apoptotic death is stimulated in a target cell leading to the activation of caspase-8. 
Finally, apoptosis of Sertoli cells is mediated by caspase-3, thereby disturbing the 
spermatogenic process (Shi et al., 2011; Figure 1.4R). These results led the authors 
hypothesize that ROS generation may play a critical role in the initiation of β-HCH-
induced apoptosis by activation of the JNKs, translocation of NF-ƘB, expression of 
FasL and further activation of caspase cascade. 
Yu et al. (2008) studied the individual effect of p,p'-DDE and β-HCH as well as the 
effect of their mixture on JNK and MAPK pathway in rat Sertoli cells. The latter were 
exposed to these OCPs at the final concentration of 10, 30 and 50 µM/L for 24 hours in 
each case. In both treatments, the expression of JNK and c-jun were elevated in a dose 
dependent manner after 24 hours of exposure. Liang et al. (2008) showed that at these 
levels p,p'-DDE, β-HCH and their mixture could induce apoptosis in rat Sertoli cells 
which was associated with activation of caspase-3 mediated by cleavage of caspase-8 
and caspase-9. As stated for the case of p,p'-DDE above, these levels are also 
unrealistically high if compared even with the highest occupational exposures. 
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As for specific mechanisms, OCPs, which are themselves fairly un-reactive from the 
chemical point of view, are able to cause or trigger oxidative stress. However, little is 
known or hypothesized at the molecular level. Only the porphyrinogenic pesticide 
hexachlorobenzene is known for its ability to directly generate oxidative stress due to its 
unique property to act as an electron sink either as such or, more likely, through 
biotransformation products such as tetrachloro-1,4-benzoquinone (van Ommen and van 
Bladeren, 1989). That HCB is able to trigger apoptosis through the mitochondrial 
pathway has been demonstrated in the liver (Giribaldi et al., 2011) and in the thyroid 
(Chiappini et al., 2009). 
 
Figure 1.4R. β-HCH–induced signaling pathways leading to apoptosis. In this proposed model, ROS 
generation might be responsible for initiating the β-HCH–induced apoptosis of Sertoli cells. The increase 
of ROS could result in activation of JNKs and NF-κB, and expression of FasL, then triggered FasL-
dependent pathway (FasL/caspase-8/caspase-3 signaling module). N-Acetyl-cystein (NAC) can inhibit 
triggers by protecting the sensor thiol residue of the signalling proteins. Source: Adapted from Shi et al. 
(2011) with some modifications. 
2.3  Epigenetics and OCPs’ toxicity 
Epigenetics is an emerging field of study of heritable changes that influence 
chromosomal stability and gene expression while not directly affecting changes in DNA 
sequence, such as by point mutations or chromosome disruption and re-assembly 
(Rodenhiser and Mann, 2006). One main mechanism of epigenetic modulation of 
genetic expression is methylation at 5-position of cytosines in repeated CpG sequences, 
a modification which suppresses expression of downstream DNA sequences. Thus 
suppression of specific genes or re-activation of silenced genes determines the destiny 
of individual cells towards quiescence or proliferation, thus opening the way to 
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uncontrolled cell proliferation and cancer. Moreover, when epigenetic changes occur 
during certain stages of development, they become permanent and can be inherited by 
offsprings and disturbance of epigenetic modulation is thus thought to be an important 
mechanism in many diseases (Ozanne and Constancia, 2007). 
Epigenetic effects have been hypothesized as a possible mechanism of POPs toxicity 
(Porta, 2006). For example, pregnant rats were treated with methoxychlor at the fairly 
high dose of 50–150 mg/kg during the sex-determining time window of pregnancy 
(days E7–E10). Gonads were collected from embryos in gestating mothers at E16 and 
from postnatal males showed a reduced germ cell to testis area at developmental age 
and an almost doubled fraction of apoptotic germ cells, although males were fertile and 
produced normal offspring (Cupp et al., 2003). In a further experiment (Anway et al., 
2005) exposition of pregnant rats to 100 mg/kg produced male offsprings with reduced 
sperm capacity and fertility and the compromised fertility trait was passed through the 
adult male germ line for four generations. Altered patterns of DNA methylation was 
demonstrated to occur in the germ cells of generations two and three. 
In vitro and animal studies have suggested that exposure to endocrine active 
compounds, such as POPs, may adversely affect DNA methylation patterns (Anway and 
Skinner, 2006; Anway et al., 2006). It has been proved that chemicals can alter the 
epigenetic marks and that epigenetic marks can be found in patients with the disease of 
concern or in diseased tissue (Baccarelli and Bollati, 2009). 
DDT has been shown to affect DNA methylation in experimental animals as shown by 
Shutoh et al. (2009). DDT was found to alter the methylation pattern in the 
hypothalamus of young rats (3 weeks of age) exposed at a dosage of 0.06 mg/kg/day. 
The 6 CpG islands were considerably hypomethylated as compared with controls. Thus 
the authors speculated that under low level of oxidation stress, the DNA methylation 
machinery malfunctions and this leads to incomplete methylation of specific gene 
regions. Following pyrosequencing methylation analysis of the rat livers from the rats 
exposed to high dose of mixture of twelve OCPs (1.9 mg/kg/day) showed no decrease in 
the methylation of CpG sites which is contrary to other tested chemical mixtures 
(Desaulniers et al., 2009). 
To our knowledge only two epidemiological studies have been conducted to investigate 
exposure to POPs and DNA methylation levels in a human population. The first study 
was carried on Greenlandic Inuit and suggested a significant inverse linear relationship 
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between DNA methylation and plasma concentrations of DDT, DDE, β-HCH, 
oxychlordane, α-chlordane and mirex (Rusiecki et al., 2008). This relationship was 
replicated by Kim et al. (2010) when they investigated the relationship between POPs 
exposure and DNA hypomethylation among healthy Koreans. These two studies 
demonstrated epigenetic changes related to environmental exposure although the two 
populations differ in magnitude of exposure, Greenland Inuit people being more 
exposed than Korean population. 
3.0 Conclusions 
The general population is exposed to OCPs through several ways, food being the major 
route of exposure. A few groups of the human population may show much higher levels 
of exposure than others due to the fact that they live in areas with a historical 
uncontrolled use of these pesticides in agriculture (typical examples being some areas of 
Central Asia) or that their diet mainly consists of bio-accumulating organisms, such as 
large marine mammals (the typical example is that of Arctic Inuits). In both cases the 
hazard is transmitted trans-generationally starting with breastfeeding of newborns and 
consequently the impairment of fertility can determine a demographic decline of some 
populations. 
A number of adverse health effects such as endometriosis, infertility, immunotoxicity, 
neurotoxicity and spontaneous abortions, breast cancer, prostate cancer and 
neurodegenerative disorders have been suggested as a result of this exposure. OCPs 
may exert these effects through various mechanisms. Animal and in vitro studies using 
cell cultures are most widely used to evaluate toxicity of these chemicals. OCPs act as 
agonists on ERα and/or antagonists on ERβ and also as probably antagonists on 
androgenic receptors. These effects may contribute to the tumor promoting effects of 
these pesticides, which are observed in animals treated with high doses, which are not 
representative even of worst-case human exposure levels. Thus, p,p'-DDE and HCH 
have been shown to exhibit antiandrogenic effects by binding to ARs and competing 
with natural androgens, a characteristic which supports their estrogenic effect. Although 
HCB and β-HCH elicit estrogen-like responses, they do not compete with estradiol for 
binding to the ER like estrogen does. This suggest other intracellular pathways than the 
one used by endogenous estrogen in mediating these actions. They can elicit responses 
through AhR-dependent and independent pathways. 
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Many OCPs modulate or trigger apoptosis by redox signaling which involves alterations 
in antioxidant defenses and accumulation of ROS leading to oxidative stress. When not 
regulated, apoptosis can contribute to several diseases as immunodeficiency, 
autoimmunity and cancer. However, limited information exists on full mechanistic 
events involved in the induction of cell death or survival by these pesticides. 
Although not extensively explored, epigenetics has been considered to be a potential 
mechanism of POPs toxicity. Few studies have addressed OCPs and epigenetic 
modification as evident in human studies where only two studies have been conducted 
to elucidate the involvement of OCPs in health effects at epigenetic level. However 
some of these studies have shown OCPs may operate at epigenetic level. Thus more 
studies (both animals and human) are needed to document evidence of involvement of 
pesticides at epigenetics level in eliciting adverse health effects to human. 
It is also important to remark that a very common characteristics of laboratory studies is 
that they have been carried out testing unrealistically high doses, and this makes the 
extrapolation to environmental and occupational human exposures very critical. 
However they produce hypotheses that deserve an investigation through specifically 
addressed epidemiological and experimental studies. This is particularly important 
because most of the epidemiological studies we have evaluated are not conclusive, and 
often results of different epidemiological studies are conflicting. 
However, despite the not fully conclusive picture, it is evident that, having in mind the 
toxic potential, the bioaccumulation and biomagnification properties, there is a need to 
perform specific interventions addressed at reducing exposure, especially of vulnerable 
population subgroups. Thus stringent control in food safety system should be put in 
place to prevent the occurrence of OCPs in food and feedstuffs. 
The restriction of the use and the ban of most of OCPs in most developed countries 
limits the possible health threats they might pose. Cessation of direct application on 
animals or presence of OCPs in their feed, housing or pasture will help to control them. 
Removal of the contaminated items from the human food chain can be opted when 
acceptable limits have been exceeded. Withdrawal times can be appropriate means for 
growing (meat-type) animals, which do not deliver a product on a daily basis. Finally, 
continuing research is needed on these contaminants, their body burden, potential health 
effects and ways to reduce their bioavailability in food. Moreover, effective policies are 
needed to control their manufacture and release into the environment. 
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1.3 Rationale of the Study 
The interest to measure PCBs contamination in the environment, food and human 
population of Italy started in the early 1970s, a few years after the discovery of PCBs as 
a new class of ubiquitous contaminants of the Baltic Sea (Jensen, 1966; Jensen et al., 
1969; Ahling and Jensen, 1970). Between 1971 and 1989 a group at the Istituto 
Superiore di Sanità, Rome expanded the interest into the measurement of chlorinated 
pesticides (Leoni, 1971; Leoni and Biocca, 1978; Leoni et al., 1986), followed by other 
groups within the National agencies for health protection and in the academy which 
published their reports in Italian scientific journals and mainly starting from the early 
1980s in the international literature (Galassi et al., 1981; Martelli et al., 1981). One 
main health concern was reproductive toxicity (Bercovici et al., 1983; Rogan et al., 
1985; Leoni et al., 1989) since some PCBs were reprotoxic in experimental animals. 
In the 1980s several studies started establishing reference values of serum PCBs in the 
general population in countries with past or current use of PCBs. The aims were to 
confirm or refute the contribution of exposure to observed or suspected clusters of 
cancer incidence in towns where production plants were located or close to places 
where release into the environment had occurred. 
A meta-analysis of 37 studies conducted between 1990 and 2003 established a mean 
reference value (0.9–56 µg/L) for total PCB in blood in the general population (Mangili 
et al., 2004). Such levels are within the range reported in the toxicological assessment 
of PCBs performed in USA (4–19 ng/mL; ATSDR, 1997). In Brescia where the main 
PCB production plant was located, a mean value of 5.15 ng/mL for the total serum PCB 
level in the general population was measured in 2001–2003 (Apostoli et al., 2005). 
Based on this finding, further investigations were proposed aimed at determining 
geographic distribution of PCB levels in the Italian population with larger study cohorts. 
Among European countries, Italy used DDT extensively since 1945 up to the 1970s for 
controlling flies and mosquitoes (particularly malaria vectors). This led to improvement 
of health conditions especially in the Po river delta, in central–southern coastal and in 
insular Italy. The usage was estimated at 2,178 and 1,569.50 metric tonnes in 1970 and 
1975, respectively. The usage declined in 1980s and 1990s where the estimates were 
196.48, 103.20 and 54.72 metric tonnes in 1980, 1985 and 1990, respectively (WHO, 
2003). Since human exposure to OCPs can bring about significant health effects 
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exposure measurement aimed at health risk assessment of these pollutants in the general 
population is still a matter of public health concern. Despite long-time use, 
measurements are mainly targeted at environmental contamination and only limited 
information is available on actual human burden of these pollutants in the Country. 
Between 1972 and 2011 about sixteen international published articles reported OCPs 
concentration in the Italian population as exemplified in Table 4.1. Such lack of 
detailed exposure data hinders adequate human risk assessment (De Felip and Ingelido, 
2004). 
This project aimed at improving existing knowledge on the levels of exposure of the 
Italian general population to concerning polychlorinated biphenyls and 
organochlorinated pesticides. In this Thesis results of serum PCB congeners and OCPs 
obtained within REALEXPO project among the residents from three Italian population 
subgroups from general population are reported. The relationship of these POPs with 
residence, gender, age and body mass index (BMI) was explored. In future the study 
will further investigate the relationship between the levels of POPs and the development 
of breast cancer among Italian female population. 
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1.4 Objectives of the Study 
1.4.2 Broad Objective 
To assess the human exposure to persistent organic pollutants and the associated health 
risks among Italian population. 
1.4.3 Specific Objectives 
1. To determine the concentrations of polychlorinated biphenyls and 
organochlorinated pesticides in human blood serum collected from residents 
from three Italian towns. 
2. To assess the distribution of lipid-adjusted serum concentrations of 
polychlorinated biphenyls and organochlorinated pesticides among study 
subjects with respect to their places of residence. 
3. To assess the gender distribution of lipid-adjusted serum concentrations of 
polychlorinated biphenyls and organochlorinated pesticides. 
4. To compare the distribution of lipid-adjusted serum concentrations of 
polychlorinated biphenyls and organochlorinated pesticides among different 
age groups in the study subjects. 
5. To evaluate the effect of body mass index in the distribution of lipid-
adjusted serum levels of polychlorinated biphenyls and organochlorinated 
pesticides among the study subjects. 
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CHAPTER TWO 
MATERIALS AND METHODS 
2.1 Study site and selection of study population 
The project was run through three years from 2010 to 2012 as indicated in the work 
plan (Annex I). Our research group collected, in the frame of routine health checks of 
the general population, serum samples of subjects recruited from three Italian towns of 
Novafeltria (in Emilia Romagna region), Pavia and Milan in the region of Lombardy. 
Novafeltria is assumed to be a rural area (a non-industrialized area in Central Italy), 
Pavia a semi-urban town while Milan is clearly an urban area with past manufacturing 
activities. We thus expected to see variation of POPs pattern between these regions. 
2.2 Selection criteria 
The study subjects were recruited based on established inclusion criteria. These are 
absence of significant body weight loss (10% or more) a year before the study 
commenced, absence of dyslipidemia and other chronic metabolic diseases. The 
recruited subjects were also supposed to have neither history of occupational exposure 
nor accidental exposure to POPs from identified sources. 
2.3 Ethical consideration 
Informed consent was properly obtained from all study participants and the study was 
approved by the Institutional Ethical Committee of Ospedale San Paolo, Milano, Italy. 
Information about the nature of the study as well as possible risks and benefits was 
given to the study subjects. There were no monetary benefits. Confidentiality and 
privacy was assured throughout the study. 
After securing informed consent recruited subjects filled in data collection forms 
regarding personal information like demographic information (age, gender, occupational 
and residential histories), anthropometric measurements (height and weight), lifestyle 
(usual diet, cigarette smoking, alcohol consumption, physical exercises) and use of 
medications. This information was collected at interview by using designed data 
collection forms (Annex II). After filling the forms the subjects were asked to donate a 
10 mL of blood samples. 
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2.4 Blood sample collection 
A 10 ml venous blood sample was obtained from each subject from the antecubital vein 
and collected in silicone-coated Vacutainer (Becton & Dickinson, USA) without 
anticoagulants. Serum was separated within 24 hours after collection, kept at 4˚C until 
shipment and frozen at -20˚C upon receipt at the laboratory until analysis. 
For the PCB study, selected information and serum samples were collected from a total 
number of 372 subjects where 163 from Novafeltria (a 7,000-inhabitant small town in 
Central Italy), 167 from Pavia (a 70,000-inhabitant small old city in Northern Italy) and 
42 (the 1,300,000-inhabitant largest city in Northern Italy, the second-largest in Italy) 
from Milan (Figure 2.1). For the OCPs study, selected data were obtained from 137 
subjects among them, 36, 59 and 42 subjects live in the respective towns. 
 
Figure 2.1. Map of Italy showing the study locations. 
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Figure 2.2. Schematic illustration of recruitment procedure of study subjects. 
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2.5 Laboratory analyses 
All laboratory analyses were conducted at the Laboratory for Environmental and 
Toxicological Testing at Salvatore Maugeri Foundation in Pavia, Italy. 
2.5.1 Determination of serum concentrations of triglycerides and total cholesterol 
Serum concentrations of triglycerides and total cholesterol were measured in the serum 
sample by standard clinical chemistry techniques to define total lipid concentrations 
which were derived using the equation 2 reported in Philip et al. (1989). 
Total Lipid (TLa) = 2.27 x Total Cholesterol (TCb) + Triglycerides (TGc) + 0.623   (2) 
a
 in g/L; b in g/L (normal range: 120–220 mg/100 mL); c in g/L (normal range: 40–
170 mg/100 mL). 
The individual POP concentrations were adjusted for total lipid to give better estimate 
of the body burden (Koppen et al., 2002). Adjustment was computed by dividing the 
crude serum POP concentration (ng/mL) by total lipid concentration in serum (g/L) to 
yield OCP concentration in nanograms per gram of serum lipids which was finally 
converted to picomoles per gram serum lipid (pmol/g serum lipid). This allows 
comparison between congeners since there are substantial differences in molecular 
weight between the compounds (Fängström et al., 2005). The same conversion was 
applied to results published in the scientific literature which were used as reference in 
the interpretation of our own measurements. When results in the literature were 
expressed without lipid adjustment and no blood lipids levels were reported, an 
adjustment was nevertheless performed by taking the lower and upper levels of normal 
concentrations of cholesterol and triglycerides into equation 2 above. 
2.5.2 Extraction and purification of PCBs and OCPs 
Prior to extraction the blood serum was thawed at room temperature. Thereafter 2 mL of 
methanol was added to 2 mL of serum and solution was vortexed for 30 seconds to 
precipitate proteins. Lipophilic organic substances were extracted by adding to the 
sample 5 mL of a 1:1 (v/v) mixture of ethyl ether and hexane. This procedure was 
repeated twice. The combined organic layer was evaporated under a steam of nitrogen 
down to about 500 µL. This residue was purified on a Bond Elut PCB (Supelco, 
Milano, Italy) solid-phase extraction cartridge. Activation of the cartridge was obtained 
by percolating 1 mL of hexane. The fraction extracted from serum was loaded and 
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eluted first with 3 mL hexane and then with 3 mL ethyl ether/hexane (1:1, v/v). The 
eluites were collected and dried in a stream of nitrogen. The dry residue was re-
dissolved in 100 µL of hexane just prior to analysis. After extraction and clean up of 
extracts, the analytes were measured by gas chromatography–mass spectrometry (GC–
MS). 
2.5.3 PCBs and OCPs analyzed 
We analyzed thirty six PCB congeners and eight OCPs in the overall study population 
which were selected based on their abundance, availability in the environment and 
potential toxicity. 
Specifically 36, 34 and 15 PCB congeners were analyzed in serum samples of 
Novafeltria, Pavia and Milan, respectively. Due to differences in the number of 
measured congeners in the sites, 15 congeners commonly investigated in all sites were 
selected to facilitate comparison of total PCB levels among the sites (Figure 2.4 and 
Table 2.1). For practical and economic reasons, it was decided to reduce the number of 
measured PCBs congeners to 15 in the Milan cohort, which was the last to be analyzed. 
The experience from previous studies conducted elsewhere and from the two cohorts 
from Pavia and Novafeltria which were analyzed earlier, showed that most of the fifteen 
congeners (such as PCBs 28, 52, 101, 118, 138, 153 and 180) are stable in the 
environment and may be good markers for human PCB exposure without the need to 
perform a much longer analysis. 
The eight targeted OCPs were beta-hexacyclohexane (β-HCH); hexachlorobenzene 
(HCB), 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethylene (o,p'-DDE), 1,1-
dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p'-DDE), 1,1-dichloro-2-(o-chlorophenyl)-
2-(p chlorophenyl)ethane (o,p'-DDD), 1,1-dichloro-2, 2-bis (4-chlorophenyl)ethane 
(p,p'-DDD), 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p chlorophenyl)-ethane (o,p'-DDT) 
and 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (p,p'-DDT). 
2.5.4 GC–MS Measurement of PCBs and OCPs 
The analytical technique for determination of these compounds, limits of detection and 
accuracy of the method are described elsewhere (Turci et al., 2004, 2006, 2010a). 
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In brief, a Shimadzu (Shimadzu Deutschland GmbH, Duisburg, Germany) gas 
chromatograph mass spectrometer GCMS-QP5050A (Figure 2.3) equipped with an 
auto injector/auto-sampler AOC-20 was used to analyze the selected POPs. A 
50m×0.2mm×0.5µm, J&W 100% dimethylpolysiloxane PONA capillary column was 
used with helium as carrier gas at a constant flow of 0.8 mL/min. Two microliters was 
injected in splitless mode with the split outlet opened after 0.7 min. Injector and 
detector temperatures was set at 270 and 280˚C, respectively. The oven temperatures 
program was: 80˚C for 1 min, 3˚C/min to 200˚C, then 5˚C /minutes to 300˚C and 6 
minutes holds at 300˚C. The mass spectrometer operated in electron ionization mode 
(EI) at 70 eV. A SIM program was constructed for GC–MS acquisition and 
quantification. Two ions (M+ and [M+2]+ ions) were monitored for each level of 
chlorination. Retention time, masses and the abundance ratio of the chromatographic 
peaks of each analyte recorded by the two ions ([M+2]+ confirmation ion to M+. target 
ion) was used as identification and purity check criteria. Peak areas were measured by 
the GCMS Postrun Analysis program of the Shimadzu Workstation GCMS solution 
software for GCMS-QP5000 Series, which also calculated slopes, intercepts and the 
coefficients of correlation. Peak area ratios (analyte response/internal standard response) 
were plotted against amount ratios (analyte concentration/internal standard 
concentration) and standard calibration curves was obtained from linear regression 
analysis of the data. Minimum detectable amounts of POPs, expressed as Limit of 
Detections (LoDs) were in the range of 0.05–0.50 nanograms per millilitre (ng/mL). 
 
Figure 2.3. GS–MS for laboratory analysis of selected persistent organic pollutants. 
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Figure 2.4. Molecular structures of the priority fifteen PCB congeners and eight OCPs commonly investigated in the three sites. 
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Table 2.1. The IUPAC numbers of thirty six investigated PCB congeners in the overall population. 
General Structure Classification Formula Mwt IUPAC Nos. of PCB congeners 
 
 
trichlorobiphenyl C12H7Cl3 257.55 28, 31 
tetrachlorobiphenyl C12H6Cl4 291.99 44, 47, 49, 52, 61, 66, 70, 74, 77, 81 
pentachlorobiphenyl C12H5Cl5 326.44 99, 101, 105, 118, 126 
hexachlorobiphenyl C12H4Cl6 360.88 128, 138, 146, 149, 153, 156, 157, 167, 169 
heptachlorobiphenyl C12H3Cl7 395.33 170, 171, 172, 177, 180, 183, 187, 189, 190, 193 
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2.6 Statistical analyses 
The data were analyzed by using the Statistical Package for Social Sciences (SPSS) 
software version 17.0 (SPSS Inc, Chicago, IL, USA) and custom Microsoft Excel2003 
spreadsheets. A bar chart was used to present prevalence of each OCP in the study 
population subgroups (Figure 3.1). All statistical analyses were performed on serum 
lipid adjusted concentrations expressed in pmol/g lipid. 
Subjects with undetectable values were assigned half the detection limits (LoDs) before 
adjustment for lipids and calculation of the medians included these values. After lipid 
adjustment half LoDs differed for every sample due to differences in total lipid. The 
median concentrations were computed and reported for those analytes detectable in 
more than 50% of the population sample or 50% of the groups classified by sex, age, 
place of residence and body mass index. 
Statistical analyses were conducted to assess inter-individual variability in analytes 
levels and to highlight differences with respects to sex, age, body mass index and 
residence. The dependent variable in this study is serum lipid-adjusted concentrations of 
analytes under investigation. The analytes concentrations were summarised for the 
whole sample and for the individual sites and separately for males and females using 
medians, minimum and maximum values. 
Shapiro Wilks’ test for normality was used to check the distribution of PCB congeners 
and OCPs. Since distribution of PCB congeners and OCPs levels among the subjects 
were non-symmetrical, all statistical tests were performed by non-parametric tests and 
medians were used as a measure of central tendency. Thus Kruskal Wallis (KW) Test 
was used to test the difference in concentration of individual organochlorine pesticides 
and PCB congeners between place of residence, age groups and BMI categories. The 
Mann–Whitney U test assessed the difference in analytes concentrations between the 
gender groups. The correlation analyses were performed by Spearman correlation test. 
Multivariate model were used to check the relationship between POPs and predictor 
variables under investigation. The variance explained by the model was estimated by 
using the determination coefficient, R2. In most cases statistical tests were considered 
significant at the 0.05 level and in some cases at the 0.01 level. 
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As for OCPs statistical analyses were restricted to β-HCH, HCB, p,p'-DDE, p,p'-DDD, 
o,p'-DDD and o,p'-DDT which were detected in more than 50% of the population 
sample. 
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CHAPTER THREE 
RESULTS 
According to the PhD work plan, all the results achieved have been discussed in 
conferences and congresses and have been submitted to Scientific Journals. Therefore, 
proceedings and presentations are published or have been accepted for publication (see 
the list of articles in page xii).  
The two study populations are mostly composed of different subjects, although they 
were recruited in the same places. Only 122 subjects were common to both studies: 21 
in Novafeltria, 59 in Pavia and 42 in Milan. All main characteristics of the individual 
subjects are collected in Annex IV–VI. 
3.1 Organochlorinated pesticides study 
3.1.1 Study population 
The main characteristics of the study subjects are indicated in Table 3.1. Our study 
population was composed of 65 (47%) females and 71 (52%) males. The distribution of 
gender in Pavia and Milan was skewed with female and male subjects under 
represented, respectively. The mean body weight of the study subjects was 69.85 kg and 
mean BMI of 24.01 kg/m2 which are consistent with the reported mean weight and 
mean BMI of a representative general Italian adult population of 18 years old or above 
(69.4 kg and 24.5 kg/m2, respectively) (Gallus et al., 2006). On average our study 
population had individuals who were in the normal or healthy range in terms of BMI 
classification. 
Table 3.1. Main characteristics of study population – OCPs study. 
Characteristic 
All Sample Novafeltria Pavia Milan 
n = 137 n = 36 n = 59 n = 42 
Female, n (%) 65 (47) 17 (47) 17 (29) 31 (74) 
Male, n (%) 71 (52) 19 (53) 42 (71) 10 (24) 
Age (years) 39.0 (19–70) 44.5 (22–59) 40.0 (20–70) 33.0 (19–69) 
Body weight (kg) 68.0 (45–131) 70.0 (45–100) 72.5 (45–131) 60.0 (45–90) 
BMI (kg/m2) 23.52 (17.58–38.5) 23.31 (17.58–32.3) 24.56 (18.29–38.5) 21.70 (18.70–31.96) 
Note: Genders are expressed as valid percentages (%) and absolute number (n); age, body weight and 
BMI are expressed as medians (minima and maxima). 
Note: Twenty one subjects from Novafeltria were among those who were recruited 
for PCB study and 15 were newly recruited subjects. All 59 subjects from Pavia and 
42 from Milan participated in the PCBs study. 
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3.1.2 Serum concentrations of OCPs and of their metabolites 
A summary of the levels of individual OCPs in the subjects classified by residence and 
gender is reported in Table 3.2. To understand the complex pattern of OCPs, the 
targeted analytes were shrunk to chemically and metabolically analogous groups, by 
summing together the DDT-like compounds (DDT, DDE and DDD) with p,p'- and o,p'- 
chlorine substitution (p,p'-DDX and o,p'-DDX, respectively). Total OCP was computed 
as the sum of levels of all OCPs analyzed from an individual subject whereas total DDT 
included the summation of DDT related compounds (all isomers of DDT+DDE+DDD). 
This data reduction approach leads to six OCP groups (Table 3.3). 
The most persistent isomer of HCH (β-HCH) was detected in 74 samples (54%) with 
median concentration of 123 pmol/g lipid (28–1023 pmol/g lipid). HCB and p,p'-DDE 
were the most frequently detected OCPs in the overall study population (99% and 97%, 
respectively) with median concentrations of 154 and 395 pmol/g lipid, respectively. 
p,p'-DDT and o,p'-DDE were the least detected and thus they were excluded from the 
analysis. The median levels of total OCP, total DDT, total p,p'-DDX and o,p'-DDX 
were 1756, 1229, 514 and 173 pmol/g lipid, respectively in the overall sample 
population (Table 3.4). 
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Table 3.2. Median, minimum, maximum and significance values of OCPs (in pmol/g serum lipid) between females and males subjects from 3 Italian 
population subgroups. 
Analyte 
Novafeltria Pavia Milan 
Females (n=17) Males (n=19) p 
value 
Females (n=17) Males (n=42) p 
value 
Females (n=31) Males (n=10) p 
value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. 
β-HCH 47 65 815 28 59 756 0.173 118 327 1023 109 303 860 0.987 39 52 84 40 50 75 0.484 
HCB 7 220 2014 12 189 970 0.428 64 86 182 62 100 406 0.569 17 627 1215 323 472 834 0.029 
p,p'-DDE 20 538 1348 33 339 1556 0.987 16 143 789 71 173 1854 0.770 15 5363 17531 1233 3398 8339 0.101 
p,p'-DDD 11 49 1231 7 31 920 0.124 26 116 401 12 86 564 0.379 12 16 732 12 16 977 0.963 
o,p'-DDT 16 78 1826 6 118 3378 0.899 12 330 1854 9 336 1343 0.913 11 15 1747 11 14 2495 0.939 
o,p'-DDD 12 26 382 5 21 348 0.366 16 81 155 12 71 349 0.503 12 16 25 12 15 23 0.509 
∑OCPs 216 1371 4534 525 1378 4865 0.862 689 1233 3050 502 1352 4726 0.907 126 6155 19363 1734 4604 9314 0.182 
∑DDT 76 876 2834 331 1144 3956 0.887 161 693 2505 149 769 3530 0.960 59 5495 18103 1277 4076 8405 0.236 
Note: Significant difference in distribution of HCB was observed between males and females in only Milan (p = 0.029, Females > Males). In Novafeltria and Pavia there 
was no evidence of significant difference in distribution of all analyzed OCPs between males and females. 
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Table 3.3. Main Results of the measurement of OCPs in the examined subjects (in pmol/g serum lipids). 
Analyte All Sample (n = 137) Novafeltria (n = 36) Pavia (n = 59) Milan (n = 42) 
Min Med Max. Min. Med Max Min Med Max. Min. Med Max. 
∑OCP 126 1756 19363 216 1375 4865 502 1285 4726 126 5286 19363 
HCB 7 154 2014 7 209 2014 62 100 406 17 571 1215 
β-HCH 28 122 1023 28 65 815 109 323 1023 39 51 84 
∑DDT 59 1229 18103 76 1055 3956 149 767 3530 59 4651 18103 
∑p,p'-DDX 30 514 18077 39 576 2248 86 312 2418 30 4396 18077 
∑o,p'-DDX 23 173 3561 25 157 3561 28 407 2003 23 30 2512 
Note: One subject from Milan was excluded from the analysis due to lack of most data. Keys: p,p'-DDX , ∑p,p'-DDE, p,p'-
DDD; o,p'-DDX, ∑o,p'-DDD, o,p'-DDT; ∑DDT, (p,p'-DDX + o,p'-DDX); ∑OCP, (β-HCH + HCB + ∑DDT). 
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Table 3.4. Median, minimum and maximum concentrations (in pmol/g serum lipid) of OCPs/metabolites in selected 3 
Italian population subgroups. 
Analyte 
All Subjects (n = 137) Novafeltria (n = 36) Pavia (n = 59) Milan (n = 41) 
p-Value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. 
β-HCH 28 123 1023 28 65 815 109 323 1023 39 51 84 0.000 
HCB 7 154 2014 7 209 2014 62 100 406 17 571 1215 0.000 
p,p'-DDE 15 395 17531 20 428 1556 16 163 1854 15 4380 17531 0.000 
o,p'-DDD 5 22 382 5 22 382 12 79 349 12 16 25 0.000 
p,p'-DDD 7 45 1231 7 35 1231 12 110 564 12 16 977 0.001 
o,p'-DDT 6 109 3378 6 100 3378 9 336 1854 11 14 2495 0.000 
∑p,p'-DDX 30 515 18077 39 576 2248 86 312 2418 30 4396 18077 0.000 
∑o,p'-DDX 23 173 3561 25 157 3561 28 407 2003 23 30 2512 0.000 
∑DDT 59 12305 18103 76 1055 3956 149 767 3530 59 4651 18103 0.000 
∑OCP 126 1756 19363 216 1375 4865 502 1285 4726 126 5286 19363 0.000 
Note: One subject from Milan was excluded from this analysis due to lack of some important information. 
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3.1.3 Distribution of OCPs by place of residence  
Novafeltria 
The median total OCP and total DDT in Novafeltria (36 subjects) were 1375 and 1055 
pmol/g lipid, respectively. HCB with a median concentration of 209 pmol/g lipid was 
found in all analyzed samples while β-HCH was detected in 11% of the samples. The 
main metabolite of DDT (p,p'-DDE) was the most abundant OCP in Novafeltria 
detected in 35 samples (median: 428 pmol/g lipid). o,p'-DDT and o,p'-DDD were each 
detected in 28 samples equivalent to 34% of 82 analyzed samples and 37% of 75 
analyzed samples, respectively. p,p'-DDD was detected in 29 samples accounting for 
29% of the analyzed samples (n = 84) in the overall sample population. 
Pavia 
The median total OCP and total DDT in Pavia (59 subjects) was 1285 and 767 pmol/g 
lipid, respectively. HCB and β-HCH were detected in all 59 samples with median 
concentration of 100 and 323 pmol/g lipid, respectively. This account for 44% (n = 135) 
and 80% (n = 74) of the overall samples with detectable levels of HCB and β-HCH, 
respectively. p,p'-DDE was detected in 58 accounting for 44% of subjects with 
detectable levels in the overall population (n = 133, median: 163 pmol/g lipid). o,p'-
DDT, o,p'-DDD, p,p'-DDD and o,p'-DDE were detected in 62% (51/82), 63% (47/75), 
55% (46/84) and 27% (3/11) of the samples with detectable levels of these OCPs, 
respectively. 
Milan 
The median total OCP and total DDT of 41 subjects (98%) in Milan was 5286 and 4651 
pmol/g lipid, respectively. β-HCH, o,p'-DDE and o,p'-DDD were under detection limit 
in all samples whereas p,p'-DDT was detected in only one sample with a concentration 
of 395 pmol/g lipid. As in other sites, HCB and p,p'-DDE were the most frequent 
detected in 40 samples accounting for 30% of the samples analyzed in the overall 
population sample (n = 135, n = 133). o,p'-DDT, p,p'-DDD and p,p'-DDT were the least 
prevalent in this population subgroup. 
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Figure 3.1. Percentage frequency of detection of individual OCP/metabolite in the three Italian 
population subgroups. 
Comparison among places of residence 
A trend of the median level of total OCP, total DDT, p,p'-DDE and HCB was observed 
among the residents in the investigated sites (Figure 3.2). Pavia showed the lowest 
median level for these OCPs while Milan the highest level. These levels were 
significant different across these sites (Milan > Novafeltria > Pavia, p < 0.0001). The 
highest median levels of total o,p'-DDX, β-HCH, o,p'-DDD, p,p'-DDD and o,p'-DDT 
were observed in Pavia and the lowest in Milan. The distribution of these OCPs differed 
significantly across the sites (Pavia > Novafeltria > Milan, p < 0.001). Whereas β-HCH 
was the most frequently detected in Pavia and Novafeltria group, it was under detection 
limit in all Milan samples. 
3.1.4 Distribution of OCPs by gender 
In overall sample, females had significantly higher median total OCP than males (3050 
and 1489 pmol/g lipids, respectively; p < 0.0001). Similar observation was seen for total 
DDT (medians: 2417 and 995 pmol/g lipid for females and males, respectively; p = 
0.001). 
The fungicide HCB was detected in 64 female samples (99%) while p,p'-DDE in 62 
samples (95%) with median levels of 482 and 789 pmol/g lipid, respectively. These 
OCPs were detected in all 71 male subjects with median levels of 107 and 268 pmol/g 
lipids, respectively. The level of HCB and p,p'-DDE differed significantly between 
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females and males (p < 0.0001). Out of 65 female samples analyzed, p,p'-DDD was 
detected in 40 samples (62%), o,p'-DDD and o,p'-DDT were each detected in 31 
samples (48%). o,p'-DDE and p,p'-DDT were the least abundant among female 
subjects. Gender distributions of total OCP, total DDT, p,p'-DDE, p,p'-DDD, HCB and 
β-HCH are illustrated in Figure 3.3. 
Based on individual study site, β-HCH was detected in 15 subjects of Novafeltria 8 of 
them were females (53%) with median concentration of 65 pmol/g lipid. HCB was 
detected in all 17 women (median: 220 pmol/g lipid) whereas p,p'-DDE, p,p'-DDD and 
o,p'-DDT were found in 16, 14 and 13 subjects respectively, with median 
concentrations of 538, 49 and 78 pmol/g lipid, respectively. 
Among male subjects of Novafetria 7 subjects (47%) had detectable concentrations of 
serum β–HCH, with a median of 59 pmol/g lipid. HCB and p,p'-DDE found in all 19 
subjects with a median concentration of 189 and 339 pmol/g lipid, respectively. p,p'-
DDD, o,p'-DDT and o,p'-DDD were detected in 15 subjects with median concentration 
of 31, 118 and pmol/g lipid, respectively. There was no evidence of significant 
difference in levels of all analyzed OCPs between males and females (Table 3.2). 
In Pavia, β-HCH and HCB were detected in all 17 females (29%) with median 
concentrations of 327 and 86 pmol/g lipid, respectively. p,p'-DDE and p,p'-DDD were 
each detected in 16 subjects with median concentrations of 143 and 116 pmol/g lipid, 
respectively. o,p'-DDD and o,p'-DDT were detected in 14 and 15 subjects, respectively 
with a median concentration of 81 and 330 pmol/g lipid. In males group, β-HCH, HCB 
and p,p'-DDE were detected in all 42 subjects. The median concentrations of these 
OCPs were 303, 100 and 173 pmol/g lipid, respectively. p,p'-DDD, o,p'-DDT and o,p'-
DDD detected in 30 (66%), 37 (73%) and 32 (68%) subjects, respectively with median 
concentrations of 86, 337 and 72 pmol/g lipid. As for Novafeltria, no evidence to 
account for the significant difference between males and females for all analyzed OCPs 
(Table 3.2). 
In Milan HCB and p,p'-DDE were detected in 40 subjects of these 10 were male 
subjects (25%). Their median concentrations were 472 and 3397 pmol/g lipid, 
respectively. o,p'-DDT (median 14 pmol/g lipid) and p,p'-DDD (median 16 pmol/g 
lipid) were each detected in only two samples. Among female subjects of Milan, HCB 
and p,p'-DDE had median concentrations of 627 and 5363 pmol/g lipid, respectively. 
Contrary to Novafeltria and Pavia, significant difference in the distribution of HCB was 
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observed between males and females from Milan (p = 0.029), females having higher 
median level than males (Table 3.2). 
3.1.5 Distribution of OCPs by Subjects’ Age 
To evaluate the effect of age, subjects’ ages were categorized into four 15-year groups 
(10–25, 26–40, 41–55 and 56–70). The analyzed OCPs were compared for the total 
content and the distribution across the age groups for the overall population and for the 
individual sites. No subject was younger than 19 years, while the majority of subjects 
aged between 26–40 and 41–55 (approx. 41 and 34%, respectively) and 14 were in the 
56–70 years age. Compared to other sites Milan had younger subjects (Table 3.5). 
The median concentration of total OCPs in the overall population sample were found to 
be 3060, 1678, 1536 and 1636 pmol/g lipid across these age groups, respectively. In 
Novafeltria the distribution of total OCPs (p = 0.015) and total DDT (p = 0.039) 
differed significantly across these age groups. However the significance value for total 
p,p'–DDX was very close but within the level of statistical significance (p = 0.051). The 
median concentrations along the respective age groups were 539, 1112, 1618 and 1782 
pmol/g lipid (for total OCPs); 251, 375, 706 and 1091 pmol/g (for total p,p'-DDX) and 
331, 781, 1458 and 1444 pmol/g lipid (for total DDT). The distribution of these OCP 
groups monotonically increased with subject age (r2 = 0.181, p = 0.01; r2 = 0.138, p = 
0.026 and r2 = 0.156, p = 0.017; for total OCP, total p,p'-DDX and total DDT, 
respectively). In Milan the distribution of these OCP groups were not statistically 
significant different across the age groups although their median levels increase 
consistently across age (5115, 5337, 5494 and 19363 pmol/g lipid for total OCP; 4428, 
4693, 4999 and 18103 pmol/g lipid for total DDT; 4297, 4512, 4973 and 18077 pmol/g 
lipid for total p,p'-DDX). 
As for individual analytes, the concentration of only β-HCH presented a statistically 
significant increasing trend across these age groups for only Pavia population subgroup 
(p = 0.027). The median concentrations of this compound for the four age groups 10–
25, 26–40, 41–55 and 56–70 were 305, 401, 249 and 467 pmol/g lipid respectively. 
However correlation analysis did not reveal any significant correlation with age (r = 
0.021, p = 0.874). No evidence for significant difference in distribution for other 
detected OCPs across these age groups as illustrated in Figure 3.4. 
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Table 3.5. Absolute frequency of study subjects in each age category for all 
subjects and for population of Novafeltria (NF), Pavia (PV) and Milan (MI). 
Age 
Class Description All  NF PV MI 
10–25 Born after 1995, never experienced direct 
exposure to DDT 20 3 5 12 
26–40 Born 1970–1985; DDT ban in 1978; direct 
exposure to DDT unlikely 56 10 26 20 
41–55 Born 1955–1960; may have experienced DDT use while in the child and youth age 46 21 17 8 
56–70 Born 1940–1954; may have experienced DDT use while in the child and youth age 14 2 11 1 
Total  136 36 59 41 
3.1.6 Distribution of OCPs by BMI  
The minimum and maximum BMI in our study population were 17.58 and 38.53 kg/m2, 
respectively. The four main BMI categories and a total of 11 sub-classes as per 
international classification (http://www.indexmundi.com/italy/sex_ratio.html) reflect the 
status of the body fat in population studies, ranging from those underweight (BMI < 
18.50 kg/m2) to those severely obese (BMI ≥ 40 kg/m2). Based on this classification our 
study group had 4 (3%) underweight individuals, 89 (65%) normal and 43 (32%) 
overweight (Table 3.6). None of the subjects fell into the severely underweight or 
severely obese. 
Table 3.6. Distribution of the examined subjects according to the International Classification of adult 
underweight, overweight and obesity measured by BMI. 
Classification BMI (kg/m2) All Subjects 
Novafeltria 
Subjects 
Pavia 
Subjects 
Milan 
Subjects 
 
Principal 
cut-off points 
Additional 
cut-off points 
23.52 
(17.58–
38.5) 
23.31 
(17.58–32.3) 
24.56 
(18.29–
38.5) 
21.70 
(18.70–
31.96) 
Underweight <18.50 <18.50 4 3 1 – 
Normal range 18.50–24.99 
18.50–22.99 55 14 15 26 
23.00–24.99 34 8 20 6 
Overweight ≥25.00 ≥25.00 43 11 23 9 
Total   136 36 59 41 
Figure 3.5 illustrates the distribution of these OCPs across the main BMI categories. 
Statistical test was performed to assess the influence of BMI in individual OCP level 
and total OCPs levels in both entire data set and individual population subgroups. 
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Considering the entire data set, significant difference was observed in distribution of 
total OCP and total DDT across the 4 categories namely <18.50, 18.50–22.99, 23.00–
24.99 and ≥25.00 kg/m2 (p = 0.018 and 0.023, respectively). The median levels of total 
OCP in these categories were 1097, 3050, 1359, 1855 pmol/g lipid (for total OCP) and 
696, 2497, 963 and 1307 pmol/g lipid (for total DDT). However when analyses were 
restricted to individual sites, the significance value of p,p'-DDE fell exactly on the limit 
of significance level (p = 0.050) for Pavia group. Otherwise there was no evidence of 
significant difference in distribution of all other individual OCPs and total OCP across 
the BMI categories in all investigated population subgroups. 
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Figure 3.2. Distribution of OCPs concentration expressed in pmol/g serum lipid (logarithmic scale) among the study population stratified by geographical 
locations. Displayed results are for total OCP, total DDT and some individual OCPs with significantly different distribution across the investigated study sites. 
Keys: О, mild outliers; *, extreme outliers. 
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Figure 3.3. Distribution of OCPs concentration expressed in pmol/g serum lipid (logarithmic scale) among the study population stratified by gender. 
Displayed results are for total OCP, total DDT, p,p'-DDE, HCB and β-HCH with significantly different concentrations between males and females (except 
p,p'-DDD). 
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Figure 3.4. Distribution of OCPs expressed in pmol/g serum lipid (logarithmic scale) stratified by age groups. Displayed results are for total OCP, total DDT 
(overall population sample and Novafeltria samples), HCB (overall population sample), total p,p'-DDX (Novafeltria) and β-HCH (Pavia). Keys: PS, overall 
population sample; NF, Novafeltria; PV, Pavia. 
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Figure 3.5. Distribution of total OCP, total p,p'-DDT (overall population sample) and p,p'-DDE (Pavia) where significant difference was evident across 
BMI categories except for total o,p'-DDX, total p,p'-DDX and p,p'-DDD (overall population sample). The concentrations were expressed in pmol/g 
serum lipid in logarithmic scale. Keys: PS, overall population sample; PV, Pavia. 
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3.2 Polychlorinated biphenyls study  
3.2.1 Study population 
The study population is mostly composed of different subjects from that of the OCP 
study as state earlier. Table 3.7 displays the main characteristics of the study subjects. 
Only in Milan the distribution of gender was skewed with females under represented. 
The mean body weight of the subjects (69.94 kg) and mean BMI (24.36 kg/m2) are in 
accordance with those reported by Gallus et al. (2006) for a general Italian adult 
population (69.4 kg and 24.5 kg/m2, respectively). Our population had individuals who 
were fairly normal in terms of BMI. In total 372 subjects participated in the study, five 
subjects who had incomplete information were excluded from the analysis. Thus the 
final statistical analyses were based on 367 subjects (164 from Pavia, 162 from 
Novafeltria and 41 from Milan). 
Table 3.7. Main characteristics of population study subjects – PCB study. 
Characteristic 
All Subjects Novafeltria Pavia Milan 
n = 367 n = 162 n = 164 n = 41 
Males, n (% ) 182 (50.3) 81 (49.7) 70 (42.2) 31 (75.6) 
Females, n (% ) 185 (49.5) 82 (50.3) 94 (57.3) 10 (24.4) 
Age (years) 40.0 (19–70) 42.5 (19–61) 40.0 (19–70) 33.0 (19–69) 
Body weight (kg) 69.0 (42–131) 69.0 (43–110) 70.0 (42–131) 60.0 (45–90) 
BMI (kg/m2) 24.1(15.6–38.5) 24.43(15.6–38.1) 24.32(17.6–38.5) 21.70(18.7–32.0) 
Note: Genders are expressed as valid percentages (%) and absolute number (n); Body weight and 
age are expressed as medians (minima and maxima). 
3.2.2 Serum concentrations of PCB congeners 
Table 3.8 illustrates the frequency determination of serum PCBs among the study 
subjects. For better understanding of complex pattern of PCB congeners occurring in 
samples, PCB congeners were classified in five classes according to the increasing 
number of chlorine atoms in their structures i.e. tri–, tetra–, penta–, hexa– and hepta–
chlorobiphenyls (CBs) and according to toxicological characteristics, according to their 
insertion into the dioxin–like (DL–PCBs) or non dioxin-like PCBs (NDL–PCBs). Thus, 
levels of PCBs were computed from the individual results of sample analysis as follows: 
• total PCB as sum of 15 PCB congeners (Σ28, 31, 52, 77, 101, 105, 118, 126, 138, 
153, 156, 167, 169, 180); 
• total tri–CBs as the sum of PCBs 28 and 31; total tetra–CBs as the sum of PCBs 52 
and 77; total penta–CBs as the sum of 4 PCBs (Σ101, 105, 118, 126), total hexa-
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CBs as the sum of 5 PCBs (Σ128, 138, 153, 156, 169) and total hepta–CBs as the 
sum of PCB 170 and 180; 
• total DL–PCBs as the sum of 6 DL–PCBs (Σ77, 105, 118, 126, 156, 169); total 
NDL–PCB as the sum of 9 NDL–PCBs (Σ28, 31, 52, 101, 118, 138, 153, 167, 180). 
To account for the undetected congeners, censored data corresponding to half LoDs for 
each congener were included in the summations (Table 3.9). 
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Table 3.8. Absolute and percentage frequency of PCB congeners as measured in the serum of 
subjects in the general population of the three Italian population subgroups. 
PCB N˚Cl 
Absolute Frequency Percentage Frequency 
All Samples Novafeltria Pavia Milan All Samples Novafeltria Pavia Milan 
n = 367 n = 162 n = 164 n = 41 n = 367 n = 162 n = 164 n = 41 
Marker PCBs 
28 3 151 81 70 ND 41.0 50 42.7 ND 
52 4 170 10 150 10 46.2 6.2 91.5 23.8 
101 5 4 4 ND ND 1.1 2.5 ND ND 
118 5 182 146 36 ND 49.5 90.1 22 ND 
138 6 366 162 164 40 99.5 100 100 95.2 
153 6 366 162 164 40 99.5 100 100 95.2 
180 7 362 162 164 36 98.4 100 100 85.7 
DL–PCBs (non-ortho) 
77 4 5 3 2 ND 1.4 1.9 1.2 ND 
81 4 0 ND * * ND ND * * 
126 5 2 2 ND ND 0.5 1.2 ND ND 
169 6 6 4 2 ND 1.6 2.5 1.2 ND 
DL–PCBs (mono-ortho) 
105 5 13 10 3 ND 3.5 6.2 1.8 ND 
118 5 182 146 36 ND 49.5 90.1 22.0 ND 
156 6 276 138 138 ND 75.5 85.2 84.1 ND 
157 6 1 ND 1 * 0.3 ND 0.6 * 
167 6 75 17 58 * 20.4 10.5 35.4 * 
189 7 2 2 * * 0.5 1.2 * * 
NDL–PCBs 
28 3 151 81 70 ND 41.0 50.0 42.7 ND 
31 3 139 64 75 ND 37.8 39.5 45.7 ND 
44 4 65 ND 65 * 17.7 ND 39.6 * 
47 4 292 156 136 * 79.3 96.3 82.9 * 
49 4 66 ND 66 * 17.9 ND 40.2 * 
52 4 170 10 150 10 46.2 6.2 91.5 23.8 
61 4 29 25 4 * 7.9 15.4 2.4 * 
66 4 128 26 102 * 34.8 16.0 62.2 * 
70 4 136 19 117 * 37.0 11.7 71.3 * 
74 4 307 151 156 * 83.4 93.2 95.1 * 
99 5 105 102 3 * 28.5 63.0 1.8 * 
101 5 4 4 ND ND 1.1 2.5 ND ND 
128 6 6 3 ND 3 1.6 1.9 ND 7.1 
138 6 366 162 164 40 99.5 100 100 95.2 
146 6 190 73 117 * 51.6 45.1 71.3 * 
149 6 152 ND 152 * 41.3 ND 92.7 * 
153 6 366 162 164 40 99.5 100 100 95.2 
170 7 332 160 164 8 90.2 98.8 100 19 
171 7 94 34 60 * 25.5 21.0 36.6 * 
172 7 94 57 37 * 25.5 35.2 22.6 * 
177 7 172 86 86 * 46.7 53.1 52.4 * 
180 7 362 162 164 36 98.4 100 100 85.7 
183 7 231 134 97 * 62.8 82.7 59.1 * 
187 7 299 159 140 * 81.3 98.1 85.4 * 
190 7 115 73 42 * 31.3 45.1 25.6 * 
193 7 136 84 52 * 37.0 51.9 31.7 * 
Keys: N˚Cl, number of chlorine atoms; *, the PCB congener not investigated; ND, not detected; DL–PCB, 
dioxin like polychlorinated biphenyls; NDL–PCBs, non dioxin-like polychlorinated biphenyls. Note: Thirty 
six, 34 and 15 individual PCB congeners were investigated in Novafeltria, Pavia and Milan, respectively. 
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Table 3.9. Results of PCB congeners measurements (in pmol/g serum lipids) in 3 Italian population subgroups. 
PCB group All subjects n = 367 Novafeltria n = 162 Pavia n = 164 Milan n = 41 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. 
∑PCB 199 1131 6556 199 857 3236 340 1355 5416 310 2062 6556 
∑DL–PCB 9 96 1127 14 110 858 9 51 1127 128 167 273 
∑NDL–PCB 162 988 6221 162 742 2454 310 1278 4602 814 1781 6221 
∑Tri–CBs 3 13 594 3 9 142 4 10 594 30 39 63 
∑Tetra–CBs 3 24 884 3 7 156 5 48 414 52 72 884 
∑Penta–CBs 2 61 1060 9 79 763 2 13 1060 58 76 125 
∑Hexa–CBs 107 615 4401 112 494 1591 155 721 2997 107 1280 4401 
∑Hepta–CBs 21 303 1855 38 261 1234 64 347 1628 21 423 1855 
 
 
 
 
 85 
3.2.3 Distribution of PCB congeners by places of residence 
Novafeltria 
The median total PCB in Novafeltria was 857 pmol/g lipid whereas total DL– and 
NDL–PCB were 110 and 742 pmol/g lipid, respectively. Total hexa–CBs presented the 
highest median concentration of 493 pmol/g lipid followed by total hepta–CBs (261 
pmol/g lipid) (Table 3.9). PCB 138, 153, 180, 170, 156 and 118 were detected in 
between 85–100% of the samples with median levels of 174, 265, 189, 77, 30 and 70 
pmol/g lipid, respectively. PCB 77, 126 and 128 were detected in <2% of the samples 
(Table 3.8 and 3.10). 
Pavia 
The median total PCB, DL– and NDL–PCBs were 1355, 51 and 1278 pmol/g lipid, 
respectively. Total hexa– and hepta–CBs presented the highest median levels of 721 and 
347 pmol/g lipid, respectively (Table 3.9). PCB 52, 138, 153, 156, 170 and 180 
(median: 44, 294, 394, 33, 88 and 259 pmol/g lipid, respectively) were detected in 
between 84–100% of the samples. PCB 77, 105 and 169 were detected in <2% of the 
samples whereas congener 101, 126 and 128 were under LoDs (Table 3.8 and 3.10). 
Milan 
The median total PCB was 2062 pmol/g lipid. All DL–PCBs were not detected in 
Milan. As for Novafeltria and Pavia, total hexa–CBs presented the highest median 
(1281 pmol/g lipid) followed by hepta–CBs (423 pmol/g lipid). Total tetra–CBs had the 
median of 72 pmol/g lipid (Table 3.9). Of 15 PCB congeners investigated, six were 
above the LoDs the most prevalent ones being PCB 138, 153 and 180 with median 
concentrations of 532, 668 and 403 pmol/g lipid, respectively. PCBs 52, 170 and 128 
were the least abundant congeners (Table 3.8 and 3.10). 
Comparison among places of residence 
The distribution of total PCB, total DL–PCB, total tri–, tetra–, penta–, hexa– and hepta–
CBs concentrations were significantly different across the sites (p < 0.0001). The 
median levels of these PCB groups follow the order Novafeltria < Pavia < Milan with 
exception of total DL–PCB and penta–CBs. Based on PCB homologues in overall 
population, the order is ∑hexa–CBs > ∑hepta–CBs > ∑penta–CBs > ∑tetra–CBs > 
∑tri–CBs (Table 3.11). 
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The highly prevalent PCBs were 138, 153, 156, 170 and 180 in overall population and 
in individual sites with exception of 156 and 170 in Milan which were under LoDs. 
These congeners differed significantly across the sites (p < 0.0001; Figure 3.6). The 
median levels of PCB 138, 153 and 180 follows the order 138 < 180 < 153 for 
Novafeltria and Pavia with a slight change in Milan (180 < 138 < 153). PCB 153 had 
the highest median concentrations in each site. 
PCB 52 was more prevalent in Pavia (92%). PCB 118 (Novafeltria) and PCB 156 
(Novafeltria and Pavia) were detected in >50% samples whereas PCB 28 and 31 were 
detected in <50% of the samples in each site. PCB 126 was detected in only two 
samples both from Novafeltria (Table 3.8). 
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Table 3.10. Median, minimum and maximum concentrations of 15 PCB congeners measured in the sera of subjects of the general population 
recruited in 3 Italian population subgroups (expressed in pmol /g serum lipid). 
PCBs N°Cl 
All subjects (n = 367) Novafeltria (n = 162) Pavia (n = 164) Milan (n = 41) p 
value Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. 
NLD–PCBs 
28 3 2 nc 353 2 nc 67 2 nc 353 15 nc 32 0.000 
31 3 2 nc 336 2 nc 89 2 nc 336 15 nc 32 0.000 
52 4 2 nc 830 2 nc 153 3 44 409 13 nc 830 0.000 
101 5 0.47 nc 102 2 nc 102 0.47 nc 5 12 nc 25 0.000 
128 6 0.42 nc 506 1 nc 53 0.42 nc 5 21 nc 506 0.000 
138 6 13 236 1612 49 174 685 41 294 1223 13 532 1612 0.000 
153 6 13 342 2205 27 265 884 77 394 1704 13 668 2205 0.000 
170 7 3 75 1010 3 772 279 10 88 353 10 nc 1010 0.000 
180 7 10 223 1616 35 190 955 47 259 1275 10 403 1616 0.000 
DL–PCBs 
77 4 1 nc 84 2 nc 55 1 nc 50 39 nc 84 0.000 
126 5 0.47 nc 115 2 nc 115 0.47 nc 5 23 nc 50 0.000 
169 6 0.42 nc 328 1 nc 328 0.42 nc 46 21 nc 45 0.000 
105 5 0.47 nc 210 2 nc 210 0.47 nc 206 12 nc 25 0.000 
118 5 0.47 nc 845 2 70 547 0.47 nc 845 12 nc 25 0.000 
156 6 2 28 143 2 25 96 2 33 143 21 nc 45 0.066 
Keys: N˚Cl, number of chlorine atoms attached to biphenyl ring; nc, not computed since the congeners were detected in less than 50% of the samples in the 
respective group. 
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Table 3.11. Median, minimum and maximum concentrations of total PCBs in three Italian population subgroups (expressed in pmol /g serum lipid). 
PCB group 
All Subjects (n = 367) Novafeltria (n = 162) Pavia (n = 164) Milan (n = 41) p value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. 
∑PCB 199 1131 6556 199 857 3236 340 1355 5416 3104 2062 6556 0.000 
∑DL–PCBs 9 96 1127 14 110 857 9 51 1127 128 167 273 0.000 
∑NDL–PCBs 147 1004 6317 176 756 2473 323 1283 4609 147 1870 6317 0.000 
∑Tris–CBs 3 13 593 3 9 142 4 10 593 30 39 63 0.000 
∑Tetra–CBs 3 24 884 3 7 156 5 48 414 52 72 884 0.000 
∑Penta–CBs 2 61 1060 9 79 763 2 13 1060 58 76 125 0.000 
∑Hexa–CBs 107 615 4401 112 493 1591 155 721 2997 107 1281 4401 0.000 
∑Hepta–CBs 21 303 1855 38 261 1234 64 347 1628 21 423 1855 0.000 
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Figure 3.6. Distribution of serum PCB 138, 153, 180, 170, 118 and 156 in pmol/g lipid (logarithmic scale) among the study population stratified by residence. 
Displayed results had significant different concentrations between the areas of residence. Keys: О, mild outliers; *, extreme outliers. 
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3.2.4 Distribution of PCBs by gender 
A total of 182 females and 185 males were investigated. The median total PCB levels 
were 1142 and 1051 pmol/g lipid, respectively. There was no evidence for the 
difference in distribution of total PCB levels between genders. However, total DL–PCB 
levels were significantly higher in females than in males (median 120 and 75 pmol/g 
lipid, respectively; p < 0.0001). Significant difference was also evident for total penta-
CBs concentration (median 78 and 17 pmol/g lipid, respectively; p < 0.0001, Figure 
3.7). 
In overall population sample, PCB 118 was detected in 102 females (56%) with median 
concentration of 52 pmol/g lipid while in males it was detected in 80 samples (43%). 
The distribution of this congener differed significantly by gender (p < 0.0001). PCB 128 
was least prevalent detected in 1.7 and 1.6% of females and males, respectively. 
As observed in overall population, no evidence of variation of total PCB concentrations 
between genders in individual sites. However, the distribution of total DL–PCB and 
total penta–CBs differed significantly by gender in Novafeltria and Pavia. As for total 
tetra–CBs, the distribution differed significantly between genders in only Novafeltria (p 
= 0.045). No evidence of significant difference in distribution of most congeners 
between genders with exception of PCB 52 and 105 (in Novafeltria) and 118 
(Novafeltria and Pavia) (Table 3.12). 
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Figure 3.7. Distribution of total -PCB, -DL–PCB, -NDL–PCB, -penta–CBs, PCB 128 and 118 by gender expressed in pmol/g serum lipid (logarithmic scale) in the overall population 
sample (PS). Displayed results had significant different concentrations between females and males with exception of total -PCB and -NDL–PCB. Keys: О, mild outliers; *, extreme 
outliers. 
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Table 3.12. Medians, minima and maxima concentrations (in pmol/g serum lipids) for PCB congeners stratified by residence and sex. 
  Novafeltria n = 162 Pavia n = 164 Milan n = 41 
PCB Female n = 81 Male n = 81 p  Female n = 70 Male n = 94 p Female n = 31 Male n = 10 p 
 Min. Med. Max. Min. Med. Max. value Min. Med. Max. Min. Med. Max. value Min. Med. Max. Min. Med. Max. value 
NLD–PCBs 
28 2 nc 57 2 6 67 0.999 2 nc 353 2 nc 351 0.203 15 nc 32 15 nc 28 0.445 
31 2 nc 63 2 nc 89 0.826 2 nc 336 2 nc 280 0.842 15 nc 32 15 nc 28 0.445 
52 2 nc 57 2 nc 153 0.037 3 47 409 3 42 407 0.271 13 nc 830 14 nc 269 0.964 
101 2 nc 98 2 nc 102 0.061 2 nc 5 1 nc 5 0.328 12 nc 25 12 nc 22 0.445 
128 2 nc 4 1 nc 53 0.151 2 nc 5 0.4 nc 5 0.328 21 nc 506 21 nc 40 0.200 
138 49 175 685 51 173 607 0.782 92 316 889 41 268 1223 0.364 13 572 1612 374 492 635 0.286 
153 55 255 846 27 286 884 0.633 119 403 1160 77 347 1704 0.458 13 763 2205 435 566 803 0.143 
170 3 73 184 3 81 279 0.216 10 94 292 16 85 354 0.934 10 nc 855 10 nc 1010 0.643 
180 42 178 830 35 198 955 0.332 49 254 687 47 261 1275 0.813 11 412 1616 10 391 1587 0.823 
DL–PCBs 
77 2 nc 56 2 nc 5 0.060 1.8 nc 29 0.5 nc 50 0.422 39 nc 84 405 nc 75 0.445 
126 2 nc 115 2 nc 496 0.061 1.7 nc 5 0.5 nc 5 0.328 23 nc 50 24 nc 44 0.445 
169 2 nc 328 1 nc 61 0.083 1.5 nc 43 0.4 nc 46 0.432 21 nc 45 21 nc 40 0.445 
105 2 nc 210 2 nc 180 0.030 1.7 nc 5 0.5 nc 206 0.312 12 nc 25 12 nc 22 0.445 
118 3 81 547 2 58 490 0.000 1.9 nc 407 0.5 nc 845 0.005 12 nc 25 12 nc 22 0.445 
156 2 24 90 2 28 96 0.434 2.2 34 143 1.8 29 140 0.445 21 nc 45 21 nc 40 0.445 
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3.2.5 Distribution of PCBs by age 
Subjects’ age were categorized into 4 groups: 10–25, 26–40, 41–55 and 56–70. Majority 
of subjects had age between 26–40 and 41–55. Compared to other sites, Milan had 
fewer subjects in age group 26–40, 41–55 and 56–70 whereas Novafeltria had fewer 
subjects in group 10–25 (Table 3.13). 
Table 3.13. Absolute frequency of study subjects in each age 
category for the overall and individual population subgroups. 
Age 
Class 
All 
Subjects Novafeltria Pavia Milan 
10-25 32 7 13 12 
26-40 159 66 73 20 
41-55 136 73 55 8 
56-70 40 16 23 1 
Total 367 162 164 41 
In the overall population sample, the median concentrations of total PCB, total DL–
PCBs, total NDL–PCBs, total hexa– and hepta–CBs increased consistently across the 
age groups (p < 0.0001). The trend was inconsistent for the total tri–, tetra– and penta–
CBs. The median concentrations of PCB 138, 153, 180, 156 and 170 presented 
statistically significant increasing trend across these age groups (p < 0.0001) (Figure 
3.8 and 3.9). 
In individual sites, similar trends and significance levels were observed for Novafeltria 
and Pavia populations. In Milan PCB 153 and 180 levels were shown to increase 
consistently and significantly (p = 0.032 and 0.033, respectively) (Figure 3.10 and 
3.11). Although PCB 138 had median concentrations which tend to increase across the 
age groups, there was no evidence of significant difference in its distribution along 
these age groups. 
The trends observed were supported by positive correlations between subjects’ age and 
some PCB congeners. In the overall population sample, PCB 138, 153, 156, 170 and 
180 had positive correlations between 0.285 and 0.569 (p < 0.0001). Correlations 
observed in Novafeltria were between 0.404 and 0.670 and in Pavia were between 0.424 
and 0.666. PCB 118 correlated significantly with age in Novafeltria (r = 0.267, p = 
0.001). In Milan, positive correlations were observed for PCB 138, 153 and 180 (r = 
0.346, p = 0.027; r = 0.417, p = 0.007 and r = 0.329, p = 0.035; respectively). In all sites 
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age correlated positively with total PCB (r = 0.598, p < 0.0001; r = 0.545, p < 0.0001; r 
= 0.327, p = 0.037; for Novafeltria, Pavia and Milan, respectively) but at different 
levels; Novafeltria and Pavia at 0.01 level while Milan at 0.05 level (Table 3.14). 
Table 3.14. Correlations between age and serum PCBs levels in the 3 Italian population 
subgroups (Spearman). 
PCBs N˚Cl 
Novafeltria Pavia  Milan  
r p–value r p–value r p–value 
138 6 0.573 <0.0001 0.523 <0.0001 0.346 0.027 
153 6 0.568 <0.0001 0.571 <0.0001 0.417 0.007 
156 6 0.545 <0.0001 0.516 <0.0001 -0.400 0.009 
170 7 0.641 <0.0001 0.578 <0.0001 -0.040 0.787 
180 7 0.670 <0.0001 0.666 <0.0001 0.329 0.035 
∑PCB  0.598 <0.0001 0.545 <0.0001 0.327 0.037 
∑DL–PCB  0.404 <0.0001 0.424 <0.0001 -0.404 0.009 
3.2.6 Distribution of PCBs by BMI 
The minimum and maximum BMI in the study population were 15.6 and 38.5 kg/m2, 
respectively. Based on international classification of BMI our population had 5 
underweight individuals (1%), 213 normal (58%) and 149 overweight (41%). None of 
the subjects were severely underweight or severely obese. The influence of BMI in 
distribution of PCBs was assessed. 
Significant difference in distribution across BMI categories was observed for PCB 170 
(p = 0.010). Though not significant, consistent increase in median concentrations was 
observed for PCB 138 across the categories (median: 204, 239, 241 and 243 pmol/g 
lipid). The median concentrations of PCB 153 and 180 tend to increase across the 
categories but the trends were inconsistent (Table 3.15–3.18). Correlation analyses 
supported the observed trends. Thus significant correlations with BMI were observed 
for PCB 170 (overall sample); 138 (Novafeltria); 138, 153, 180 and 170 (Pavia). In 
Milan this relationship was not observed. All significant correlations observed range 
between 0.182 and 0.197 (Table 3.19). 
When analyses were stratified by gender while controlling for places of residence and 
age we found a weak positive relationship between BMI and PCB 118 concentration in 
females of overall population (r = 0.032; p = 0.030). Inverse relationship was observed 
with PCB 28 and 31 in females (r = -0.031, p = 0.01; r = -0.026, p = 0.029, respectively) 
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whereas in males the relationship was observed with PCB 101, 128, 180 and 156 (r = -
0.011, p = 0.02; r = -0.011, p = 0.04; r = 0.010, p = 0.050; r = -0.018, p = 0.044). When 
analyses were stratified by places of residence and gender while controlling for age a 
weak positive relationship between BMI and PCB 118 among females of Pavia (r = 
0.064; p = 0.038) was observed. Inverse relationship with PCB 180 was observed in 
female and male subjects of Novafeltria (r = -0.016, p = 0.033; r = -0.013, p = 0.043, 
respectively) and with PCB 28 in only females of the same population subgroup (r = -
0.0.036, p = 0.007). 
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Figure 3.8. Distribution of total -PCB, -DL–PCB, -NDL–PCB, penta–, hexa– and hepta–CBs levels by age group expressed in pmol/g serum lipid 
(logarithmic scale) in the pooled sample (PS). Displayed results had significant different concentrations across the groups with exception of total penta–
CBs. Keys: О, mild outliers; *, extreme outliers. 
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Figure 3.9. Distribution of PCB 153, 138, 180, 169, 156 and 170 concentrations by the age groups expressed in pmol/g serum lipid (logarithmic scale) in 
the pooled sample (PS). Displayed results had significant different concentrations across the groups. Keys: О, mild outliers; *, extreme outliers.  
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Figure 3.10. Distribution of PCB 153 and 180 concentrations by age groups expressed in pmol/g lipid (logarithmic scale). Displayed results had 
significant different concentrations across the groups. Keys: О, mild outliers; ٭, extreme outliers; NF, Novafeltria; PV, Pavia; MI, Milan. 
 
 
 
 99 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
10000
1000
100
10
40
PCB 138 - NF
p < 0.0001
 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
10000
1000
100
10
284
301
302
PCB 138 - PV
p < 0.0001
 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
10000
1000
100
10
350
346
343
PCB 138 - MI
p = 0.095
 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
1000
100
10
33
119
66
111
31
32
PCB 170 - NF
p < 0.0001
 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
1000
100
10
195
208
189
301
PCB 170 - PV
p < 0.0001
 
Age groups
56-7041-5526-4010-25
p
m
o
l
/
g
 
s
e
r
u
m
 
l
i
p
i
d
1000
100
10
358
357 339
360
PCB 170 - MI
p = 0.486
 
Figure 3.11. Distribution of PCB 138 and 170 concentrations by age groups expressed in pmol/g lipid (logarithmic scale). Displayed results showed 
significant different concentrations across the groups with exception of PCB 138 and 170 in Milan (MI). Keys: О, mild outliers; *, extreme outliers; NF, 
Novafeltria; PV, Pavia. 
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Table 3.15. All subjects stratified by BMI categories. 
PCBs 
BMI Categories   % detection of individual congeners in each BMI group when 
half are not included 
<18.50 18.50–22.99 23.00–24.99 >25.00 
P value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. <18.50 18.50–22.99 23.00–24.99 >25.00 
28 8 28 47 2 nc 353 3 nc 161 2 nc 351 0.098 100 40 34 44 
31 7 19 54 2 nc 336 3 nc 253 2 nc 280 0.054 100 39 29 39 
52 3 nc 89 2 nc 830 2 nc 304 2 nc 407 0.226 40 48 42 47 
101 3 nc 4 2 nc 98 2 nc 102 0.47 nc 17 0.001 0 1 3 0 
128 2 nc 4 1 nc 506 2 nc 53 0.42 nc 233 0.003 0 1 3 2 
138 96 203 208 13 230 1612 51 241 871 41 243 1223 0.433 100 99 100 100 
153 120 251 341 13 339 2205 70 357 1049 27 339 1704 0.454 100 99 100 100 
170 35 50 109 3 65 855 12 83 257 3 83 1010 0.010 100 85 94 95 
180 49 117 264 10 225 1616 58 220 651 11 227 1070 0.280 100 98 100 99 
77 3 nc 22 2 nc 84 2 nc 59 0.52 nc 58 0.002 20 1 0 1 
126 3 nc 115 2 nc 50 2 nc 49 0.47 nc 35 0.001 20 0 2 0 
169 2 nc 328 1 nc 45 2 nc 56 0.42 nc 61 0.002 20 1 2 1 
105 3 nc 4 2 nc 110 2 nc 175 0.47 nc 210 0.014 0 1 5 5 
118 3 nc 87 2 nc 270 2 nc 549 0.47 41 845 0.937 40 47 48 53 
156 4 21 62 2 27 143 2 27 97 2 30 140 0.560 80 72 75 79 
∑PCB 393 809 1553 214 1138 6556 304 1147 3000 199 1112 5416 0.589 100 97 100 100 
∑DL–PCB 25 76 611 14 108 371 15 84 817 9 90 1127 0.613 80 75 77 84 
∑NDL–PCB 368 734 981 147 1067 6317 242 1037 2885 176 976 4374 0.389 100 97 100 100 
∑Tri–CBs 15 47 100 3 nc 593 5 nc 406 4 nc 582 0.053 100 44 37 47 
∑Tetra–CBs 7 25 92 3 nc 884 4 nc 307 3 nc 411 0.089 60 48 42 48 
∑Penta–CBs 11 nc 204 8 nc 332 10 nc 732 2 57 1060 0.668 40 47 48 53 
∑Hexa–CBs 227 521 918 107 613 4401 154 652 2024 114 611 2997 0.621 100 97 100 100 
∑Hepta–CBs 85 167 352 21 297 1855 83 311 903 29 310 1568 0.196 100 100 100 100 
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Table 3.16. Novafeltria subjects stratified by BMI groups. 
PCBs 
BMI Categories   % detection of individual congeners in each BMI group when 
half are not included <18.50 18.50–22.99 23.00–24.99 >25.00 
p value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. <18.50 18.50–22.99 23.00–24.99 >25.00 
28 8 28 41 2 9 67 3 nc 53 2 nc 358 0.035 100 57 41 45 
31 74 19 23 2 nc 63 3 nc 89 2 nc 43 0.036 100 46 24 387 
52 3 nc 5 2 nc 153 2 nc 4 2 nc 60 0.058 0 8 0 7 
101 3 nc 4 2 nc 98 2 nc 102 2 nc 5 0.013 0 3 7 0 
128 3 nc 4 1 nc 4 2 nc 53 1 nc 19 0.039 0 0 7 1 
138 96 193 208 49 151 607 51 235 485 51 192 685 0.160 100 100 100 100 
153 120 217 319 52 227 884 70 355 770 27 293 787 0.430 100 100 100 100 
170 35 50 109 3 70 222 16 100 188 3 79 279 0.395 100 98 100 99 
180 90 117 233 40 177 830 58 216 522 35 190 955 0.753 100 100 100 100 
77 3 nc 22 2 nc 55 2 nc 4 2 nc 5 0.012 33 2 0 1 
126 3 nc 115 2 nc 4 2 nc 49 2 nc 5 0.008 33 0 3 0 
169 3 nc 328 1 nc 32 2 nc 56 1 nc 62 0.013 33 2 3 1 
105 3 nc 4 2 nc 110 2 nc 133 2 nc 210 0.109 0 3 7 9 
118 4 83 87 3 70 205 3 71 181 2 68 547 0.815 67 92 86 91 
156 4 21 60 2 23 96 2 34 83 2 26 92 0.476 67 87 93 81 
∑PCB 393 753 1553 214 751 2448 304 1092 2255 199 875 3236 0.714 100 100 100 100 
∑DL–PCB 25 120 611 18 112 341 16 118 402 14 106 857 0.946 67 95 97 93 
∑NDL–PCB 368 633 942 181 647 2280 242 970 2002 176 777 2473 0.515 100 100 100 100 
∑Tri–CBs 15 47 63 3 10 120 5 nc 142 4 8 78 0.021 100 59 41 51 
∑Tetra–CBs 7 nc 25 3 nc 156 4 nc 9 3 nc 65 0.036 33 8 0 9 
∑Penta–CBs 17 96 204 12 82 332 11 79 419 9 79 763 0.781 67 92 86 91 
∑Hexa–CBs 227 436 918 112 408 1591 154 652 1345 114 536 1457 0.313 100 100 100 100 
∑Hepta–CBs 125 167 342 45 239 923 83 311 710 38 273 1234 0.671 100 100 100 100 
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Table 3.17. Pavia subjects stratified by BMI groups. 
PCBs 
BMI Categories   % detection of individual congeners in each BMI 
group when half are not included <18.50 18.50–22.99 23.00–24.99 >25.00 
 p value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. Min. Med. Max. <18.50 18.50–22.99 23.00–24.99 >25.00 
28 24 35 47 2 nc 353 3 nc 161 2 nc 351 0.742 100 39 32 49 
31 10 32 54 2 nc 336 3 nc 253 2 nc 280 0.809 100 48 39 46 
52 41 65 89 3 46 409 4 35 304 3 45 407 0.628 100 95 84 91 
101 3 nc 3 2 nc 4 2 nc 5 0.47 nc 5 0.036 0 0 0 0 
128 2 nc 3 1 nc 4 2 nc 5 0.42 nc 4 0.035 0 0 0 0 
138 203 205 207 79 285 889 98 242 871 41 377 1223 0.227 100 100 100 100 
153 251 296 341 113 383 1360 142 343 1049 77 496 1704 0.232 100 100 100 100 
170 36 62 88 10 85 353 27 75 252 16 116 328 0.096 100 100 100 100 
180 49 157 264 54 244 1275 72 216 651 47 334 999 0.066 100 100 100 100 
77 3 nc 4 2 nc 29 2 nc 6 1 nc 49 0.056 0 2 0 1 
126 3 nc 3 2 nc 4 2 nc 5 0.47 nc 5 0.036 0 0.0 0 0 
169 2 nc 3 1 nc 43 2 nc 5 0.42 nc 46 0.055 0 2 0 1 
105 3 nc 3 2 nc 4 2 nc 175 0.47 nc 206 0.034 0 0 3 3 
118 3 nc 3 2 nc 270 2 nc 549 0.47 nc 845 0.137 0 23 19 23 
156 18 40 62 2 31 143 2 15 96 2 39 140 0.061 100 87 71 87 
∑PCB 809 912 1015 340 1242 4757 440 1228 3000 340 1605 5416 0.126 100 100 100 100 
∑DL–PCB 34 55 76 14 48 371 15 36 817 9 61 1127 0.471 67 87 71 87 
∑NDL–PCB 734 857 981 323 1209 4609 421 1160 2885 331 1529 4289 0.100 100 100 100 100 
∑Tri–CBs 33 67 100 4 nc 593 6 nc 406 5 12 582 0.912 100 48 39 50 
∑Tetra–CBs 45 68 92 6 49 414 7 40 307 5 48 411 0.636 100 95 84 91 
∑Penta–CBs 11 12 13 8 12 279 9 13 732 2 12 1060 0.138 0 23 19 23 
∑Hexa–CBs 521 546 572 200 716 2321 251 589 2024 155 921 2997 0.211 100 100 100 100 
∑Hepta–CBs 85 219 352 64 327 1628 108 284 903 78 446 1321 0.068 100 100 100 100 
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Table 3.18. Milan subjects stratified by BMI groups. 
PCBs 
BMI Categories  % detection of individual congeners in each BMI group when 
half are not included 18.50–22.99 23.00–24.99 >25.00 
p value 
Min. Med. Max. Min. Med. Max. Min. Med. Max. <18.50 18.50–22.99 23.00–24.99 >25.00 
28 15 nc 32 15 nc 22 15 nc 22 0.218 0 0 0 0 
31 15 nc 32 15 nc 22 15 nc 22 0.218 0 0 0 0 
52 14 nc 830 16 nc 105 13 nc 324 0.232 0 31 20 10 
101 12 nc 25 12 nc 18 12 nc 17 0.218 0 0 0 0 
128 22 nc 506 21 nc 32 21 nc 233 0.805 0 4 0 20 
138 13 524 1612 245 619 668 376 597 1060 0.744 0 96 100 100 
153 13 661 2205 459 628 958 438 719 1574 0.665 0 96 100 100 
170 10 nc 855 12 nc 257 10 nc 1010 0.958 0 15 20 30 
180 10 402 1616 290 345 584 11 428 1070 0.856 0 89 100 80 
77 41 nc 84 40 nc 59 39 nc 58 0.218 0 0 0 0 
126 24 nc 50 24 nc 35 23 nc 35 0.212 0 0 0 0 
169 22 nc 45 21 nc 32 21 nc 31 0.218 0 0 0 0 
105 12 nc 25 12 nc 18 12 nc 17 0.218 0 0 0 0 
118 12 nc 25 12 nc 18 12 nc 17 0.218 0 0 0 0 
156 22 nc 45 21 nc 32 21 nc 31 0.218 0 0 0 0 
∑PCB 310 2120 6556 1499 1758 2483 1144 2149 4521 0.664 0 85 100 100 
∑DL–PCB 134 174 273 129 163 193 128 155 190 0.218 0 0 0 0 
∑NDL–PCB 147 1902 6317 1330 1598 2353 954 1978 4374 0.656 0 85 100 100 
∑Tri–CBs 31 40 63 30 38 45 30 36 44 0.218 0 0 0 0 
∑Tetra–CBs 55 72 884 65 69 145 52 64 369 0.229 0 31 20 10 
∑Penta–CBs 61 79 125 59 74 88 58 71 87 0.218 0 0 0 0 
∑Hexa–CBs 107 1196 4401 957 1281 1707 908 1363 2915 0.600 0 85 100 100 
∑Hepta–CBs 21 418 1855 302 358 841 29 443 1568 0.741 0 100 100 100 
 
 104 
 
 
 
 
 
 
Table 3.19. Correlations between BMI with serum PCBs levels in the 3 Italian population 
subgroups (Spearman). 
PCBs N˚Cl  
Novafeltria Pavia Milan 
r p–value r p–value r p–value 
138 6 0.157 0.046 0.186 0.017 -0.053 0.745 
153 6 0.106 0.181 0.179 0.022 -0.086 0.596 
156 6 -0.008 0.924 0.136 0.082 -0.306 0.055 
170 7 0.078 0.327 0.183 0.019 -0.113 0.489 
180 7 0.039 0.621 0.197 0.011 -0.166 0.307 
∑PCB  0.063 0.424 0.182 0.019 -0.189 0.242 
∑DL–PCB    -0.028 0.719 0.099 0.207 -0.306 0.055 
 
 
 
 
 
 
 
 
Table 3.20. Coefficient of determination (R2) and significance levels (p–values) for the relationship 
between predictor variables (age, sex, BMI, residence) and dependent variables (total PCBs). 
 ∑PCB ∑DL–PCB ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs 
Age 0.000 0.000 0.951 0.728 0.001 0.000 0.000 
Gender 0.404 0.021 0.316 0.962 0.013 0.080 0.183 
BMI 0.062 0.397 0.891 0.298 0.913 0.271 0.004 
Residence 0.000 0.124 0.000 0.000 0.123 0.000 0.000 
R2 0.445 0.082 0.055 0.253 0.061 0.452 0.360 
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CHAPTER FOUR 
DISCUSSION 
4.1 Organochlorinated pesticides study 
Exposure to ubiquitous pollutants of highly concern such as OCPs (mainly DDT) and 
chlorinated biphenyls was measured in the Italian general population starting in the 
early 1960s and more than 50 articles have reported concentrations in biological 
compartments such as blood serum, adipose tissue and human breast milk. In this article 
we address only OCPs, whilst polychlorinated biphenyls (PCBs) which were measured 
in a similar but not coincident cohort are reported and discussed. 
The population recruited in our study has, on the overall, a fair gender distribution with 
reference to that of the general Italian population derived from census 
(http://www.indexmundi.com/italy/sex_ratio.html). This is the case for the Novafeltria 
cohort, while those for Pavia and Milan are grossly skewed, with more males in Pavia 
and more females in Milan. The age distribution of our population does not match that 
of the Italian population (Gallus et al., 2006) since it lacks the extremes of age (<19 and 
>75), mainly due to the difficulty of accessing the younger and to ethical considerations 
on blood withdrawal in the very elderly. The age ranges were 22–59, 20–70 and 19–69 
for Novafeltria, Pavia and Milan subjects, respectively. Significant difference in age 
distribution was observed between these sites (KW test, p < 0.0001) with the highest 
median age (44.5 years) in Novafeltria population (Table 3.1). Lack of 
representativeness of our study sample to the general population of Italy, mainly for age 
and gender structure was unavoidable due to constraints in the experimental approach 
(collection of blood samples over time, during routine health surveys of the enrolled 
subjects). For the same reasons, we could not collect parity and lactation history data of 
women. This could be better used to explain and understand the difference in OCPs 
distribution among the gender group since breastfeeding is known to be a major 
pathway of excretion and transmission of mothers’ body burden of OCs to their 
newborns (Gladen et al., 1999). 
Although persistent OCPs such as DDT were banned in Italy since 1978, to date 
detectable levels are still found in the Italian general population as evident in this study. 
We have demonstrated a clear pattern of the level of total OCP, total DDTs, p,p'-DDE 
and HCB among the healthy residents in the three investigated locations of Italy. These 
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levels were significant different across these sites (Milan > Novafeltria > Pavia, p < 
0.0001) with Milan having the highest median level. 
To frame our results within the general picture, a summary of the levels of OCPs 
measured in various Italian regions between 1972 and 2011 is shown in Table 4.1. Data 
on the body burden of OCPs are not abundant and studies are very heterogeneous in 
sample size and in the number of target analytes. Limited sample sizes of individual 
studies and limited collection of data on exposure determinants hamper extrapolation of 
exposure estimation to the general population for health promotion purposes. The 
original studies also report OCPs concentrations using different units. To allow 
comparison of the levels of exposure with those of our study, we converted the results 
of some literature studies (Table 4.1) to pmol/g lipid as described in methodology 
section (Fängström et al., 2005). 
In their study targeted at assessing the levels of several organochlorines in human breast 
milk collected in 2000–2001 from lactating mothers in Italy, Weiss et al. (2003) found 
high concentration of DDE (approx. 27 ng/g fresh weight) from Milan samples. The 
authors hypothesized that the measured level may be due to the content of OCPs in food 
imported from countries where DDT is still used. 
As for specific sources of exposure to OCPs, a significant association between plasma 
levels of DDT, DDE and PCBs and fish consumption was demonstrated in the Swedish 
population (Asplund et al., 1994; Sarcinelli et al., 2003). Also in Italy, intensive 
harvesting of Manila Clam and fishing in the polluted Venice lagoon caused an increase 
in the concentration of POPs in mother milk and blood serum of Venetians (Raccanelli 
et al., 2009). However some studies failed to establish the evidence on the relationship 
between some POPs levels and consumption of particular type of foods (Abballe et al., 
2008). 
In our cohort the KW test revealed a significant difference in distribution of β-HCH 
with places of residence (p < 0.0001). Ingelido et al. (2009) demonstrated similar trend 
in β-HCH serum concentration distributions among investigated subjects from northern, 
central and southern Italy (p = 0.03). However, the median level observed in our study 
(123 pmol/g lipid) is higher than that reported in their study (62 pmol/g lipid), but lower 
than in Schiavone et al. (2010) study (250 pmol/g lipid). 
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HCB and p,p'-DDE are known to have long half-lives in human (To-Figueras et al., 
1997; Wolff et al., 2000). This explains their high prevalence (>90%) in our study 
population. The overall level of HCB observed in Milan population (median = 578, 
mean = 634 pmol/g lipid) is similar to that found in adipose tissue (mean 534 pmol/g 
serum lipid) reported elsewhere (Schiavone et al., 2010)). The observed level of p,p'-
DDE in our study is 177 ng/g lipid (geometric mean; data not shown), much lower than 
that in the Spanish study (geometric mean 822 ng/g lipid; Jakszyn et al., 2009). 
Variations by gender in concentrations of some OCPs were observed in our subjects. 
When the three sites were considered together females had significantly higher levels of 
p,p'-DDE than males (p < 0.0001). This difference can be due to inter-gender 
physiological differences. In consistent with previous studies (Jakszyn et al., 2009; 
Dirtu et al., 2006; Porta et al., 2010; Sala et al., 1999) we also observed higher HCB 
concentrations in women than in men. In addition to inter-gender physiological 
differences, our observation could also be related to differences in metabolism. It has 
been found that metabolism of HCB is higher in men than in women (To-Figueras et al., 
1997). As p,p'-DDE and HCB were the major contributor of total OCPs we also 
observed significant higher level of total OCPs in females than in male subjects. 
Contrary to our study previous studies reported lower level of p,p'-DDE in women than 
in men (Jakszyn et al., 2009; Dirtu et al., 2006; Porta et al., 2010; Kang et al., 2008; 
Kalantzi et al., 2011; Zumbado et al. 2005) which can be explained as the consequence 
of lactation and menstruation (Amodio et al., 2012; Mishra et al., 2011), the major 
routes of OCs excretion in females. 
In our population serum p,p'-DDT was detected in 11 and 14% of female and male 
subjects, respectively. The maximum concentration of 207 ng/g lipid (data not shown) 
was found, a level which is comparable to 257 ng/g lipids reported in Jakszyn et al. 
(2009), but almost double of that measured in Sweden (124 ng/g lipid) (Glynn et al., 
2000, 2007). In the latter study p,p'-DDT was highly prevalent detected in about 80% of 
females and 90% of males. 
The distribution of β-HCH between females and males was statistically significant 
different (Mann–Whitney U test, p = 0.008) with males showing higher median level 
than females (229 and 59 pmol/g lipids, respectively). While other studies observed the 
opposite trend for this OC (Kang et al., 2008; Porta et al., 2010), Ingelido et al. (2009) 
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failed to show the evidence for the significant differences in distribution of β-HCH 
between genders (Mann–Whitney U test, p = 0.81). This was also the case for our study 
when the analyses were restricted to the places of residence and gender. 
The differences of exposure between genders could not be accounted for as we did not 
have factors associated with our subjects that could provide better explanation. 
However, this variation is not anticipated in people of the general population (Dirtu et 
al., 2006). 
Age is one of the personal characteristics which plays a role in differentiating the levels 
of OCPs, since it defines the time frame of accumulation of biologically persistent 
chemicals. Usually it is expected that accumulation of these contaminants increase with 
age of the subjects. In this study total OCP and total DDT presented a significant 
increasing median concentration across the age groups in Novafeltria population. This 
behaviour was also evident in distribution of total p,p'-DDX (Novafeltria) and β-HCH 
(Pavia) except that the median concentration of age 41–55 was a little higher than that 
of age group 56–70  for total DDX while for β-HCH the median concentration of age 
group 41–55 was slightly lower than that of 10–25. However, significant and positive 
correlations with age were found for total OCP, total DDT, total p,p'-DDX, p,p'-DDE 
and HCB (r = 0.479, p = 0.003; r = 0.446, p = 0.006; r = 0.454, p = 0.005; r = 0.468, p = 
0.004 and r = 0.468, p = 0.004, respectively) in only Novafeltria group. Generally the 
oldest part of the population was characterised by the highest median concentrations. 
The increasing trend of median concentrations along the age groups was demonstrated 
by Ingelido et al. (2009), where 11, 18 and 39 ng/g lipid of β-HCH were found in 
subjects in the age ranges 20–35, 36–50 and 51–65 years, respectively. This behaviour 
was also observed in Porta et al. (2010) study where higher median concentrations of 
p,p'-DDE and HCB were found among the older subjects who were between 60–74 
years of age as compared to the younger ones with age between 18–29 years. Bates et 
al. (2004) also demonstrated increasing mean concentrations of dieldrin and p,p'-DDE 
along the age groups (15–24, 25–34, 35–49, 50–64 and 65+ years). 
BMI is a relative measurement of the amount of body fat in different subjects much 
used in population studies. OCPs preferentially accumulate in body fat and thus a larger 
body burden is expected in subjects with higher BMI compared to those with lower 
BMI (Table 3.6). It has been shown that individuals with more body fat tend to 
 109 
eliminate OCs more slowly than those with less body fat (Aylward et al., 2005; Furuya 
et al., 2010; Michalek and Tripathi, 1999). We observed that in overall sample, subjects 
with progressively higher BMI had higher levels of total OCP (p = 0.018) and total 
DDT (p = 0.023). There was no significant positive correlation between most OCPs and 
BMI with exception of HCB in Novafeltria (r = 0.435, p = 0.008) and Pavia (r = 0.268, 
p = 0.040). Sala et al. (1999) and Medehouenou et al. (2011) showed the increase in 
HCB, β-HCH and p,p'-DDE levels with BMI. 
General comparison of our results with other studies conducted outside Italy showed 
lower median level of p,p'-DDE (125.42 ng/g lipid) than those reported in some 
Westernized Asian countries such as Japan and Korea (221 and 224 ng/g lipid, 
respectively) (Kang et al., 2008; Tsukino et al., 2006), in other European countries such 
as Romania and Sweden (1975 and 497 ng/g lipid, respectively) (Dirtu et al., 2006; 
Glynn et al., 2003), in New Zealand (919 ng/g lipid; Zumbado et al., 2005) and in the 
USA (204 ng/g lipid; Meeker et al., 2007). However this level is slightly higher than 
100 ng/g lipid reported in the United Kingdom (Thomas et al., 2006). β-HCH had a 
median concentration of 35.68 ng/g lipid which was higher than those reported in some 
studies (Bates et al., 2004; Thomas et al., 2006 ) but lower than in other studies (Dirtu 
et al. 2006; Kang et al., 2008; Tsukino et al., 2006; Glynn et al., 2003). HCB had a 
median of 43.84 ng/g lipid which is higher than those reported in these studies (Dirtu et 
al., 2006; Kang et al., 2008; Tsukino et al., 2006; Meeker et al., 2007; Thomas et al., 
2006) but lower than that in Glynn et al. (2003) (median of 65 ng/g lipid). HCB had a 
geometric mean of 54.38 ng/g lipid (data not shown) which is lower than 379 ng/g lipid 
reported in Jakszyn et al. (2009) The observed concentrations of HCB among women in 
Novafeltria and Milan (geometric mean 193 and 564 pmol/g serum lipid, respectively) 
were higher than those observed among Italian women with endometriosis and those 
with other gynaecologic conditions (geometric mean 126 and 144 pmol/g lipid, 
respectively) (Table 4.1; Porpora et al., 2009). 
To give a final picture of the outcome of our study, a further consideration may be 
useful. In particular, in the subjects who live in Milan and who are younger, many 
OCPs (β-HCH, p,p'-DDT, o,p'-DDE, o,p'-DDD in all genders and o,p'-DDT in females) 
were not detected. However those which were detected surprisingly presented higher 
levels than in the older subjects of Novafeltria and Pavia. Milan is an industrial city in 
Northern Italy where DDT and other chlorinated insecticides were used with much 
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lower frequency than in other regions, such as rural and Southern Italy. In the same 
decades when DDT was used, Milan hosted a high immigration of formerly rural 
workers from Center and Southern Italy, which raised its population by approx. 30% 
from 1950 to 1970. It is thus conceivable that the high level of OCPs observed in the 
current inhabitants of Milan may be due to several factors, among which: (a) the body 
burden of people coming from DDT–treated areas, including the contribution of 
contaminated agricultural food and (b) for the younger subjects, transmission of 
mothers’ body burden of DDT through pregnancy and breastfeeding. On the contrary, 
Pavia experienced much less and later immigration from remote areas of Italy while 
Novafeltria never attracted considerable immigration from distant places. Mobility 
census in Italy was abolished in the early 1970s, demographic data of the examined 
subjects were not considered when this research was planned and this information is no 
more retrievable, due to the anonymity of subjects after the questionnaire was filled in, 
in order to test this hypothetical explanation. 
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Table 4.1. Concentrations of OCPs (in pmol/g serum lipid) in blood serum and in other body compartments of Italians living in various regions (1972–2011). 
Reference Sample 
size Study Population Location 
Sampling 
Year 
Body 
Compartment β-HCH HCB p,p'-DDT 
o,p'-
DDT p,p'-DDE 
o,p'-
DDE 
p,p'-
DDD o,p'-DDD 
Cocco et al. (2004) 107 
Men who sprayed 
DDT in the 1946-1950 
anti-malarial 
campaign 
Sardinia – Blood Serum   18120–35384h  
170174– 
332310h    
Ingelido et al. 
(2009) 116 General Population 
Rome 2008–2009 Blood serum 43h        
Brescia   86h        
Naples   77h        
Porpora et al. (2009) 158 
Women who 
underwent surgery for 
endometriosis or  Rome 2004–2005 Blood serum 
 126k   1380k    
other gynaecologic 
conditions  144
k
   953k    
Turci et al. (2010a) 95 General population 
Novafeltria 
– Blood serum 
 127–248h  58–113h 294–575
h 
 23–46h 15–29h 
Pavia  70–136h  233–455h 116–227
h
  75–146h 56–108h 
Giannandrea et al. 
(2011) 98 
Testicular cancer 
patients and healthy 
men who underwent 
andrological 
examination 
Rome 2006–2008 Blood Serum  398–778j   516–1007j    
This study  137 General population 
Novafeltria  
Blood serum 
340h 209h 213h 335h 450h 34h 49h 27h 
Pavia – 324h 100h 175h 365h 173h 59h 135h 81h 
Milan  – 566h 395h 1747h 4294h - 527h  
Bergonzi et al. 
(2011) 70 
Women in highly 
polluted urban area  Brescia 2006 
Mother serum  77–150h   413–80h    
Cord serum  24–47h   0.79h    
Serum  68h   353h    
Placenta  70h   197h    
Adipose tissue  91h   635h    
Abballe et al. (2008) 39 Breast feeding 
mothers 
Venice 1998–2000 Human Breast 
Milk 
  
133–246l 27–124l  660–1604l    
Rome 2000–2001 
 
179m 124m  1384m    
Di et al. (1990) 93 Breast feeding 
mothers 
Rome 
Florence 1982–1985 
Human Breast 
Milk   7
h
  34h    
Larsen et al. (1994)  Breast feeding 
mothers 
4 Italian 
cities – 
Human Breast 
Milk 
2068–
4038i 2687–5248
i
 1735–3388i  30081–58742i    
Franchi and Focardi 
(1991) 56 
Breast-feeding 
mothers  
Certaldo 
 
Human Breast 
Milk 
 1299i 987i  7157i    
Grosseto  2223i 841i  7138i    
 112 
Table 4.1. Concentrations of OCPs (in pmol/g serum lipid) in blood serum and in other body compartments of Italians living in various regions (1972–2011). 
Reference Sample 
size Study Population Location 
Sampling 
Year 
Body 
Compartment β-HCH HCB p,p'-DDT 
o,p'-
DDT p,p'-DDE 
o,p'-
DDE 
p,p'-
DDD o,p'-DDD 
Focardi et al. (1986) 26 Patients admitted for general surgery Siena 1983–1984 Adipose tissue  2260
i
 830i  7350i    
Schiavone et al. 
(2010) 12 
Patients from general 
surgery unit Siena 2005–2006 Adipose tissue 250
i
 534i <28i <28i 6330i <31i 53i <31i 
Gallelli et al. (1995) 28 Deceased males and females  Genua 1989 Adipose tissue 732
i
  181i  1242i 732i  18i 
Mariottini et al. 
(2002) 18  Central Italy 1997–2000 Adipose tissue  1239
i
       
De Felip et al. 
(2004) 12 
Women attending 
fertility clinic who 
underwent multiple 
ovulation and oocyte 
retrieval  
Rome 2000 Follicular fluids  242–256   1981–2610    
Prati et al. (1972) 85 General Population between 1–80 years Ferrara 1966–1969 
Autopsy fat   1.6–3.0n, i  3.8–7.5n,i    
Biopsy fat   1.0–2.0n,i  2.7–5.3n,i    
Liver   2.4–4.7o, i  2.4–4.7o,i    
Kidney   1.7–3.2o, i  2.4–4.7o,i    
Brain   8.5–16.6p,i  1.2–2.3p,i    
Spleen   1.5–3.0p, i  4.2–8.3p,i    
Keys: h, median; I, mean; j, maximum level; k, geometric mean; l, range; m, individual measurement of the pooled sample; n, concentrations are multiplied by 106; o, concentrations are multiplied by 
105; p, concentrations are multiplied by 104. 
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4.2 Polychlorinated biphenyl study 
This study is one of the largest performed in Italy and in Western Europe, as for the 
number of examined subjects. Samples were taken from the participating subjects 
within the frame of population-wide surveys. Some pertinent information such as 
women’s reproductive histories, general health status with reference to degenerative 
illnesses, not to say clinical parameters such as peripheral sex hormone levels were not 
available, nor requested for. There is no chance whatsoever to retrieve this information 
retrospectively, since sample anonymization was performed well before samples were 
delivered to the laboratory for PCBs and OCPs measurements. The four determinants of 
PCB body burden which can be considered in a causative analysis given the information 
which could be collected on the subjects of our study are residence, gender, body mass 
and age. 
To understand the magnitude of exposure in our population, we compare our results 
with previous results of studies (Apostoli et al., 2005; Bergonzi et al., 2009; De Felip et 
al., 2004, 2008; Donato et al., 2008; Porpora et al., 2006, 2009; Turci et al., 2004, 2006, 
2010a; Turrio-Baldassarri et al., 2008) published in the literature and collected in Table 
4.2. For the epidemiological studies reported, only the data for control groups were 
considered, to reflect levels of exposure in the general population rather than in specific 
groups for which specific sources of exposure were known or suspected. The numbers 
of PCB congeners measured in those studies were between only four and sixty different 
molecules out of 209 congeners. As a result the total PCB levels and concentrations 
measured in the different studies also varied according to the number of congeners 
considered for laboratory analysis. In order to allow comparisons, only 15 congeners 
were considered and their units were converted to match our unit of pmol/g lipid. In 
most literature, results are reported in heterogeneous units, such as raw concentration 
(nanograms/milliliter in serum) without reporting relevant biochemical measurements 
necessary to define total blood lipid contents of the subjects. We thus used upper and 
lower limits of cholesterol and triglycerides of the healthy population to compute the 
corresponding total lipids which were used to adjust the PCB concentrations reported in 
the literature. Finally the literature results were expressed in toxicologically relevant 
molecular units as picomoles per gram serum lipid which facilitated comparison of our 
results. 
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We observed a significant difference in total PCB among residents of the three sites. 
The residents from Milan had the highest PCB concentrations followed by Pavia and 
Novafeltria. These variations may be related with different dietary habits, sample group 
characteristics (Turci et al., 2010a) and industrial activities. Milan is an urban area with 
intense past industrial activities with a considerable proportion of the population coming 
from other regions of Italy, while Pavia is a town with little current and past industrial 
activity and few immigrants. Novafeltria is a small village, with no industrial activity 
with a predominantly local population. Our results agree with previous literature studies 
which show that urban residents have significantly higher levels of PCBs than people 
from semi-urban or rural areas (Heywood et al., 2006; Wong et al., 2009). What is 
seldom clear is the exact source of higher levels in the urban population with respect to 
that of small town and of rural areas. In most industrial countries where studies were 
performed, the use of PCBs has been discontinued for at least fifteen years. Thus the 
spread of the PCB pool into the environment through several global cycles should have 
led to a leveling of differences from localized emission sources to less contaminated 
areas. 
The explanations presented to account for the observed differences in PCB body burden 
of individuals from the three locations are mostly conjectural, since no reliable 
retrospective information can be obtained to strongly support any claimed explanation. 
Starting from the reasonable assumption that for the general population dietary intake of 
PCBs is estimated to account for >90% of human exposure to these chemicals (Duarte-
Davidson et al., 1994), we nevertheless face with the very limited information available 
on dietary exposure to PCB in Italy. Studies report that, in Italy, dairy products, meat 
and fish are the principal sources of PCB contamination (Zuccato et al., 1999) while 
vegetables contribute very little to the daily dietary exposure. Turci et al. (2006) 
reported that the average daily intake of total PCBs for the population subgroup of 
Pavia is approx. 0.26 µg. Since dietary habits vary among individuals even within the 
population of an individual site, levels of PCBs and main sources may differ in different 
population subgroups. Donato et al. (2006) found high serum PCB levels in humans 
living in an industrialized town in Italy and related this observation mainly due to 
consumption of food produced in polluted areas. 
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It should also be considered that large-scale food distribution through the General 
Distribution Organization (GDO; supermarkets) has become increasingly popular in 
Italy even in small towns. This accounts, on the nation-wide average for approximately 
50% of supply, expressed as monetary value (Fulponi, 2004) and with a marked North-
South gradient (Esposti et al., 2008). These store chains get food from the global market 
at national and supra-national scale so that it is conceivable that the proportion of daily 
PCB intake which comes from ‘supermarket’ food is approximately analogous 
throughout the Italian population. 
To account for the differences in PCB body burden among the three Italia populations 
investigated, we may well propose that the amount of consumed food which originates 
locally, in presumably less-contaminated areas, and which is marketed outside the 
GDO, accounts for the lower body burden (proportional to the approximately constant 
intake) in rural Novafeltria and in small-town Pavia with reference to large urban Milan. 
Direct exposure to PCBs happens to be relatively rare in Italy outside well-known 
specific areas such as in the neighbours of the only production plant in Italy (the Caffaro 
plant in urban Brescia) and of a few big industrial areas where large electrical 
appliances and heat exchangers were manufactured or installed. Localized spills from 
transformers’ fires were however common although mostly unreported (except for the 
recording of local blackouts by maintenance staff with little if any awareness of the 
hazard of transformer oil), especially in rural areas. One case of spillage of PCB-
containing oil occurred in 1988 in Southern Italy during road transportation of a large 
transformer. This area is well distant from any of the investigated sample areas (De 
Felip and Di Domenico, 1990; Liberti et al., 1992). 
Overall population had the median total PCB level of 1131 pmol/g lipid; males having 
the median of 1051 pmol/g lipid and females of 1142 pmol/g lipid and thus showing no 
gender differences. As for congener groups, the only which showed differences were 
total dioxin–like (tDL)–PCBs (with males having lower levels than females), total 
penta–CBs (in Novafeltria and in Pavia) and total tetra–CBs (only in Novafeltria), 
which were also lower in males. Most individual PCB congeners did not differ 
significantly between genders with exception of PCB 52, 105 and 118, for which the 
levels were lower in males than in females. 
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Our measured levels are within the range (0.9 to 56 µg/L) reported in the metanalysis of 
Mangili et al. (2004) and are also consistent with results of previous studies which did 
not found substantial differences in concentrations of PCBs between males and females 
(Turci et al., 2010a; Donato et al. 2008; Burns et al., 2009; Focardi et al., 1986; 
Henriquez-Hernandez et al., 2011; Zubero et al., 2009). 
Other studies (Bates et al. 2004; Park et al., 2007; Cerná et al., 2008; Porta et al., 2010) 
measured higher PCBs concentrations in males than in females and in particular Park et 
al. (2005) found higher level of PCB 118 in males than in females. Minh et al. (2005) 
found higher concentrations of hepta–CBs in males than in female while tetra– and 
penta–CBs were lower in males. The authors suggested preferential elimination of more 
chlorinated biphenyls in females. We found total median hepta–CBs level of 303 and 
306; penta–CBs 78 and 17; and tetra–CBs 28 and 19 pmol/g lipid; for females and 
males, respectively. 
In the general population exposure to PCBs of males and females is not expected to be 
significantly different, the factor which can lead to lower serum concentrations of some 
congeners in females than in males (Thomas et al., 2006; Dirtu et al., 2006). 
Differences in the PCBs distribution between genders observed in the examined cohorts 
may be explained as inter-gender physiological differences, females having a higher 
proportion of body fat than males (Zubero et al., 2009; Geyer et al., 2002) Alternative 
explanation can be due to possible differences in exposure, males possibly having 
additional occupational exposure or their diet may be richer in fatty foods which may be 
in turn a more abundant source of ubiquitous PCBs. However, there is no clear or 
demonstrated explanation of the observed differences. 
When lower levels of PCBs are measured in women, one explanation may be that body 
burden has been cleared through breastfeeding. This explanation needs support from 
data on reproductive history of females such as parity and lactations, which could not be 
collected from our subjects and is seldom reported in literature studies. 
Body Mass Index is a proxy for the proportion of human body fat based on a calculation 
from individual’s weight and height. This is widely used in several fields of clinical 
medicine and epidemiology as a first-tier approach to understand the effect of obesity 
on health. It does not actually measure the percentage of body fat, the accurate 
evaluation of which entails the use of physiological measurements such as total body 
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impedentiometry which were not available at subjects’ recruitment stage. Due to 
lipophilic character of PCBs, ‘fatter’ subjects are expected to accumulate more of these 
chemicals than ‘leaner’ ones with the same body weight. However, we did not observe 
significant difference in distribution of most PCB congeners and total PCB across the 
BMI categories, nor any significant correlation of total PCB concentration with BMI in 
the overall population. Only for some congeners (PCB 138, 153, 180 and 170) we 
observed very weak positive correlations. 
Few studies, however, observed a positive association of BMI and PCB concentration 
(Henriquez-Hernandez et al. 2011; Fernandez et al., 2008) while in one case an inverse 
association with PCB 180 was reported (Zubero et al., 2009;). Apostoli et al. (2005) 
warned that spurious positive association between PCB levels and BMI can be obtained 
when serum lipid adjustment is not performed. However, the role of BMI on the level of 
organochlorine compounds has not yet been clearly established (Zubero et al., 2009; 
Moysich et al., 2002). In our study the multivariate analyses confirmed age and 
residence but not BMI as the only important predictors for total PCB level (Table 3.20). 
Accumulation of persistent chemicals is expected to increase with age due to continued 
exposure without excretion. We observed consistent increase in median levels of total 
PCB and of PCB congeners 138, 153, 180, 156 and 170 across the age groups, as 
highlighted by correlation analyses. Duarte-Davidson and Jones showed a relatively 
high proportion of the more persistent congeners among older people but did not 
observe significant differences in the total PCB between gender, residence and the body 
weight (Duarte-Davidson et al., 1994). The body burden of serum NDL–PCB was 
shown to increase among two 55+ year age groups living close to incineration plants in 
Italy (De Felip et al., 2008). Hirai et al. (2005) observed significant correlation between 
total PCB level and age (Spearman r = 0.62, p < 0.01). Apostoli et al. (2005) calculated 
in an Italian study population an increase of total PCB levels of a 1.7 ng/ml for every 
10-year increase in age. The increase in PCBs levels with age can be the consequence of 
exposure prior to the ban of PCB production (Henriquez-Hernandez et al., 2011). The 
influence of age on the levels of most PCB congeners has also been confirmed by a 
worldwide review conducted recently by Consonni et al. (2012) where strong 
association of subjects’ age with levels of most congeners was found. 
Our results reported in Table 3.9 show a greater accumulation of the more highly 
chlorinated PCBs. This phenomenon results from preferential clearance of lower 
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chlorinated congeners by biotransformation and excretion. The global half-life of a 
chemical with low metabolic clearance depends on the physicochemical properties, 
especially its lipophilicity (log Kow) and on its bio-transformation rate. As the number of 
chlorine atoms in the biphenyl nucleus increases, lipophilicity also increases, so that the 
compound is preferentially stored in body fat, a compartment where biotransformation 
of xenobiotics is intrinsically low, due to low-to-nil expression of pertinent enzymes by 
adipocytes. Biotransformation leading to clearance therefore occurs only for the fraction 
of PCB pool which is at equilibrium in the ‘non-fat’ body compartment, where lower-
chlorine PCB congeners are more abundantly represented. Biotransformation of PCBs 
mostly occurs by mono-oxygenation through the arene-oxide pathway catalyzed by 
P450 iso-enzymes. The biotransformation rate of individual PCB congeners thus 
depends on the availability of positions in the chemical structure where mono-
oxygenation can occur. Congeners with a higher number of suitable positions in the 
molecular structure are therefore more easily biotransformed, the fat to non-fat 
equilibrium in concentrations is thus perturbed and more of the easily bio-transformed 
congeners are displaced from the fat to the non-fat compartment, where they are 
biotransformed. As a quantitative consequence of both phenomena, the more 
chlorinated congeners, which are both, less abundant in the non-fat, biotransforming 
compartment and less efficiently biotransformed are preferably left in the body. The less 
chlorinated congeners, which are both more abundant in the non-fat, biotransforming 
compartment and more efficiently biotransformed, are preferably cleared. As such they 
may be measured as circulating hydroxy–PCBs or as conjugated products excreted 
through the biliary route; on the global they account for a minute fraction of body fat 
PCBs (Fernandez et al., 2008). 
The median concentrations of PCB 138 (Pavia) and 153 (Milan) reported in our study 
are within the lower and upper median concentrations reported in 2005 by Apostoli et 
al. (2005) and comparable with those reported in Turrio-Baldassarri et al. (2008). In 
Milan PCB138 concentration was higher than those reported in these studies. In 
Novafeltria and Pavia the median concentrations of PCB 153 and 180 fell within the 
lower and upper median levels observed in Turci et al. (2010a). In all sites the median 
levels of PCB 180 were lower compared to Apostoli et al. (2005), Donato et al. (2008) 
and Turrio-Baldassarri et al. (2008), but higher than that observed in Bergonzi et al. 
(2009) particularly in serum matrix (Table 4.2). Porpora et al. (2006) found significant 
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higher PCB 153 level in women with endometriosis (416 pmol/g lipid) than the control 
group (263 pmol/g serum lipid) (p = 0.0004). In comparison with our study PCB 153 
level (763 pmol/g lipid) found in Milan females was higher than that in endometriosis 
cases of Porpora et al. study while females of Pavia had comparable level (403 pmol/g 
lipid) with the cases. Novafeltria females had PCB 153 level of 255 pmol/g lipid which 
was comparable to the control group (Table 4.2). 
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Table 4.2. Concentrations of PCB congeners (in pmol/g serum lipid) in blood/blood serum of Italians living in various regions (2004–2010). 
Reference Sample 
size Study population Location 
Sampling 
year 
PCB Congeners represented by IUPAC numbers 
77 126 169 105 118 156 28 31 52 101 128 138 153 170 180 
Turci et al. 
(2004)h 162 General population Novafeltria – 27.4 81.5 119.2 98.3 83  17.2 13.8 39 76 29.6 197.8 290.1 80.2 202.4 
Turci et al. 
(2006)h 326 
Non occupationally 
exposed subjects 
Novafeltria 
and Pavia – 0.5  0.6 2.7 43.5 37.7 43.9 50.9 89.4   354.7 471.1 108 306.1 
Turci et al. 
(2010a)j 95 
Volunteers in the 
General population 
Novafeltria 
– 
   nc 19–37 25–48 nc nc 18–35 18–33  83–163 212–414 36–71 105–206 
Pavia    nc nc nc nc nc 49–96 nc  151–296 212–414 41–81 162–317 
This studyj 367 General population 
Novafeltria 
– 
nc nc nc nc 70.05 24.76 nc nc nc nc nc 173.70 264.92 76.62 189.16 
Pavia nc nc nc nc nc 32.59 nc nc 44.33 nc nc 293.95 394.03 88.13 258.82 
Milan nc nc nc nc nc nc nc nc nc nc nc 532.15 667.5 nc 402.97 
De Felip et al. 
(2004)k 22 
Women suspected of 
endometriosis and 
benign adnexal mass 
Rome 2000–2001 
0.17 0.12 0.04 7.66 33.7 9.7 
         0.17 0.11 0.06 7.96 36.76 11.08 
0.17 0.12 0.06 9.5 39.82 12.47 
Apostoli et al. 
(2005)j 579 General population Brescia 2001–2003     21–41 19–37      242–473 428–836 131–257 446–871 
Donato et al. 
(2008)j 527 
Random sample of 
adult residents Brescia 2001–2002            327.53 576.09 162.91 591.67 
Turrio-
Baldassarri et 
al. (2008) 
 
Local general 
population Brescia 2004–2005 <0.03 0.3 0.5 13.2 95 73.2 <1.2  <1.4 <1.2  299.3 670.6  766.5 
De Felip et al. 
(2008)k 74 
Non-occupationally 
exposed population in 
Tuscany, Grosseto 
F 
2005–2006 
<0.14 0.17 0.14 9.50 52.08 33.25          
FL <0.17 0.18 0.17 8.88 52.08 30.48          
FLA <0.14 0.37 0.24 17.77 91.90 52.65          
S <0.21 0.15 0.18 7.66 42.89 33.25          
SA <0.14 0.37 0.27 20.22 113.35 63.73          
V <0.14 0.23 0.18 19.61 91.90 38.79          
M1 <0.14 0.24 0.17 12.87 67.40 38.79          
M2 <0.14 0.17 0.14 9.50 52.08 33.25          
Porpora et al. 
(2006)h 154 
Women suspected for 
endometriosis or  2000–2004 
   30.6 156.2 61.0 21.4  8.6 11.0  235.5 415.7 32.9 164.4 
benign gynaecologic 
conditions     24.5 73.5 27.7 21.7  10.3 9.5  146.9 263.2 25.3 113.8 
Porpora et al. 
(2009)i 158 
Women with surgery 
for endometriosis or Rome 2004–2005 
   20.8 71.7 23.0 16.7  7.5 6.4  140.5 276.5 22.3 122.9 
other gynaecologic 
conditions    17.5 46.6 15.8 13.2  5.5 4.9  93.7 171.2 15.4 87.0 
Bergonzi et al. 
(2009)j 70 
Women in highly 
polluted urban area Brescia 2006     33.7 13.9 n.d     97 149.6 40.5 124.0 
Keys: F, Follonica sample pool of 9 subjects who lived 3-5 kilometres (km) from incinerator; FL, Follonica sample pool of 9 subjects who live >5 km from incinerator; FLA, Follonica sample pool of 10 subjects who live >5 km from 
incinerator; S; Scarlino pool of 8 subjects; SA, Scarlino pool of 10 subjects; V, Valpiana pool of 8 subjects; M1, Massa Marittima first sample pool 10 subjects; M2, Massa Marittima second sample pool of another 10 subjects; h, mean; 
i, geometric mean; j, median; k, level of individual pool; nc, not computed. 
 
 121 
4.3 Possible Health Effects 
The abundant organochlorine compounds (OCs) can be used as indicators in evaluating 
risk of OCs to human health. In our study the frequently detected POPs were PCB 156, 
138, 153, 170, 180, p,p'-DDE and HCB in the overall population sample. In consistent 
with previous studies, PCB 153 strongly correlated with total PCBs (r = 0.927, p < 0.05) 
and PCB 118 with total dioxin-like PCBs (r = 0.914, p < 0.05). Thus the two congeners 
are considered to be suitable indicators for total PCBs and total dioxin-like PCBs, 
respectively (Kim et al., 2005, Park et al., 2007). p,p'-DDE is another relevant 
biomarker and the major metabolite of DDT with a long biological half-live. In our 
study it correlated strongly with total DDT (r = 0.794, p < 0.05). 
Various studies have shown association between the PCB congeners and some adverse 
health effects such as endometriosis (De Felip et al. 2004; Porpora et al., 2006, 2009), 
pancreatic cancer (Hardell et al., 2007), cardiovascular diseases (Ha et al. 2007, 2009), 
breast cancer (Aronson et al. 2000; Demers et al., 2002, Laden et al. 2002; Moysich et 
al., 1999; Recio-Vega et al., 2011; Zhang et al., 2004), non-Hodgkin lymphoma 
(Bertrand et al., 2010), reproductive abnormalities (Hauser et al., 2003; Rignell-Hydbom 
et al., 2004, 2005) and diabetes (Lee et al., 2006). The levels of PCBs reported in our 
study are similar with some of those found in the studies which have shown to be 
associated with health effects (Table 4.3). Some of these studies are discussed in the 
subsequent paragraphs. 
Moysich et al., (1999) reported increased risk of breast cancer associated with the 
presence of at least one valine allele in women with serum PCB levels above the median 
of the distribution in the control group (odds ratio, 2.93; 95% confidence interval, 1.17–
7.36). Among women with low PCB body burden, no association between CYP1A1 
genotype and breast cancer risk was observed. Subjects in high PCB concentration group 
had levels ranged from 3.73 to 19.04 ng/g serum lipids (~11–58 pmol/g serum lipid for 
PCB 118; 10–53 pmol/g serum lipids for PCB 138, PCB 153 and PCB 156; 9–48 pmol/g 
serum lipid for PCB 170 and PCB 180). Our study recorded the median levels of PCB 
118 within the reported range (52 pmol/g serum lipid for the overall women) and above 
the maximum level of the range (81 pmol/g serum lipid for Novafeltria women). For 
PCB 156 we found the median levels within the range especially for women of the 
overall population, Novafeltria and Pavia (28, 24 and 34 pmol/g serum lipid, 
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respectively). Women of the overall population as well as of individual population 
subgroups had median levels of PCB 138, 153, 170 and 180 above the maximum level 
of the reported range. 
Aronson et al. (2000) demonstrated clear associations of PCBs 118, 170 and 180 with 
breast cancer risk. ORs were 2.31 (1.11–4.78), 3.27 (1.44–7.44) and 2.43 (1.09–5.43) 
respectively and concentration range in the tertiles were ≥50, 24–34 and 52–71 µg/kg 
(≥153, 61–86, 132–180 pmol/g serum lipid), respectively. For PCBs 170 and 180, risks 
were higher among postmenopausal women in the second tertile while for PCB 118 the 
risk was above two in the highest concentration categories of the whole sample. For 
PCB 170 the women of the overall population and those of Novafeltria showed median 
levels (71 and 73 pmol/g serum lipid, respectively) which are within the reported 
concentration the category in Aronson et al. study whereas Novafeltria women were 
above the maximum levels (94 pmol/g serum lipid). As for PCB 180 median 
concentrations for women of the overall population, Pavia and Milan (221, 254 and 412 
pmol/g lipid, respectively) were above the range whereas Novafeltria female had median 
of 178 pmol/g serum lipid which was within the range. For PCB 118 the observed levels 
were far below the concentration category reported for this congener. 
Demers et al. (2002) found associations between breast cancer risk and PCB 118 (OR = 
1.60, 95% CI: 1.01, 2.53 fourth vs. first quartile) and PCB 156 (OR = 1.80, 95% CI: 
1.11, 2.94 fourth vs. first quartile). Subjects in fourth quartiles had PCB 118 
concentration >22.1 µg/kg (>67 pmol/g serum lipid) which is relevant for the levels 
observed in Novafeltria women samples (81 pmol/g serum lipid) whereas for PCB 156 
subjects in fourth quartile had concentration >9.8 µg/kg (>27 pmol/g serum lipid) which 
is relevant for the levels observed in females of our overall population and Pavia sample 
(28 and 34 pmol/g serum lipid, respectively). 
Recio-Vega et al. (2011) found risk of breast cancer to be positively associated with 
PCB 118, 156, 170 and 180 cases having geometric mean of 0.51 ppb (1.56 pmol/g 
serum lipid), 0.58 ppb (1.61 pmol/g serum lipid), 0.63 and 0.57 ppb (1.60 and 1.44 
pmol/g serum lipid), respectively. As compared to this study we found higher geometric 
means of PCB 118 in our overall women samples (27 pmol/g lipid), Novafeltria women 
(69 pmol/g lipid), Pavia women (12 pmol/g serum lipid) and Milan women (15 pmol/g 
serum lipid). For PCB 156 we found higher geometric means in overall population, 
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Novafeltria and Milan (22, 18, 26 and 28 pmol/g serum lipid, respectively). We found 
higher geometric means of PCB 170 and PCB 180 in women of overall population, 
Novafeltria, Pavia and Milan (60, 63, 84 and 26 pmol/g serum lipid, respectively for 
PCB 170 and 210, 165, 237 and 300 pmol/g serum lipids, respectively for PCB 180). 
Porpora et al. (2009) reported geometric mean concentrations of PCBs 118, 138, 153, 
156, 170 and 180 (72, 141, 277, 23, 25 and 123 pmol/g, respectively) among women 
who underwent surgery for endometriosis. The reported level of PCB 118 is comparable 
to the observed level in Novafeltria women in our study (69 pmol/g serum lipid). For 
PCB 138 our study recorded higher geometric mean concentration for females in overall 
population (260 pmol/g serum lipid) as well as in individual population subgroups (171, 
313 and 518 pmol/g serum lipids respectively for NF, PV and MI). For PCB 153 our 
study reported higher geometric mean concentration among females of overall 
population, Pavia and Milan (354, 410 and 680 pmol/g serum lipid, respectively) but 
lower than that of Novafeltria females (243 pmol/g serum lipid). A geometric mean 
concentration of PCB 156 is comparable to that of the females of overall population of 
our study (22 pmol/g serum lipid). As for PCB 170 the reported geometric mean was 
comparable to that of Milan females (26 pmol/g serum lipid) but lower than of females 
of overall population, Novafeltria and Pavia (60, 63 and 84 pmol/g serum lipid, 
respectively). 
De Felip et al. (2004) reported concentrations of 34 and 37 pmol/g serum lipid (PCB 
118) and 10 and 11 pmol/g lipid (PCB 156) in the pools of women samples suspected of 
endometriosis. Our study found median concentrations of 52 and 80 pmol/g serum lipid 
(PCB 118) for the overall and Novafeltria women samples, respectively. As for PCB 
156, reported median levels of 28, 24 and 34 pmol/g serum lipid for the women of the 
overall population, Novafeltria and Pavia, respectively which were higher than those in 
the study of De Felip et al. (2004). 
Bertrand et al. (2010) found positive association between the risk of non-Hodgkin 
lymphoma with PCBs 118, 138, 153, and 180 among men cohort. The ORs for the 
highest quintile versus the lowest were 1.7 (1.0–2.9), 2.2 (1.3–3.8), 2.4 (1.4–4.2) and 2.4 
(1.4–4.3), respectively and the medians of these highest quintiles were 139 (>105–734), 
161 (>122–541), 242 (>188–761) and 154 (>126–528) ng/g serum lipid [~426 (>322–
2249); 446 (>338–1499 ); 671 (>521–2108) and 390 (>319–1336) pmol/g serum lipid]. 
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The median levels of PCB 118 in our study were lower compared to the one reported in 
this study. As for PCB 138 the median observed in men subjects of our overall 
population (228 pmol/g lipid) and of individual sites (173, 268 and 492 pmol/g serum 
lipid for Novafeltria, Pavia and Milan, respectively) were lower than the reported one in 
this study but they were within the range of the highest quintile for this congener. PCB 
153 showed similar trend. Male subjects from Milan had median concentration of PCB 
180 (391 pmol/g serum lipid) higher than the reported in Bertrand et al. (2010) whereas 
median level of the overall male population, Novafeltria and Pavia were lower falling 
below the minimum level of the highest quintile range. 
After adjusting for age, sex, race/ethnicity, poverty income ratio, BMI and waist 
circumference Hardell et al. (2007) found significant higher median level of PCB 153 
among pancreatic cancer patients [353 ng/g (~978 pmol/g lipid)] as compared with 
control 156 ng/g (~432 pmol/g lipid). Significant increase OR was observed although no 
OR could be calculated since the concentration in all cases was greater than the median 
concentration in control. As compared to our result median levels recorded in all three 
sites were lower than the reported median in this study. 
Strong positive association of Diabetes with PCB153 has been demonstrated (Lee et al., 
2006). The ORs for the highest percentile versus the lowest were 2.5 (1.1–6.0), 4.3 (2.2–
8.6), 5.9 (3.0–11.9), 5.9 (3.1–11.3) and 6.8 (3.0–15.5). The concentrations were 14.3, 
36.7, 60.2, 93.6 and 164 ng/g lipid (~40, 102, 167, 259 and 454 pmol/g lipid) in 25, 25 
to <50, 50 to <75, 75 to <90 and ≥90th percentiles, respectively. All reported 
concentrations were associated with diabetics and the trends were significantly different 
(Ptrend <0.001). Our study presented median concentration of Milan sample which is 
higher than the concentration in ≥90th percentile while overall population, Novafeltria 
and Pavia samples had median levels (342, 265 and 394 pmol/g lipid, respectively) 
higher than the levels reported in other percentiles. 
After adjusting for age, abstinence and smoking, dose-response relationships between 
PCB 138 and sperm motility (odds ratio per tertile, 1.00, 1.68, 2.35, ptrend = 0.03) was 
observed (Hauser et al., 2003). The median concentration was 31.2 ng/g (~86 pmol/g 
lipid) which is by far lower than that observed in male samples of our study (~228, 173, 
268, 492 pmol/g lipid, respectively for the overall sample, Novafeltria, Pavia and Milan 
samples). 
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In their study to investigate whether exposure to PCB 153 affects semen quantity and 
reproductive hormones Rignell-Hydbom et al. (2004) investigated Swedish fishermen, 
aged 24–65 years. They found a median PCB 153 serum level of 193 ng/g lipid (534.80 
pmol/g lipid). When PCB 153 was categorized into quintiles, the subjects in the quintile 
with the highest concentration (>328 ng/g lipid = >909 pmol/g lipid), tended to have 
decreased sperm motility compared with the subjects in the lowest quintile (<113 ng/g 
lipid = <313 pmol/g lipid). The association between PCB 153 and sperm motility, 
although not formally significant, is of interest considering the possible endocrine-
disrupting effects of polychlorinated biphenyls (PCBs). In our study we found the 
median level of 566 pmol/g lipids for PCB 153 among male subjects of Milan which 
was higher than the reported median. 
Ha et al. (2007) found positive association of dioxin–like PCBs, non dioxin–like PCBs 
and OC pesticides with the prevalence of cardiovascular diseases only among females. 
The ORs were 13.4 (1.6–115.0), 10.4 (1.1–94.1), 9.2 (1.0–84.5) for PCB 138, 153 and 
170 respectively among the individual in the highest percentile i.e ≥75th. The observed 
concentrations were 91.0, 127.0, 36.4 ng/g (~252, 352 and 92 pmol/g serum lipid), 
respectively. Our study found higher median PCB 138 levels for females of overall 
population, Pavia and Milan (258, 316, 572 pmol/g serum lipid, respectively) whereas in 
Novafeltria the median level (175 pmol/g lipid) was less than the reported level. For 
PCB 153 similar trend was observed. For PCB 170 the median level for females of Pavia 
(94 pmol/g serum lipid) was comparable to the reported level for this congener while in 
the overall sample and Novafeltria the median level were lower. 
McGlynn et al. (2008) found significant association between testicular germ cell tumour 
risk and higher plasma levels of p,p′-DDE detected from male subjects. The OR for the 
for the highest quartile vs lowest quartile was 1.71 (95% CI, 1.23–2.38, p for trend = 
0.0002) (Table 1.1R). The observed concentration in the highest quartile was >0.390 
µg/g serum lipid (>1,226 pmol/g serum lipid). As observed in our study male subjects 
from Milan had median concentration of 3,398 pmol/g serum lipids for this OCP which 
is in consistent with the level in the highest quartile of the reported study. Pavuk et al. 
(2003) observed higher serum levels of p,p′-DDE positively associated with risk of 
breast cancer in 3rd quartile (OR = 3.04, 95% Cl 0.65–14.3). The concentration in this 
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quartile was 4,389–19,912 ng/g lipid (~13,801–626,110 pmol/g serum lipid). Our study 
found median levels which are much far below the lower level of this quartile. 
Considering that the levels of some OCs in our study are similar or even higher than the 
reported levels which showed association with some health effects, adverse health 
effects for our observed levels are possible. However, our study was not designed to 
study the cause and effects relationship thus it is difficult to conclude any association 
with these health effects. This calls for a well designed and detailed studies which will 
address the causal and effects relationship of the concerning POPs which have shown an 
indication of health effects to human. In particular, further research should be addressed 
at endocrine disruption effects such as breast cancer. Recent study has reported the 
highest increase in the incidence of breast cancer (+28.68% in 2005 vs 2000 increase) 
among Italian women who are less than 45 years old an age group (Piscitelli et al., 
2009). Madigan et al. (1995) showed that only 45–55% of breast cancer cases can be 
explained by known risk factors such as later age at first birth, nulliparity, family history 
of breast cancer, higher socioeconomic status, earlier age at menarche and prior benign 
breast disease. It will be interesting to explore if environmental factors such as exposure 
to POPs can explain the observed increase in breast cancer incidence. 
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Table 4.3. Comparison of the concentrations of selected PCB congeners and OCPs (expressed in pmol/g serum lipid) reported in our study with those of previous studies which 
suggest possible associations with health effects. 
Reference Sample 
size 
Study 
population Location 
Sampling 
year 
PCB Congeners (represented by IUPAC numbers) and abundant OCPs   
118 156 138 153 170 180 p,p'-DDE HCB 
This studyj 367 General population 
PS 
 
nc 28 236 342 75 223 395 154 
Female 52 28 258 357 71 221 789 482 
Male nc 28 228 324 81 223 268 107 
NF sample 70 25 174 265 77 189 428 209 
Females 81 24 175 255 73 178 538 220 
Male 58 28 173 286 81 198 339 189 
PV sample  nc 33 294 394 88 259 163 100 
Females nc 34 316 403 94 254 143 86 
Males nc 29 268 347 85 261 173 100 
MI sample nc nc 532 668 nc 403 4380 571 
Females  nc nc 572 763 nc 411 5363 627 
Males  nc nc 492 566 nc 391 3398 472 
De Felip et al. 
(2004) 22 
Women 
suspected of 
endometriosis 
and benign 
adnexal mass  
Rome 2000–2001 
34 10 
   
 
  
37 11   
40 12   
Porpora et al. 
(2006) 154 
Women 
suspected for 
endometriosis or  Rome 2000–2004 
156 61 236 416 33 164 
  
  
benign 
gynaecologic 
conditions 
74 28 147 263 25 114   
Porpora et al. 
(2009) 158 
Women with 
surgery for 
endometriosis or  Rome 2004–2005 
72 23 141 277 22 123 
  
  
other 
gynaecologic 
conditions 
47 16 94 171 15 87   
Hardell et al. 
(2007) 21 
Pancreatic 
cancer patients Mid Sweden 1996–1999    978     
 59 Control      432     
Lee et al. 
(2006) 67/401 Diabetic Cases USA 1999–2000    
40, 102, 167, 
260, 454     
Rignell-
Hydbom et al. 
(2004) 
195 Swedish fishermen Sweden 2001–2002    535     
Hauser et al. 
(2003) 212  Males USA 2000–2001    86     
Demers et al. 
(2002) 104 
Incident case of 
breast cancer 
Quebec, 
Canada 1994–1997 > 67 > 27       
 
130 Control           
Recio-Vega et 
al. (2011) 70 
Breast Cancer 
women 
Mexico  1.56 1.61   1.60 1.44   
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Reference Sample 
size 
Study 
population Location 
Sampling 
year 
PCB Congeners (represented by IUPAC numbers) and abundant OCPs   
118 156 138 153 170 180 p,p'-DDE HCB 
 70 Control   0.70 0.67   0.63 1.01   
Bertrand et al. 
(2010) 205 
Men diagnosed 
with non-
Hodgkin 
lymphoma 
USA 1982–1984 >322–2249  >338–1499 >521–2109  >319–1336   
Ha et al. (2009) 17/45 Men samples 
cases 
USA 1999–2002  49       
Medehouenou 
et al. (2010) 
391 Men Nunavik, 
Québec-
Canada 
    535     
480 Women 2004    445     
Rignell-
Hydbom et al. 
(2005) 
176 Fishermen Sweden 2001-2002    313     
Ha et al. (2007) 462 Women USA 1999–2000 2001–2002   252 352 92 219   
Zhang et al. 
(2004) 374 
Breast cancer 
women 
Connecticut, 
USA 1999–2002 1872–7965 1693–7205 1693–7205 1693–7205 1546 1546   
Moysich et al. 
(1999)  154 
Breast Cancer 
women 
Western 
New York, 
USA 
1986–1991 11–58 10–53 10–53 10–53 9–48 9–48   
Laden et al. 
(2002) 32,826 
Breast Cancer 
women 
USA 1989–1990 2053–6096  1857–5514 1857–5514  1695–5034   
Aronson et al. 
(2000) 217 
Breast Cancer 
women 
Ontario, 
Canada 1995–1997 >153    61–86 132–180   
McGlynn et al. 
(2008) 754 
Men with 
testicular germ 
cell tumour 
USA 2002–2005       >1226  
Pavuk et al. 
(2003) 37 
Women with 
breast cancer 
Eastern 
Slovakia 1997–1999       
13801–
626110  
Keys: PS, pooled sample from the three sites; NF, Novafeltria; PV, Pavia; MI, Milan. 
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Conclusion and Recommendations 
Our study has shown detectable levels of PCB congeners and OCPs among the residents of 
Italian general population despite long time ban indicating that they are still circulating 
among non-occupationally exposed population. These levels are within the range of those 
observed in people of general population in other studies worldwide. 
We have demonstrated a pattern of distribution of the levels of the main PCB congeners and 
of OCPs in a fairly large population in Italy. PCB 138, 153 and 180 were the most abundant 
with high concentrations. Difference in PCB concentrations with places of residence was 
evident; Milan having the highest levels. A reason for these elevated concentrations in the city 
notwithstanding ban of use and cessation of industrial activities is obscured; more research is 
needed to understand the cause. Total PCBs and some abundant congeners correlated 
positively with age. The correlation with age indicates a life-long accumulation, the higher 
levels in older people being the results of accumulation over a long period of time, especially 
since the period when the use of these chemicals was more widespread. The only significant 
difference in concentrations between females and males was observed for total dioxin-like 
(tDL)–PCBs, with females having higher levels than males. This finding may concern long-
term health of women, since this particular class of PCBs shows a weak estrogenic activity 
and can thus be a factor in determining the incidence of gender-specific cancer. 
As for OCPs study, p,p'-DDE and HCB were the most abundant and major contributor of total 
OCP concentration and their concentration differed significantly with places of residence. In 
particular, the subjects who live in Milan, who are younger, presented higher levels of total 
OCP, total DDT, p,p'-DDE and HCB than in the older subjects of Novafeltria and Pavia as 
observed in PCB study. It is still not clear what caused such elevated concentrations in this 
population since in this city there was no history of intensive use of pesticides in the past. 
Residential history, diet and industrial activities are thus suspected as determinants and this 
may warrant more detailed investigations on people living in Milan. 
Data collected in our study however provide information regarding the levels of PCBs and 
OCPs exposure of the Italian general population and provides indications for the conduction 
of further investigations and opens the way to planning more detailed investigations in other 
similar population studies. Last, since POPs have been shown to have adverse effects even at 
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low concentrations, regular surveillance and monitoring programs should evaluate their trends 
and patterns in food and in the general population, to highlight exposure hotspots and counter 
their release into the environment as a consequence of past use. 
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Appendix I: Study Plan. 
 
 
 
 
Activity/Time Jan – March 2010 
April 2010 –
April 2011 
May – July 
2011 
July – Sept. 
2011 Oct. 2011 – Dec. 2012 
Literature search, 
preparation of tools, 
proposal development and 
presentation 
     
Field work       
Laboratory analysis       
Data entry and analysis      
Preparation and submission 
of papers 
   
 
 
 
 
 
Compilation and 
submission of Thesis 
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Annex II: Questionnaire. 
RESEARCH PROJECT 
Exposure to Persistent Organic Pollutant and Health Risks 
 
1. Interviewer ID: _______________________________ 
2. Surname: ___________________ Name: _________________________ 
 
3. Date of Interview  // 
 Day Month Year 
Personal Details 
4. Date of birth // 
 Day Month Year 
5. Place of birth Region _______________________________ 
 District _______________________________ 
6. Place of Residence Region _______________________________ 
 District _______________________________ 
7. Sex 
 Female = 1               Male = 2 
8. Residence Years 
 
9. Are there in the neighbourhood: Industries?                             Yes = 1   No = 0 
Heavy traffic streets/roads?   Yes = 1   No = 0 
Power Plants?                        Yes = 1   No = 0 
10. Height 
 Centimetres 
11. Weight  Kilograms 
12. Level of education 1 = Literate 
2 = Primary School 
3 = Lower Middle School 
4 = Upper Middle School 
5 = University  
Lifestyle 
13. Do you smoke? Yes = 1   No = 0 
14. How many cigarettes per day?  
15. Do you chew tobacco? Yes = 1   No = 0 
16. How many times per day? 
 
17. Are you an ex smoker? Yes = 1     No = 0 
18. How many years of smoking? 
 
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19. Do you do physical exercise e.g. sports? Yes = 1           No = 0 
20. How many hours per week? 
 
Dietary and drinking habits 
21. The following questions are 
related to eating and drinking 
habits last year. How often, on 
average, do you eat/drink the 
following products? 
N
ev
er
=
0 
1 
tim
e 
pe
r 
m
o
n
th
 
=
1 
2-
4 
tim
es
 
pe
r 
m
o
n
th
 
=
2 
1-
2 
tim
es
 
pe
r 
w
ee
k=
3 
3-
4 
tim
es
 
pe
r 
w
ee
k=
4 
1 
da
y 
=
5 
2-
4 
da
ys
=
6 
5-
6 
da
ys
=
7 
≥
6 
da
ys
 
=
8 
 
21a. Chicken          Chicken 
21b. Cattle           Cattle 
21c. Sheep           Sheep 
21d. Pork          Pork 
21e. Rabbit          Rabbit 
21f. Fish          Fish 
21g. Fruits          Fruits 
21h. Eggs          Eggs 
21i. Cheese          Cheese 
21j. Vegetables          Vegetables 
21k. Coffee          Coffee 
21l. Milk          Milk 
21m. Wine          Wine 
21n. Liquor (Strong alcohol)          Liquor 
 
 21o. The source of cooking/drinking water 1 = Bottled Water 
2 = Tap water 
3 = Well Water 
89 = Other sources 
Mention_________________________ 
Occupation History 
22. (a) What is your current job? 
_________________________________________________________________________
________________________________________________________________________ 
22. (b) What is your monthly income? 
_________________________________________________________________________ 
23. What was your past job? 
_________________________________________________________________________
_________________________________________________________________________ 
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24. What are/were your main responsibilities/tasks? 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________ 
Health Status 
25. Pathological History 
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
________ 
26.Allergy:________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
________ 
27.Drugs:_________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
_________________________________________________________________________
__________ 
 28. Maximum blood pressure :____________49. Minimum blood pressure:_________ 
    
LABORATORY PARAMETERS (from hospital personal clinical records) 
29. Blood Glucose: _________ 38. Gamma Glutanin Transpeptidases _________ 
30. Blood Nitrogen: _________ 39.  Alanine transaminase (ALT) _________ 
31. Blood Creatinine: _________ 40. Erythrocyte sedimentation rate: _________ 
32. Potassium: _________ 41. White Blood Cells: _________ 
33. Cholesterol: _________ 42. Red Blood Cells _________ 
34. Creatinine in Urine: _________ 43. Haemoglobin: _________ 
35. Triglycerides: _________ 44. Hematocrit: _________ 
36. Aspatite (AST): _________ 45. Platelets: _________ 
37. Urine Examination:  _________    
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Jan.2002 – March 2006: Research Scientist, Ifakara Health Research and 
Development Centre (IHRDC). 
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Ospedale San Paolo – Polo Universitario, Aula Curie – Settore Didattico, Milan – Italy, 10 
May 2012. The Seminar was delivered by John Rosecrance, Associate Professor, 
Colorado State University, USA. 
A Training Course in Health Risk Assessment (Pesticides, water quality and 
nanotechnology) given by Faculty of Health Science, University of Witwatersrand, South 
Africa, 22 Feb. – 1 Mar. 2012. 
The 47th Congress of the European Societies of Toxicology (EUROTOX 2011) held in 
Paris, France, 28 – 31 Aug. 2011. 
The Conference on “Malaria: Stato Dell’Arte e Prospettive Future” held in Centro 
Ospedaliero di Milano (Ospedale Militare) Via Simone Saint Bon, 7 Milano, Italy, 27 – 28 
May 2011. 
A Short Course on Data Analysis by SPSS, Computer Lab, MUHAS, Dar es Salaam, 
Tanzania 1 – 5 May 2011. 
A 20th Anniversary of International Centre for Pesticides and Health Risk Prevention Risk 
Assessment of Chemicals, Aula Magna Ospedale Luigi Sacco, Milano, Italy, 11 Nov. 
2010. 
The Conference entitled Nuove Sfide per La Medicina del Lavoro: Immigrazione-
Promozione Della Salute, Facolta di Medicina e Chirurgia Università degli Studi di Brescia 
6 Nov. 2010. 
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Zootecnica Italiana, Centro Fiera Via Brescia129-25018 Montichiari (BS), 20 Feb. 2010.  
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Occupational Medicine) offered by Department of Occupational Health, Università degli 
Studi di Milano, Italy with a period from Feb. – Dec. 2010. The seminars were delivered 
by Prof. Pieralberto Bertazzi and Dr. Dario Consonni. 
A Short Course in Introductory Epidemiology and Biostatistics, SOSMED Conference 
Hall, Dar es Salaam, Tanzania 20 April – 1 May 2009. 
The Training of Trainers Workshop for National Facilitators of Local Government 
Authority on HIV and AIDS on Community Capacity Enhancement, Bagamoyo, Tanzania 
17 – 26 Nov. 2008. 
A Webster Memorial Seminar: Using Biological Monitoring to Reduce Occupational 
Exposure: Action to Improve Working Conditions, National Institute for Occupational 
Health (NIOH), Johannesburg, South Africa 30 Oct. 2008. 
Analytical Course given by Analytical Services Laboratory, National Institute for 
Occupational Health (NIOH) , Johannesburg, South Africa 10 – 30 Oct. 2008. 
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and Public Health Sciences, Department of Public Health and Clinical Medicine, Umeå 
University, Sweden 2 – 14 June 2008. 
A Short Course on Ethical Issues In African Health Research, SOSMED Conference 
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Stakeholders’ Workshop on Reviewing Monitoring and Evaluation Tools for Occupational 
Health Services, NAM Hotel, Dodoma, Tanzania 5 – 9 June 2008. 
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Detection and Monitoring of Insecticide Resistance Among Malaria Vectors in the Context 
of Insecticide Treated Nets Scaling-Up in Tanzania, Hotel Kola Prieto, Tanga 24 – 26 Nov. 
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Annex IV: Individual personal characteristics of the examined subjects and results of individual PCB congeners’ measurements (All PCB measurements are reported in 
pmol/g serum lipid). 
PID Sex Age (years) 
Weigh 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) 
PCB 
31 
PCB 
28 
PCB 
52 
PCB 
101 
PCB 
77 
PCB 
118 
PCB 
105 
PCB 
153 
PCB 
138 
PCB 
126 
PCB 
156 
PCB 
128 
PCB 
180 
PCB 
169 
PCB 
170 
1NF M 44 76 183 22.69 526.9 9.29 6.30 3.25 2.91 3.25 30.38 2.91 256.13 163.10 2.91 22.47 2.63 193.28 2.63 85.26 
2NF M 45 74 180 22.84 488.4 31.40 34.09 3.51 3.14 3.51 58.58 3.14 206.74 104.56 3.14 32.09 2.84 196.61 2.84 38.94 
3NF M 57 78 174 25.76 480.4 4.04 4.04 3.56 3.19 3.56 69.57 3.19 449.70 289.39 3.19 32.24 2.88 414.53 2.88 139.28 
4NF F 52 58 157 23.53 780.8 6.65 6.97 2.19 1.96 2.19 86.70 1.96 352.80 262.04 1.96 31.22 1.77 191.19 1.77 70.86 
5NF M 55 74 168 26.22 513.3 13.69 17.08 3.34 2.98 3.34 78.39 2.98 336.00 222.98 2.98 60.65 2.70 258.21 2.70 111.62 
6NF M 44 101 175 32.98 601.1 7.00 6.01 2.85 2.55 2.85 47.67 2.55 188.85 132.37 2.55 12.36 2.31 117.56 2.31 40.77 
7NF M 47 81 180 25.00 513.8 3.78 8.53 3.33 2.98 3.33 70.03 2.98 292.64 215.56 2.98 26.06 2.70 197.96 2.70 84.51 
8NF M 54 71 168 25.16 594.8 7.76 4.91 2.88 2.58 2.88 64.36 2.58 312.17 205.85 2.58 36.99 2.33 277.17 2.33 97.63 
10NF F 60 65 163 24.46 571.3 3.40 11.08 3.00 2.68 3.00 79.52 2.68 357.04 256.64 2.68 33.61 2.42 278.68 2.43 101.94 
11NF F 54 55 155 22.89 541.5 3.59 4.32 3.16 2.83 3.16 70.06 2.83 308.05 230.13 2.83 22.81 2.56 206.60 2.56 80.94 
12NF M 36 87 177 27.77 586.8 13.70 17.65 2.92 2.61 2.92 64.79 2.61 249.76 171.55 2.61 19.32 2.36 158.07 2.36 70.19 
13NF F 32 58 168 20.55 437.3 21.77 10.37 3.92 3.50 3.92 82.47 3.50 227.43 159.56 3.50 15.04 3.17 119.83 3.17 45.90 
14NF M 40 82 176 26.47 507.2 3.83 3.83 3.38 3.02 3.38 49.43 3.02 285.83 219.13 3.02 27.95 2.73 168.89 2.73 72.07 
15NF F 39 56 165 20.57 515.5 3.77 3.77 3.32 2.97 3.32 41.30 2.97 129.04 110.85 2.97 16.13 2.69 108.80 2.69 54.04 
16NF F 39 80 175 26.12 440.1 4.41 4.41 3.89 3.48 3.89 69.26 3.48 288.06 192.21 3.48 49.92 3.15 135.00 3.15 72.58 
17NF F 31 64 163 24.09 505.8 3.84 3.84 3.39 3.03 3.39 59.81 3.03 172.36 120.90 3.03 12.67 2.74 94.77 2.74 40.26 
18NF M 52 88 170 30.45 857.6 2.26 2.26 2.00 1.79 2.00 65.64 1.79 419.78 289.79 1.79 34.05 1.62 213.84 1.62 86.14 
19NF M 38 80 180 24.69 509.3 88.50 53.33 3.36 102.27 3.36 180.92 133.07 355.36 235.29 3.01 63.04 17.60 210.95 2.72 99.60 
20NF F 39 65 160 25.39 457.0 4.25 4.25 3.75 3.35 3.75 72.99 3.35 273.70 175.15 3.35 23.39 3.03 190.12 3.03 82.70 
21NF F 48 70 170 24.22 411.0 4.72 4.72 4.17 3.73 4.17 174.77 3.73 571.47 392.73 3.73 58.81 3.37 309.94 3.37 128.78 
22NF M 43 73 170 25.26 648.4 8.64 11.17 2.64 2.36 2.64 39.28 2.36 130.68 96.98 2.36 16.88 2.14 131.23 2.14 46.70 
23NF F 57 69 168 24.45 741.3 2.62 2.62 2.31 2.07 2.31 96.65 2.07 629.41 387.13 2.07 57.79 1.87 352.28 1.87 136.74 
24NF F 56 70 168 24.80 654.6 2.97 2.97 2.62 2.34 2.62 108.44 2.34 477.11 318.92 2.34 41.73 2.12 309.37 2.12 113.45 
25NF F 45 50 159 19.78 459.3 4.23 4.23 3.73 3.33 3.73 93.86 3.33 499.06 337.33 3.33 53.11 3.02 329.47 3.02 156.58 
26NF F 53 55 163 20.70 868.9 2.23 7.56 1.97 1.76 1.97 70.12 1.76 302.32 190.88 1.76 36.78 1.59 233.53 1.59 95.53 
27NF F 40 62 159 24.52 521.1 3.73 3.73 3.29 2.94 3.29 70.14 2.94 371.61 240.64 2.94 37.90 2.66 250.79 2.66 92.63 
28NF M 38 97 191 26.59 550.0 3.53 8.75 3.11 2.79 3.11 54.99 2.79 208.23 142.50 2.79 15.93 2.52 166.74 2.52 48.72 
29NF M 40 78 180 24.07 640.8 3.03 16.89 2.67 2.39 2.67 27.96 2.39 102.42 76.65 2.39 13.35 2.16 93.31 2.16 18.51 
30NF F 55 59 157 23.94 430.8 4.51 4.51 3.97 3.56 3.98 136.42 3.56 688.34 464.93 3.56 61.71 3.22 458.71 3.22 183.90 
31NF F 50 75 167 26.89 505.9 3.84 3.84 3.38 3.03 3.38 80.46 3.03 446.01 317.85 3.03 31.58 2.74 296.52 2.74 120.83 
32NF M 45 83 176 26.79 617.0 3.15 3.15 2.78 2.48 2.78 11.71 2.48 180.71 125.51 2.48 2.25 2.25 95.53 2.25 46.85 
33NF F 36 58 163 21.83 465.6 4.17 4.17 3.68 3.29 3.68 56.21 3.29 106.16 81.14 3.29 2.98 2.98 80.53 2.98 5.89 
34NF M 44 78 178 24.62 466.6 4.16 8.27 3.67 47.84 3.67 115.61 95.27 396.35 275.19 48.61 82.71 52.76 277.44 55.78 129.83 
35NF F 26 49 160 19.14 422.9 7.79 15.21 4.05 3.62 4.05 98.09 3.62 138.07 117.67 3.62 15.66 3.28 102.54 3.28 29.66 
36NF F 29 65 170 22.49 515.9 3.76 3.76 3.32 2.97 3.32 86.81 2.97 228.50 162.38 2.97 13.50 2.69 144.32 2.69 47.79 
37NF M 31 77 178 24.30 679.4 2.86 2.86 2.52 2.25 2.52 10.63 2.25 186.62 92.74 2.25 15.43 2.04 75.65 2.04 31.99 
38NF F 39 52 160 20.31 587.5 8.19 22.94 2.91 2.61 2.91 204.98 85.56 511.53 290.74 2.61 42.26 2.36 830.16 2.36 92.38 
39NF F 37 60 168 21.26 600.8 63.13 56.99 56.65 97.80 55.47 121.94 109.53 214.07 143.61 2.55 31.25 2.31 102.16 2.31 45.75 
40NF F 30 65 158 26.04 422.9 4.59 4.59 4.05 3.62 4.05 61.47 3.62 138.20 94.49 3.62 3.28 3.28 87.81 3.28 35.99 
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PID Sex Age (years) 
Weigh 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) 
PCB 
31 
PCB 
28 
PCB 
52 
PCB 
101 
PCB 
77 
PCB 
118 
PCB 
105 
PCB 
153 
PCB 
138 
PCB 
126 
PCB 
156 
PCB 
128 
PCB 
180 
PCB 
169 
PCB 
170 
41NF F 47 50 168 17.72 500.9 22.74 40.51 3.42 3.06 21.86 83.29 3.06 319.08 208.17 114.66 60.00 2.77 233.20 327.73 109.19 
42NF F 34 64 168 22.68 518.6 3.74 3.74 3.30 2.95 3.30 51.01 2.95 157.81 114.64 2.95 21.51 2.67 132.32 2.67 42.14 
43NF M 50 82 173 27.40 598.7 15.73 14.72 2.86 2.56 2.86 44.04 2.56 146.71 111.52 2.56 15.89 2.31 106.91 2.31 55.57 
44NF F 48 68 157 27.59 598.7 3.24 3.24 2.86 2.56 2.86 58.58 2.56 202.02 168.89 2.56 20.05 2.31 164.60 2.31 60.32 
45NF F 28 63 160 24.61 462.0 4.20 4.20 3.71 3.32 3.71 37.97 3.32 69.87 70.96 3.32 10.55 3.00 57.98 3.00 24.52 
46NF F 43 58 164 21.56 511.9 3.79 3.79 3.35 2.99 3.35 54.88 2.99 208.38 149.78 2.99 17.19 2.71 176.52 2.71 64.18 
47NF F 46 62 155 25.81 616.0 3.15 3.15 11.81 2.49 2.78 48.93 2.49 254.56 178.65 2.49 30.25 2.25 193.80 2.25 73.34 
48NF M 46 92 172 31.10 657.1 2.95 9.15 2.61 2.33 2.61 71.77 2.33 343.80 253.03 2.33 24.57 2.11 203.96 2.11 80.70 
49NF M 21 70 175 22.86 578.1 3.36 3.36 2.96 2.65 2.96 32.15 2.65 52.38 55.55 2.65 3.78 2.40 39.97 2.40 18.00 
50NF F 31 63 168 22.32 386.9 5.02 5.02 23.98 56.03 4.43 58.51 3.96 57.16 54.10 3.96 5.05 3.58 57.97 3.58 20.75 
51NF M 52 80 170 27.68 540.1 17.58 9.92 3.17 2.84 3.17 92.59 2.84 26.63 461.90 2.84 92.05 2.57 276.15 2.57 114.61 
52NF M 48 80 174 26.42 525.0 3.70 3.70 3.26 2.92 3.26 55.43 2.92 418.81 274.36 2.92 30.73 2.64 317.38 2.64 117.98 
53NF M 43 75 172 25.35 1013.4 1.92 1.92 1.69 1.51 1.69 53.69 1.51 239.31 157.02 1.51 18.09 1.37 118.26 1.37 46.88 
54NF M 39 78 177 24.90 589.2 3.29 3.29 2.91 2.60 2.91 33.76 2.60 89.21 51.02 2.60 12.48 2.35 66.28 2.35 25.90 
55NF M 48 110 170 38.06 537.8 3.61 3.61 3.18 2.85 3.18 47.42 2.85 140.18 109.53 2.85 35.85 2.58 110.86 2.58 63.71 
56NF F 40 53 155 22.06 456.0 4.26 4.26 3.75 3.36 3.76 58.17 3.36 81.94 86.51 3.36 4.35 3.04 80.87 3.04 35.38 
57NF M 31 74 183 22.10 452.3 14.55 10.01 3.79 3.39 3.79 58.14 3.39 250.28 174.16 3.39 23.93 3.06 181.91 3.06 70.98 
58NF F 46 59 169 20.66 499.8 3.88 10.52 3.43 3.06 3.43 53.27 3.06 139.38 108.31 3.06 4.18 2.77 90.12 2.77 33.92 
59NF F 48 63 159 24.92 615.0 3.16 24.47 2.78 2.49 2.78 35.94 2.49 83.18 63.71 2.49 2.53 2.25 63.32 2.25 22.37 
60NF F 57 57 156 23.42 606.7 3.20 3.20 2.82 2.52 2.82 32.35 2.52 101.96 86.25 2.52 8.73 2.28 91.27 2.28 33.02 
61NF M 44 77 172 26.03 609.2 3.19 3.19 2.81 2.51 2.81 2.51 2.51 146.56 147.30 2.51 12.62 2.27 129.28 2.27 74.10 
62NF M 44 72 176 23.24 566.5 10.85 11.20 3.02 2.70 3.02 70.53 2.70 369.00 231.07 2.70 53.70 2.45 294.34 2.45 122.93 
63NF F 52 73 163 27.48 642.5 12.80 14.00 2.67 2.38 2.67 101.70 49.04 474.06 356.53 2.38 44.53 2.16 260.77 2.16 98.08 
64NF F 31 60 166 21.77 506.6 3.83 3.83 3.38 3.02 3.38 100.23 3.02 223.38 150.27 3.02 2.73 2.73 178.57 2.73 59.14 
65NF M 55 75 173 25.06 631.6 3.07 11.06 2.71 2.43 2.71 72.44 2.43 391.80 291.33 2.43 41.54 2.19 239.79 2.19 85.03 
66NF F 52 63 156 25.89 929.2 8.63 9.50 1.84 1.65 1.84 79.82 42.30 308.62 205.06 1.65 35.22 1.49 200.44 1.49 84.19 
67NF F 42 50 155 20.81 396.8 4.89 19.53 4.32 3.86 4.32 100.85 3.86 187.43 134.33 3.86 16.74 3.49 178.41 3.49 81.59 
68NF F 40 53 160 20.70 793.4 2.45 2.45 2.16 1.93 2.16 116.87 1.93 327.47 200.18 1.93 23.51 1.75 200.70 1.75 81.94 
69NF F 20 43 160 16.80 521.4 18.81 28.02 3.28 2.94 3.28 87.47 2.94 217.33 193.30 2.94 20.51 2.66 116.69 2.66 50.08 
70NF M 42 69 175 22.53 538.5 3.61 3.61 3.18 2.84 3.18 61.27 2.84 883.58 606.96 2.84 95.65 2.57 551.37 2.57 222.32 
71NF F 44 60 152 25.97 418.5 4.64 4.64 4.09 3.66 4.09 546.59 209.51 675.38 684.58 3.66 90.32 3.31 238.93 3.31 110.45 
72NF F 46 49 150 21.78 566.8 3.43 3.43 3.02 2.70 3.02 87.84 2.70 488.86 292.07 2.70 35.58 2.44 280.63 2.44 106.38 
73NF M 40 85 178 26.83 484.8 4.00 11.21 3.53 3.16 3.53 89.80 38.78 314.46 222.48 3.16 19.35 2.86 199.17 2.86 81.38 
74NF F 51 49 156 20.13 536.1 3.62 18.17 3.19 2.86 3.19 128.51 2.86 574.47 358.78 2.86 49.95 2.58 366.62 2.58 132.13 
75NF M 40 85 180 26.23 575.5 3.37 3.37 2.98 2.66 2.98 48.51 2.66 231.09 149.59 2.66 24.57 2.41 190.32 2.41 84.78 
76NF F 30 52 167 18.65 494.9 3.92 3.92 3.46 3.10 3.46 3.10 3.10 189.49 132.18 3.10 13.73 2.80 133.83 2.80 57.09 
77NF M 35 70 170 24.22 483.5 4.02 4.02 3.54 3.17 3.54 3.17 3.17 243.17 236.18 3.17 68.22 2.87 255.97 2.87 158.04 
78NF F 48 55 170 19.03 506.2 7.98 12.26 3.38 3.03 3.38 107.78 3.03 291.79 191.22 3.03 26.26 2.74 214.04 2.74 89.16 
79NF M 45 86 186 24.86 412.1 4.71 4.71 4.16 3.72 4.16 94.59 3.72 386.07 227.80 3.72 36.57 3.36 263.50 3.36 102.60 
80NF F 41 57 165 20.94 557.8 3.48 3.48 3.07 2.75 3.07 56.60 2.75 275.95 205.36 2.75 24.76 2.48 194.77 2.48 80.32 
81NF M 57 60 175 19.59 430.4 16.10 14.79 3.98 3.56 3.98 63.72 3.56 390.31 200.11 3.56 76.20 3.22 412.25 3.22 145.84 
82NF M 29 98 177 31.28 376.3 27.89 24.53 4.55 4.07 4.55 71.81 4.07 130.77 99.46 4.07 13.55 3.68 84.65 3.68 20.97 
83NF F 42 60 167 21.51 625.1 30.98 14.64 2.74 2.45 2.74 78.31 2.45 202.82 247.99 2.45 44.36 2.22 165.14 2.22 52.15 
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84NF M 56 69 172 23.32 899.2 9.61 5.74 1.90 1.70 1.90 50.83 1.70 469.37 255.71 1.70 52.59 1.54 322.61 1.54 112.48 
85NF M 59 78 171 26.67 338.6 5.73 20.29 5.06 4.52 5.06 489.50 180.10 668.47 530.80 4.52 79.32 4.09 955.30 4.09 278.76 
86NF F 38 52 162 19.81 639.6 13.61 43.86 2.68 2.39 2.68 83.98 2.39 295.47 204.27 2.39 21.82 2.17 176.31 2.17 70.14 
87NF M 38 60 173 20.05 499.3 16.08 18.37 3.43 3.07 3.43 38.07 3.07 199.61 116.69 3.07 12.68 2.78 202.97 2.78 84.28 
88NF M 46 85 186 24.57 401.3 4.84 19.92 4.27 3.82 4.27 155.06 3.82 769.99 485.10 3.82 83.22 3.45 522.28 3.45 187.97 
89NF M 43 85 180 26.23 950.5 2.04 2.04 11.10 1.61 1.80 26.97 1.61 173.88 118.14 1.61 19.28 1.46 127.97 1.46 55.42 
90NF M 28 71 170 24.57 550.8 18.31 11.32 3.11 2.78 3.11 47.68 2.78 118.74 98.33 2.78 12.78 2.52 72.70 2.52 16.15 
91NF M 48 84 174 27.74 677.5 14.01 14.98 15.37 2.26 2.53 78.26 2.26 436.52 245.32 2.26 47.78 2.05 292.91 2.05 101.36 
92NF F 54 62 156 25.48 566.2 42.81 34.98 30.76 2.71 3.02 106.27 2.71 311.79 206.69 2.71 42.42 2.45 237.44 2.45 106.81 
93NF M 44 90 180 27.78 598.6 3.24 3.24 2.86 2.56 2.86 91.95 2.56 186.75 141.47 2.56 17.82 2.31 107.29 2.31 70.46 
94NF M 41 60 167 21.51 514.1 3.78 3.78 3.33 2.98 3.33 53.23 2.98 203.84 144.43 2.98 20.34 2.69 159.18 2.69 55.47 
95NF F 26 55 168 19.49 601.2 22.22 27.94 20.65 2.55 2.85 91.90 2.55 157.66 116.43 2.55 15.04 2.30 98.77 2.30 27.81 
96NF F 48 52 167 18.65 520.5 3.73 18.45 3.29 2.94 3.29 82.95 2.94 356.14 216.18 2.94 43.21 2.66 297.46 2.66 99.67 
97NF M 48 53 164 19.71 556.5 3.49 66.72 153.09 2.75 3.08 108.22 2.75 323.10 206.15 2.75 71.76 2.49 229.90 2.49 85.48 
98NF M 21 75 180 23.15 409.4 4.74 4.74 4.18 3.74 4.18 3.74 3.74 110.36 79.22 3.74 24.75 3.38 77.50 3.38 23.58 
99NF M 21 92 185 26.88 406.0 11.94 11.58 4.22 3.77 4.22 3.77 3.77 52.36 51.15 3.77 3.41 3.41 34.58 3.41 3.12 
100NF M 28 87 186 25.15 376.7 5.15 5.15 59.99 4.07 4.55 4.07 4.07 113.89 101.64 4.07 3.68 3.68 73.92 3.68 18.93 
101NF F 42 55 164 20.45 614.1 19.89 11.37 7.08 2.49 2.79 81.91 2.49 189.56 125.96 2.49 2.26 2.26 132.66 2.26 56.12 
102NF M 58 92 187 26.31 446.3 29.78 4.35 3.84 3.43 3.84 45.04 3.43 390.68 215.23 3.43 3.10 3.10 385.54 3.10 142.73 
103NF M 19 76 174 25.10 330.6 5.87 5.87 5.18 4.63 5.18 4.63 4.63 293.43 189.85 4.63 4.19 4.19 155.17 4.19 84.61 
104NF F 53 59 158 23.63 525.4 5.90 16.43 3.26 2.92 3.26 82.79 2.92 405.24 298.18 2.92 23.16 2.64 219.63 2.64 83.13 
105NF F 37 48 160 18.75 578.4 6.59 3.36 2.96 2.65 2.96 39.19 2.65 166.49 92.89 2.65 13.33 2.40 148.50 2.40 54.43 
106NF F 28 53 167 19.00 567.9 6.57 11.06 3.02 2.70 3.02 53.12 2.70 161.06 122.27 2.70 19.39 2.44 96.75 2.44 44.36 
107NF M 48 72 168 25.51 806.5 6.46 11.22 2.12 1.90 2.12 63.33 1.90 294.22 169.58 1.90 27.92 1.72 206.37 1.72 82.57 
108NF M 55 65 170 22.49 554.7 5.70 14.30 3.09 2.76 3.09 51.90 2.76 351.62 135.38 2.76 32.95 2.50 229.84 2.50 73.08 
109NF F 29 68 155 28.30 471.5 7.60 30.54 3.63 3.25 3.63 151.42 3.25 327.27 199.68 3.25 6.35 2.94 146.33 2.94 68.16 
110NF F 19 45 170 15.57 362.5 6.74 7.96 4.72 4.23 4.72 4.23 4.23 120.07 95.60 4.23 3.82 3.82 89.60 3.82 35.23 
111NF M 50 84 164 31.23 765.4 3.26 2.54 2.24 2.00 4.73 57.82 40.20 352.26 249.06 2.00 86.96 18.50 299.32 60.81 169.20 
112NF M 54 90 175 29.39 612.6 4.60 3.17 2.80 2.50 2.80 80.92 2.50 372.21 208.76 2.50 34.26 2.26 259.76 2.26 106.05 
113NF F 37 50 162 19.05 529.9 6.33 14.44 3.23 2.89 3.23 46.25 2.89 178.64 113.31 2.89 28.84 2.61 158.19 32.36 81.18 
114NF M 53 83 170 28.72 602.5 4.35 18.83 2.84 2.54 2.84 114.27 2.54 654.45 455.15 2.54 53.47 2.30 430.12 2.30 170.37 
115NF M 35 63 168 22.32 538.3 4.63 5.75 3.18 2.85 3.18 90.00 2.85 316.22 172.40 2.85 23.49 2.57 169.04 2.57 69.78 
116NF F 33 48 160 18.75 527.1 3.68 11.92 3.25 2.91 3.25 68.06 2.91 209.43 141.70 2.91 26.37 2.63 163.35 2.63 70.83 
117NF F 40 50 155 20.81 594.1 4.32 11.22 2.88 2.58 2.88 50.07 2.58 292.51 159.01 2.58 23.88 2.33 225.86 2.33 89.18 
118NF F 34 72 160 28.13 518.2 3.75 3.75 3.30 2.96 3.30 118.29 2.96 157.42 111.90 2.96 12.45 2.67 75.10 2.67 40.65 
119NF M 28 80 173 26.73 596.3 3.26 3.26 2.87 2.57 2.87 43.11 2.57 169.85 94.53 2.57 2.32 2.32 94.27 2.32 44.00 
120NF F 28 57 162 21.72 411.0 17.95 33.51 4.17 3.73 4.17 78.26 3.73 151.43 98.95 3.73 16.17 3.37 104.63 3.37 43.46 
121NF F 59 69 155 28.72 699.7 4.18 2.91 2.45 2.19 2.45 50.84 2.19 326.34 191.59 2.19 27.11 1.98 216.63 1.98 79.01 
122NF M 48 93 178 29.35 504.2 3.85 3.85 3.40 3.04 3.40 41.98 3.04 327.91 200.00 3.04 27.95 2.75 256.76 2.75 96.99 
123NF F 19 51 165 18.73 505.9 6.44 14.43 3.38 3.03 3.38 3.03 3.03 54.92 48.61 3.03 2.74 2.74 52.21 2.74 33.04 
124NF F 44 68 169 23.81 434.6 4.47 4.47 3.94 3.52 3.94 98.18 3.52 382.43 258.49 3.52 27.98 3.19 219.42 3.19 119.33 
125NF M 37 76 175 24.82 520.0 3.73 3.73 3.29 2.95 3.29 98.36 2.95 394.32 234.69 2.95 34.67 2.66 216.40 2.66 108.20 
126NF F 33 63 162 24.01 412.7 4.70 4.70 4.15 3.71 4.15 99.16 3.71 140.07 130.19 3.71 3.36 3.36 88.47 3.36 38.11 
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127NF M 52 82 177 26.17 762.1 2.55 2.55 2.25 2.01 2.25 89.72 2.01 332.70 204.73 2.01 34.74 1.82 200.83 1.82 76.01 
128NF M 30 88 178 27.77 787.6 10.25 14.24 2.17 1.94 2.17 87.35 1.94 152.63 93.87 1.94 14.51 1.76 76.48 1.76 20.03 
129NF F 61 62 151 27.19 913.8 2.12 2.12 1.87 1.68 1.87 26.02 1.68 115.48 74.33 1.68 19.43 1.52 87.24 1.52 37.58 
130NF F 61 56 167 20.08 635.2 3.06 3.06 2.70 2.41 2.70 75.19 2.41 241.13 134.99 2.41 41.52 2.18 289.32 2.18 108.28 
131NF M 33 100 182 30.19 604.9 3.53 15.98 2.83 2.53 2.83 52.99 2.53 250.77 154.11 2.53 15.74 2.29 135.85 2.29 48.36 
132NF F 42 62 167 22.23 402.1 4.83 4.83 4.26 3.81 4.26 113.38 3.81 411.54 242.68 3.81 31.56 3.45 239.03 3.45 100.20 
133NF F 38 55 165 20.20 537.3 3.61 3.61 3.19 2.85 3.19 79.48 2.85 150.49 112.58 2.85 2.58 2.58 115.24 2.58 55.99 
134NF F 40 48 160 18.75 437.7 5.75 25.87 3.91 3.50 3.91 122.91 3.50 462.87 282.89 3.50 39.10 3.17 276.03 3.17 93.47 
135NF F 40 56 162 21.34 500.7 6.01 11.54 3.42 3.06 3.42 82.57 3.06 326.85 189.02 3.06 31.10 2.77 214.98 2.77 80.26 
136NF M 56 100 185 29.22 495.5 3.92 3.92 3.46 3.09 3.46 96.45 3.09 786.67 496.53 3.09 64.32 2.80 635.17 2.80 237.82 
137NF F 43 66 172 22.31 479.3 4.05 4.05 3.57 3.20 3.57 94.97 3.20 397.74 221.71 3.20 31.32 2.89 234.58 2.89 104.73 
138NF M 51 94 181 28.69 658.8 2.95 2.95 2.60 2.33 2.60 101.93 2.33 468.83 268.95 2.33 32.42 2.10 278.62 2.10 112.37 
139NF M 55 80 172 27.04 423.7 4.58 4.58 4.04 3.61 4.04 67.71 3.61 541.78 358.39 3.61 46.52 3.27 361.88 3.27 133.23 
140NF M 61 55 165 20.20 1001.6 4.25 8.92 1.71 1.53 1.71 105.79 1.53 466.00 297.97 1.53 39.23 1.38 303.61 1.38 124.90 
141NF M 38 83 164 30.86 539.6 9.75 21.13 3.17 2.84 3.17 74.12 2.84 224.69 172.49 2.84 2.57 2.57 130.27 2.57 51.84 
142NF F 38 49 156 20.13 593.0 3.27 3.27 2.89 2.58 2.89 65.04 2.58 293.75 170.08 2.58 23.32 2.34 180.63 2.34 72.71 
143NF M 39 74 166 26.85 525.3 4.69 13.45 3.26 2.92 3.26 95.19 2.92 324.46 170.77 2.92 30.18 2.64 188.19 2.64 69.06 
144NF M 45 76 174 25.10 567.5 3.42 12.81 3.02 2.70 3.02 94.17 2.70 397.15 243.49 2.70 31.49 2.44 228.35 2.44 82.06 
145NF F 38 57 163 21.45 458.9 7.87 21.78 3.73 3.34 3.73 100.69 3.34 408.74 288.09 3.34 51.05 3.02 246.13 3.02 96.22 
146NF F 48 50 154 21.08 878.3 4.24 11.48 1.95 1.74 1.95 52.72 1.74 213.39 150.51 1.74 26.71 1.58 128.46 1.58 50.40 
147NF M 38 88 183 26.28 767.7 2.53 2.53 2.23 2.00 2.23 62.77 2.00 245.45 137.92 2.00 29.55 1.80 174.14 1.80 77.22 
148NF F 37 60 164 22.31 477.5 4.07 4.07 3.59 3.21 3.59 3.21 3.21 77.23 54.90 3.21 2.90 2.90 42.37 2.90 2.65 
149NF F 32 60 170 20.76 484.1 4.01 4.01 3.54 3.16 3.54 106.19 3.16 228.17 158.75 3.16 2.86 2.86 153.15 2.86 70.15 
150NF F 54 65 160 25.39 532.1 3.65 3.65 3.22 2.88 3.22 74.75 2.88 208.76 118.78 2.88 25.64 2.60 151.30 2.60 73.41 
151NF F 61 55 160 21.48 580.9 3.34 3.34 2.95 2.64 2.95 200.23 2.64 846.29 499.95 2.64 78.15 2.39 415.77 2.39 170.28 
152NF M 33 93 181 28.39 638.4 10.12 25.79 2.68 2.40 2.68 47.49 2.40 200.17 156.88 2.40 2.17 2.17 131.68 2.17 47.79 
153NF M 47 78 170 26.99 711.0 2.73 2.73 2.41 2.15 2.41 79.51 2.15 198.85 146.66 2.15 1.95 1.95 124.10 1.95 53.43 
154NF M 35 91 181 27.78 654.2 6.26 17.35 2.62 2.34 2.62 2.34 2.34 157.08 151.84 2.34 2.12 2.12 100.11 2.12 45.07 
155NF M 27 63 172 21.30 453.6 4.28 4.28 3.78 3.38 3.78 3.38 3.38 145.15 58.80 3.38 3.05 3.05 101.99 3.05 18.34 
156NF M 26 54 158 21.63 473.1 8.87 15.82 3.62 3.24 3.62 3.24 3.24 176.87 127.31 3.24 32.17 2.93 125.76 2.93 57.50 
157NF F 53 80 156 32.87 647.1 3.00 3.00 2.65 2.37 2.65 106.94 2.37 406.93 312.95 2.37 40.93 2.14 212.97 2.14 78.12 
158NF M 59 75 173 25.06 786.9 2.47 20.23 2.18 1.95 2.18 40.99 1.95 243.44 173.23 1.95 33.86 1.76 231.93 1.76 99.45 
159NF M 27 74 179 23.10 566.2 8.16 10.65 3.02 2.71 3.02 2.71 2.71 125.41 95.79 2.71 2.45 2.45 71.80 2.45 33.74 
160NF M 35 75 176 24.21 574.0 3.38 3.38 2.98 2.67 2.98 2.67 2.67 327.21 187.28 2.67 47.60 2.41 198.93 2.41 103.85 
161NF F 50 79 160 30.86 466.5 4.16 4.16 3.67 3.28 3.67 147.74 3.28 348.06 253.54 3.28 2.97 2.97 181.95 2.97 80.76 
162NF M 41 82 181 25.03 700.4 2.77 2.77 2.44 2.19 2.44 78.87 2.19 352.78 230.09 2.19 29.66 1.98 233.23 1.98 94.81 
163NF M 53 84 173 28.07 490.5 3.96 3.96 3.49 3.12 3.49 3.12 3.12 315.92 236.71 3.12 2.82 2.82 200.72 2.82 105.29 
1PV M 32 68 175 22.20 417 4.65 4.65 31.09 3.67 4.11 3.67 3.67 405.17 265.35 3.67 5.73 3.32 267.21 3.32 101.22 
2PV M 35 69 169 24.16 468 8.51 4.15 15.31 3.27 3.66 3.27 3.27 273.86 226.75 3.27 8.44 2.96 163.37 2.96 56.73 
3PV F 32 46 152 19.91 740 2.62 2.62 21.92 2.07 2.31 2.07 2.07 169.66 127.26 2.07 7.80 1.87 97.22 1.87 22.55 
4PV F 27 59 155 24.56 487 3.99 3.99 3.52 3.15 3.52 3.15 3.15 163.98 131.32 3.15 2.84 2.84 81.32 2.84 26.80 
5PV M 51 98 179 30.58 586 3.31 3.31 22.57 2.61 2.92 2.61 2.61 473.63 315.45 2.61 34.79 2.36 432.58 2.36 123.61 
6PV M 40 78 174 25.76 498 3.90 3.90 11.76 3.08 3.44 3.08 3.08 629.49 457.51 3.08 39.36 2.78 377.89 2.78 127.62 
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7PV F 27 45 155 18.73 588 3.30 3.30 9.80 2.61 2.91 2.61 2.61 153.04 131.93 2.61 2.36 2.36 77.70 2.36 18.53 
8PV M 48 73 174 24.11 405 4.79 4.79 17.79 3.78 4.23 549.22 174.94 710.54 644.95 3.78 81.84 3.42 437.48 3.42 127.09 
9PV M 46 75 180 23.15 455 4.26 4.26 29.93 3.36 3.76 3.36 3.36 343.05 223.38 3.36 3.04 3.04 261.75 3.04 101.94 
10PV F 36 48 162 18.29 484 9.85 23.54 41.14 3.17 3.54 3.17 3.17 340.96 207.31 3.17 18.07 2.86 263.91 2.86 88.10 
11PV M 23 68 170 23.53 478 4.06 4.06 25.92 3.20 3.58 3.20 3.20 203.45 155.99 3.20 4.37 2.90 91.61 2.90 29.67 
12PV M 40 104 182 31.40 347 5.60 5.60 24.99 4.42 4.94 4.42 4.42 650.03 504.89 4.42 28.48 3.99 394.34 3.99 123.43 
13PV F 40 54 164 20.00 414 4.69 4.69 29.64 3.70 4.14 3.70 3.70 468.36 322.96 3.70 29.63 3.35 304.18 3.35 106.46 
14PV M 27 66 174 21.80 542 3.58 3.58 25.45 2.82 3.16 2.82 2.82 119.47 87.02 2.82 2.55 2.55 62.20 2.55 16.14 
15PV M 41 131 188 37.06 439 4.42 4.42 24.85 3.49 3.90 3.49 3.49 342.15 259.07 3.49 3.16 3.16 207.81 3.16 70.14 
16PV M 41 65 179 20.29 583 3.33 3.33 25.22 2.63 2.94 2.63 2.63 244.96 173.53 2.63 16.49 2.38 208.43 2.38 57.20 
17PV M 63 79 167 28.33 472 4.11 4.11 28.71 3.24 3.62 3.24 3.24 1009.33 738.82 3.24 70.88 2.93 737.09 2.93 230.61 
18PV M 71 85 176 27.44 346 5.62 66.00 39.76 4.43 4.95 844.94 205.70 1703.82 1222.77 4.43 62.66 4.01 966.42 4.01 276.00 
19PV F 56 74 154 31.20 502 3.87 58.76 36.85 3.05 3.41 406.90 3.05 1159.78 769.68 3.05 102.46 2.76 632.39 2.76 210.93 
20PV M 59 97 172 32.79 509 3.81 3.81 3.36 3.01 3.36 3.01 3.01 474.05 394.64 3.01 38.53 2.72 341.68 2.72 100.87 
21PV M 52 89 176 28.73 559 3.47 3.47 57.16 2.74 3.06 2.74 2.74 659.46 545.61 2.74 42.43 2.48 334.49 2.48 90.50 
22PV M 40 83 182 25.05 535 3.63 3.63 40.06 2.86 3.20 2.86 2.86 330.32 270.20 2.86 2.59 2.59 72.67 2.59 67.03 
23PV M 45 68 165 24.98 608 3.19 3.19 21.16 2.52 2.82 2.52 2.52 735.92 514.58 2.52 2.28 2.28 462.59 2.28 143.90 
24PV M 38 81 172 27.38 509 3.81 3.81 3.36 3.01 3.36 3.01 3.01 792.22 534.62 3.01 46.51 2.72 470.17 2.72 154.48 
25PV M 52 77 168 27.28 475 4.09 4.09 14.93 3.23 3.61 3.23 3.23 777.69 520.28 3.23 42.96 2.92 414.52 2.92 135.00 
26PV M 42 69 182 20.83 514 3.78 3.78 31.86 2.98 3.33 2.98 2.98 317.38 241.27 2.98 36.53 2.70 243.79 2.70 80.72 
27PV F 50 50 155 20.81 484 4.01 4.01 24.63 3.17 3.54 3.17 3.17 455.86 289.91 3.17 40.99 2.87 231.91 2.87 60.30 
28PV F 50 62 150 27.55 576 3.37 3.37 31.71 2.66 2.98 2.66 2.66 354.62 336.03 2.66 35.00 2.41 202.71 2.41 58.43 
29PV M 40 80 173 26.73 542 3.58 3.58 60.65 2.82 3.16 2.82 2.82 313.39 243.39 2.82 29.35 2.56 172.48 2.56 69.90 
30PV M 40 118 175 38.53 649 2.99 2.99 16.52 2.36 2.64 2.36 2.36 241.90 226.74 2.36 2.14 2.14 47.14 2.14 40.10 
31PV M 35 85 185 24.83 524 3.71 3.71 28.84 2.92 3.27 2.92 2.92 292.85 234.13 2.92 2.64 2.64 122.82 2.65 30.33 
32PV M 58 89 175 29.06 422 4.61 4.61 23.64 3.63 4.06 3.63 3.63 503.75 378.47 3.63 61.98 3.29 362.41 3.29 67.54 
33PV M 56 88 178 27.77 502 3.87 3.87 3.41 3.05 3.41 3.05 3.05 725.56 602.04 3.05 72.07 2.76 497.20 2.76 181.01 
34PV M 64 68 170 23.53 412 4.72 4.72 4.16 3.72 4.16 3.72 3.72 579.26 595.16 3.72 94.72 3.36 623.07 3.37 202.67 
35PV M 31 87 187 24.88 466 4.16 4.16 3.67 3.28 3.67 3.28 3.28 232.57 195.21 3.28 2.97 2.97 111.60 2.97 39.35 
36PV M 34 72 175 23.51 485 4.00 4.00 3.53 3.16 3.53 3.16 3.16 265.78 271.63 3.16 20.48 2.85 133.51 2.85 75.46 
37PV M 64 68 165 24.97 557 3.48 3.48 33.97 2.75 3.07 2.75 2.75 604.29 457.72 2.75 56.22 2.49 282.32 2.49 84.88 
38PV M 58 67 164 24.91 451 4.31 4.31 43.84 3.40 3.80 3.40 3.40 649.29 542.29 3.40 33.21 3.07 363.71 3.07 106.62 
39PV F 34 48 154 20.24 615 3.15 3.15 2.78 2.49 2.78 2.49 2.49 290.96 223.41 2.49 10.80 2.25 136.76 2.25 45.50 
40PV F 39 59 156 24.24 306 6.35 6.35 5.60 5.01 5.60 5.01 5.01 456.84 451.46 5.01 33.01 4.53 216.21 4.53 67.57 
41PV F 42 50 155 20.81 494 3.93 3.93 24.21 3.10 3.46 3.10 3.10 417.37 374.27 3.10 14.79 2.80 224.85 2.80 53.37 
42PV M 53 60 167 21.51 507 3.83 3.83 44.20 3.02 3.38 3.02 3.02 536.17 388.64 3.02 64.62 2.73 391.37 2.73 121.53 
43PV M 37 70 175 22.86 531 3.65 3.65 33.18 2.88 3.22 2.88 2.88 175.99 165.44 2.88 3.21 2.61 76.43 2.61 25.18 
44PV M 25 65 173 21.72 581 3.34 3.34 20.39 2.64 2.95 2.64 2.64 161.81 129.64 2.64 13.12 2.39 75.62 2.39 35.04 
45PV M 39 79 168 28.00 788 2.46 2.46 15.34 1.94 2.17 1.94 1.94 202.40 161.46 1.94 1.76 1.76 101.93 1.76 33.70 
46PV M 48 85 163 31.99 612 3.17 3.17 36.02 2.50 2.80 2.50 2.50 760.08 595.10 2.50 61.98 2.26 485.83 2.26 150.11 
47PV F 29 59 166 21.41 627 45.60 31.04 91.12 2.44 2.73 2.44 2.44 200.96 168.83 2.44 2.21 2.21 70.83 2.21 36.59 
48PV F 30 48 154 20.24 518 51.59 48.93 91.42 2.96 3.31 2.96 2.96 207.50 194.09 2.96 2.68 2.68 62.82 2.68 35.35 
49PV F 52 50 163 18.82 416 52.47 61.16 136.30 3.69 4.12 3.69 3.69 355.45 323.01 3.69 30.77 3.33 299.46 3.33 101.43 
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50PV F 25 48 165 17.63 566 53.61 46.77 89.03 2.71 3.03 2.71 2.71 250.96 202.93 2.71 62.03 2.45 49.41 2.45 35.82 
51PV M 53 70 165 30.80 626 3.10 3.10 25.07 2.45 2.74 2.45 2.45 270.37 193.57 2.45 19.26 2.21 132.98 2.21 37.61 
52PV M 39 78 177 24.89 474 4.09 4.09 30.15 3.23 3.61 3.23 3.23 315.38 237.62 3.23 2.92 2.92 189.47 2.92 52.48 
53PV M 33 89 187 25.45 541 3.59 3.59 27.97 2.83 3.17 2.83 2.83 262.56 128.64 2.83 60.40 2.56 62.30 2.56 15.74 
54PV M 45 64 167 22.94 728 2.67 2.67 42.42 2.11 2.35 2.11 2.11 260.15 233.78 2.11 6.99 1.90 133.46 1.90 54.28 
55PV M 44 100 169 35.00 637 3.05 3.05 2.69 2.41 2.69 2.41 2.41 531.48 442.84 2.41 49.22 2.18 262.73 2.18 73.04 
56PV M 35 72 170 24.91 382 5.09 5.09 35.09 4.01 4.49 4.01 4.01 235.35 227.55 4.01 3.63 3.63 126.46 3.63 47.84 
57PV M 45 65 171 22.23 407 4.78 4.78 53.64 3.77 4.21 3.77 3.77 567.49 424.82 3.77 24.98 3.41 334.86 3.41 145.26 
58PV M 34 87 172 29.41 309 6.29 6.29 61.34 4.96 5.55 4.96 4.96 490.49 531.02 4.96 4.49 4.49 227.31 4.49 116.49 
59PV M 41 69 166 25.04 519 3.74 3.74 56.47 2.95 3.30 2.95 2.95 271.54 214.49 2.95 2.67 2.67 134.78 2.67 46.26 
60PV F 34 65 165 23.87 459 4.23 4.23 64.99 3.33 3.73 3.33 3.33 297.58 282.74 3.33 3.02 3.02 136.47 3.02 60.32 
61PV M 35 77 175 25.14 795 98.28 94.23 155.69 1.93 2.15 1.93 1.93 202.86 121.62 1.93 17.47 1.74 148.64 1.74 57.09 
62PV M 21 78 183 23.29 429 132.03 97.11 175.43 3.57 3.99 3.57 3.57 143.01 106.86 3.57 3.23 3.23 71.78 3.23 42.79 
63PV M 42 78 176 25.18 453 4.28 4.28 61.24 3.38 3.78 3.38 3.38 755.80 486.83 3.38 84.36 3.06 553.93 3.06 225.81 
64PV M 32 83 185 24.25 465 185.59 141.90 280.04 3.29 3.68 3.29 3.29 277.65 190.40 3.29 12.56 2.98 146.84 2.98 63.26 
65PV M 54 80 175 26.12 466 217.09 148.64 284.49 3.29 3.68 3.29 3.29 76.55 322.73 3.29 43.62 2.97 439.32 2.97 133.30 
66PV F 27 60 167 21.51 456 238.10 352.86 373.98 3.36 3.75 3.36 3.36 450.87 296.10 3.36 30.96 3.04 269.86 3.04 98.75 
67PV F 23 52 164 19.33 356 251.16 221.47 409.27 4.31 4.82 4.31 4.31 273.16 208.91 4.31 7.79 3.90 137.48 3.90 44.50 
68PV M 37 87 168 30.82 485 246.12 210.59 327.66 3.16 49.45 183.86 3.16 507.14 388.58 3.16 95.07 2.86 330.11 45.73 165.77 
69PV M 24 64 178 20.20 481 75.86 56.96 67.81 3.18 3.56 3.18 3.18 258.58 146.11 3.18 38.03 2.88 139.05 2.88 40.38 
70PV M 57 83 183 24.78 653 103.38 85.73 138.64 2.35 2.62 2.35 2.35 257.63 160.78 2.35 22.66 2.12 250.70 2.12 84.51 
71PV M 54 94 187 26.88 519 122.18 113.82 235.19 2.95 3.30 2.95 2.95 738.50 472.24 2.95 92.40 2.67 760.23 2.67 261.56 
72PV M 26 104 186 30.06 507 164.12 119.31 222.33 3.02 3.38 3.02 3.02 152.09 115.20 3.02 12.11 2.73 92.16 2.73 32.58 
73PV M 56 79 172 26.70 375 280.27 258.60 406.74 4.09 4.57 4.09 4.09 1111.46 712.12 4.09 125.64 3.70 952.69 3.70 328.18 
74PV F 52 70 160 27.34 567 186.87 150.41 266.22 2.70 3.02 2.70 2.70 246.49 172.03 2.70 36.20 2.44 258.54 2.44 86.74 
76PV M 27 70 180 21.60 680 119.72 94.78 163.59 2.25 2.52 2.25 2.25 212.66 134.10 2.25 7.44 2.04 135.85 2.04 33.75 
77PV M 50 100 171 34.20 862 104.02 73.97 190.90 1.78 1.99 1.78 1.78 292.80 214.63 1.78 28.52 1.61 205.77 1.61 80.73 
78PV M 44 86 187 24.59 451 62.33 52.10 86.37 3.40 3.80 3.40 3.40 350.67 196.77 3.40 44.10 3.07 265.20 3.07 85.90 
79PV M 38 83 169 29.06 691 135.42 158.77 194.32 2.22 2.48 2.22 2.22 224.88 157.77 2.22 23.52 2.01 177.46 2.01 62.44 
80PV M 28 83 186 23.99 516 253.14 152.87 304.05 2.97 3.32 2.97 2.97 188.63 122.77 2.97 14.92 2.69 119.73 2.69 51.42 
81PV M 63 84 174 27.74 506 172.28 225.37 267.69 3.03 3.38 3.03 3.03 1075.66 708.58 3.03 93.29 2.74 808.45 2.74 273.79 
82PV M 40 78 165 28.65 901 95.68 74.61 135.45 1.70 1.90 1.70 1.70 137.06 95.58 1.70 8.40 1.54 102.92 1.54 35.50 
83PV M 30 118 185 34.48 884 129.84 96.58 178.59 1.73 1.94 1.73 1.73 152.97 120.56 1.73 6.96 1.57 108.91 1.57 39.49 
84PV F 32 60 165 22.04 435 207.32 169.54 291.56 3.52 3.93 3.52 3.52 381.47 261.48 3.52 20.08 3.18 272.62 3.18 101.90 
85PV M 37 88 172 29.74 657 231.24 351.12 313.83 2.33 2.61 2.33 2.33 299.84 209.00 2.33 2.11 2.11 244.12 2.11 73.92 
86PV M 64 96 171 32.83 563 176.48 143.04 241.47 2.72 3.04 2.72 2.72 405.28 300.43 2.72 40.56 2.46 303.99 2.46 102.66 
87PV M 53 90 178 28.40 552 148.09 126.04 213.93 2.77 3.10 2.77 2.77 853.20 671.29 2.77 65.65 2.51 660.53 2.51 256.30 
88PV M 21 74 189 20.72 722 120.32 104.25 174.21 2.12 2.37 2.12 2.12 113.22 79.22 2.12 3.37 1.92 57.14 1.92 19.94 
89PV F 46 55 160 21.48 602 154.24 134.23 206.59 2.54 2.84 2.54 2.54 329.95 205.26 2.54 36.84 2.30 288.57 2.30 101.58 
90PV M 67 72 181 21.97 412 264.49 194.39 330.34 3.72 4.16 3.72 3.72 1359.96 824.70 3.72 129.40 3.36 1274.83 3.37 353.48 
92PV F 53 64 163 24.08 485 202.18 160.69 290.75 3.16 3.53 3.16 3.16 565.80 407.11 3.16 43.57 2.86 372.02 2.86 124.13 
93PV F 47 57 162 21.72 498 176.79 149.22 253.31 3.08 3.44 3.08 3.08 717.05 406.75 3.08 93.29 2.78 676.51 2.78 201.10 
94PV M 43 69 164 25.65 3266 31.77 26.02 43.30 0.47 0.52 0.47 0.47 89.55 57.53 0.47 6.95 0.42 59.32 0.42 22.74 
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95PV F 23 68 179 21.22 750 132.36 103.74 193.56 2.04 2.28 2.04 2.04 186.85 117.48 2.04 13.87 1.85 102.11 1.85 23.75 
96PV F 32 61 165 22.40 777 143.79 128.59 210.70 1.97 2.20 1.97 1.97 366.38 264.46 1.97 25.84 1.78 227.94 1.78 78.88 
97PV M 53 83 172 28.05 761 150.94 153.86 216.80 2.01 2.25 2.01 2.01 680.20 40.92 2.01 56.53 1.82 500.50 1.82 175.88 
98PV M 44 54 164 20.07 742 125.79 113.78 101.49 2.06 2.31 2.06 2.06 255.41 165.14 2.06 26.02 1.87 260.30 1.87 88.15 
99PV M 30 83 181 25.33 686 134.47 117.44 180.43 2.23 2.50 2.23 2.23 210.23 138.64 2.23 30.32 2.02 162.47 2.02 61.16 
100PV M 33 76 181 23.20 524 60.64 61.73 147.92 2.92 3.27 2.92 2.92 142.09 98.18 2.92 5.05 2.64 104.31 2.64 45.72 
101PV F 44 53 158 21.23 704 91.07 134.28 239.14 2.18 2.43 2.18 2.18 233.28 170.60 2.18 10.70 1.97 174.68 1.97 49.66 
102PV M 44 118 188 33.39 774 58.43 41.17 96.92 1.98 2.21 1.98 1.98 315.83 230.40 1.98 27.59 1.79 183.07 1.79 65.93 
103PV M 36 92 172 31.10 655 24.57 20.01 37.28 2.34 2.61 2.34 2.34 508.06 420.21 2.34 55.17 2.11 325.20 2.11 130.31 
104PV M 33 86 174 28.40 499 106.73 81.31 120.96 3.07 3.43 3.07 3.07 165.21 122.62 3.07 2.78 2.78 116.51 2.78 43.40 
105PV M 34 95 174 31.37 741 74.64 58.53 114.44 2.07 2.31 2.07 2.07 167.46 122.09 2.07 12.90 1.87 109.32 1.87 38.89 
106PV F 20 50 162 19.05 466 78.55 59.98 142.18 3.29 3.68 3.29 3.29 118.54 91.97 3.29 2.98 2.98 54.07 2.98 10.02 
107PV M 25 89 188 25.18 1297 3.62 6.90 10.21 1.18 1.32 1.18 1.18 122.30 103.28 1.18 13.78 1.07 66.72 1.07 31.21 
108PV M 69 64 162 24.38 687 5.30 16.06 26.73 2.23 2.49 223.21 2.23 797.87 565.34 2.23 79.75 2.02 592.19 2.02 181.01 
109PV F 43 69 165 25.34 658 2.95 2.95 32.09 2.33 2.60 67.89 2.33 330.70 291.79 2.33 24.06 2.11 200.35 2.11 98.90 
110PV F 41 69 158 27.64 828 10.13 16.59 17.90 1.85 2.07 69.68 1.85 288.75 240.45 1.85 28.06 1.67 186.08 1.67 66.98 
111PV F 49 61 170 21.10 522 23.44 38.40 42.98 2.94 3.28 2.94 2.94 530.06 410.00 2.94 43.93 2.66 337.62 2.66 124.71 
112PV M 33 72 182 21.73 402 4.83 4.83 44.80 3.81 4.26 86.89 3.81 453.57 395.24 3.81 41.39 3.45 276.17 3.45 135.31 
113PV M 60 90 173 30.07 439 4.42 4.42 47.26 3.49 3.90 3.49 3.49 902.84 674.48 3.49 125.59 3.15 999.39 3.15 321.35 
114PV M 56 87 183 25.98 492 3.94 21.43 24.61 3.11 3.48 190.20 3.11 793.90 587.27 3.11 85.24 2.81 579.44 2.81 182.83 
115PV M 27 81 182 24.45 457 4.25 4.25 42.12 3.35 3.75 3.35 3.35 442.94 384.40 3.35 28.79 3.03 223.09 3.03 112.55 
116PV F 54 98 160 38.28 416 4.67 4.67 4.12 3.69 4.12 3.69 3.69 707.61 591.02 3.69 60.10 3.33 422.08 3.33 172.72 
117PV M 58 81 178 25.56 467 8.55 12.83 28.08 3.28 3.67 3.28 3.28 1189.42 759.50 3.28 115.93 2.97 911.50 2.97 316.10 
118PV M 59 93 170 32.18 481 11.85 21.51 25.51 3.19 3.56 3.19 3.19 664.72 527.72 3.19 60.04 2.88 519.24 2.88 191.21 
119PV M 22 82 176 26.47 673 4.75 15.17 16.72 2.28 2.55 2.28 2.28 192.11 159.72 2.28 10.75 2.06 94.04 2.06 47.59 
120PV F 52 77 159 30.45 655 2.96 2.96 19.40 2.34 2.61 2.34 2.34 502.29 390.14 2.34 32.67 2.11 332.93 2.11 115.53 
121PV F 24 60 166 21.77 502 3.87 3.87 46.16 3.05 3.41 3.05 3.05 559.16 476.35 3.05 37.52 2.76 302.13 2.76 146.05 
122PV M 67 98 178 30.93 436 27.29 51.63 48.44 3.52 3.93 3.52 3.52 1316.72 970.87 3.52 139.78 3.18 887.55 3.18 321.65 
123PV F 44 43 150 19.11 389 4.99 4.99 32.65 3.94 4.40 3.94 3.94 530.40 466.01 3.94 62.49 3.56 382.25 3.56 147.21 
124PV M 41 75 173 25.06 423 4.59 4.59 4.05 3.62 4.05 3.62 3.62 339.23 235.41 3.62 3.27 3.27 259.89 3.27 95.35 
125PV F 28 51 158 20.43 479 30.21 4.05 147.65 3.20 3.57 176.44 3.20 624.84 524.65 3.20 76.09 2.89 361.73 2.89 171.91 
126PV F 29 59 167 21.15 588 19.76 3.30 28.81 2.60 2.91 2.60 2.60 386.12 340.72 2.60 32.43 2.36 210.52 2.36 100.15 
127PV F 30 53 164 19.70 426 4.56 4.56 4.02 3.60 4.02 3.60 3.60 412.80 284.88 3.60 3.25 3.25 250.84 3.25 82.52 
128PV F 44 75 176 24.21 403 4.82 4.82 44.46 3.80 4.25 3.80 3.80 1049.30 871.16 3.80 96.17 3.44 650.93 3.44 252.15 
129PV F 33 49 460 19.14 463 32.73 4.20 67.48 3.31 3.70 3.31 3.31 1060.82 820.78 3.31 90.96 3.00 651.29 3.00 291.81 
130PV F 37 66 168 23.38 436 4.45 4.45 54.32 3.51 3.93 3.51 3.51 787.92 689.86 3.51 77.45 3.18 475.50 3.18 197.11 
131PV F 38 63 170 21.80 503 31.65 92.91 58.97 3.05 3.41 182.60 3.05 681.25 586.27 3.05 55.81 2.76 469.01 2.76 185.68 
132PV F 28 77 165 28.28 382 41.54 5.09 48.63 4.01 4.49 161.95 4.01 756.00 597.18 4.01 74.74 3.63 380.64 3.63 176.70 
133PV F 32 42 150 18.66 403 68.47 86.29 107.36 3.80 4.25 210.86 3.80 1085.62 888.57 3.80 142.98 3.44 686.59 3.44 272.04 
135PV M 46 83 179 25.90 469 60.11 102.75 73.25 3.27 3.65 198.54 3.27 1007.64 783.89 3.27 65.70 2.95 665.28 2.95 299.81 
136PV F 38 61 150 27.10 468 4.15 4.15 41.10 3.27 3.66 121.06 3.27 534.19 483.39 3.27 47.81 2.96 351.70 2.96 162.43 
137PV F 28 50 148 22.82 583 3.33 3.33 46.11 2.63 2.94 82.46 2.63 383.07 324.56 2.63 34.48 2.37 213.62 2.37 24.81 
138PV F 21 62 162 23.62 614 3.16 3.16 28.10 2.50 2.79 123.94 2.50 430.77 374.35 2.50 33.98 2.26 222.95 2.26 92.35 
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139PV M 49 77 175 25.14 383 104.57 125.12 88.09 3.99 4.47 178.88 55.71 441.76 328.90 3.99 113.70 3.61 377.73 3.61 163.39 
140PV F 57 53 154 22.34 771 16.30 17.61 39.08 1.99 2.22 116.75 1.99 601.95 457.20 1.99 55.66 1.80 457.87 1.80 169.32 
141PV M 68 75 167 26.89 660 2.94 2.94 40.39 2.32 2.59 228.52 2.32 672.36 517.35 2.32 37.86 2.10 354.20 2.10 118.87 
142PV M 37 67 179 20.91 571 3.40 3.40 18.78 2.68 3.00 2.68 2.68 478.05 346.62 2.68 19.74 2.43 288.29 2.43 65.42 
143PV F 34 55 167 19.72 471 4.12 4.12 21.02 3.25 3.63 3.25 3.25 230.01 169.28 3.25 2.94 2.94 109.55 2.94 44.69 
144PV F 41 48 153 20.50 585 3.32 3.32 54.79 2.62 2.93 2.62 2.62 737.73 538.52 2.62 58.99 2.37 405.55 2.37 156.70 
145PV F 34 53 155 22.06 551 3.52 3.52 88.53 2.78 3.11 2.78 2.78 889.01 721.33 2.78 62.69 2.51 461.14 2.51 192.07 
146PV F 29 56 153 23.92 630 125.48 3.08 171.56 2.43 2.72 146.32 2.43 230.56 148.26 2.43 3.55 2.20 100.07 2.20 58.12 
147PV F 39 52 165 19.10 578 87.39 77.85 42.28 2.65 2.96 2.65 2.65 347.50 213.95 2.65 2.40 2.40 256.67 2.40 70.26 
148PV F 46 71 154 29.93 738 2.63 2.63 144.72 2.08 2.32 110.37 2.08 342.57 255.67 2.08 17.55 1.88 186.04 1.88 50.58 
149PV M 59 93 173 31.07 826 2.35 2.35 64.93 1.85 2.07 132.35 1.85 570.67 375.68 1.85 33.72 1.68 517.07 1.68 118.04 
150PV M 57 98 177 31.28 608 3.19 3.19 48.93 2.52 2.81 201.72 2.52 737.00 553.65 2.52 72.91 2.28 415.51 2.28 128.10 
151PV F 50 58 160 22.65 614 3.16 3.16 40.74 2.50 2.79 196.51 2.50 773.05 531.54 2.50 84.39 2.26 507.12 2.26 186.72 
152PV F 38 55 163 20.70 634 3.06 3.06 19.64 2.42 2.70 2.42 2.42 401.93 313.46 2.42 29.40 2.19 242.83 2.19 107.59 
153PV F 49 55 160 21.48 726 2.67 2.67 24.96 2.11 2.36 112.65 2.11 514.55 370.76 2.11 54.30 1.91 338.42 1.91 118.22 
154PV F 37 60 165 22.03 930 2.09 2.09 32.95 1.65 1.84 105.33 1.65 375.33 318.56 1.65 25.52 1.49 189.13 1.49 84.93 
155PV F 48 73 161 28.16 585 3.32 3.32 52.58 2.62 2.93 227.06 2.62 803.69 617.63 2.62 54.37 2.37 456.86 2.37 132.54 
156PV F 52 69 161 26.61 676 2.87 2.87 42.15 2.27 2.53 174.26 2.27 679.01 548.40 2.27 57.30 2.05 339.01 2.05 127.78 
157PV F 42 54 160 21.09 601 3.23 3.23 2.85 2.55 2.85 130.71 2.55 496.97 401.77 2.55 51.09 2.31 333.27 2.31 128.47 
158PV F 35 53 160 20.70 533 3.64 3.64 45.35 2.87 3.21 270.34 2.87 856.08 647.75 2.87 66.05 2.60 470.08 2.60 164.42 
159PV F 32 66 170 22.83 614 3.16 3.16 42.81 2.50 2.79 222.09 2.50 552.05 449.97 2.50 34.09 2.26 239.80 2.26 87.64 
160PV F 27 58 173 19.37 671 2.89 2.89 190.56 2.28 2.55 166.48 2.28 203.03 155.75 2.28 25.78 2.06 91.57 2.06 50.90 
161PV F 42 58 158 23.23 644 157.94 103.23 166.39 2.38 2.66 93.89 2.38 366.10 247.39 2.38 9.06 2.15 176.28 2.15 52.26 
162PV F 29 61 172 20.61 703 336.30 257.17 256.95 2.18 29.22 217.51 2.18 323.03 265.30 2.18 76.36 1.97 164.06 43.34 63.72 
163PV F 52 52 155 21.64 758 149.21 100.28 147.13 2.02 2.26 2.02 2.02 332.99 213.29 2.02 32.51 1.83 214.43 1.83 71.12 
164PV F 38 85 183 25.38 822 95.03 47.01 79.31 1.86 2.08 1.86 1.86 190.50 140.55 1.86 18.44 1.69 139.71 1.69 40.74 
165PV F 49 56 164 20.82 542 165.26 3.58 184.69 2.83 3.16 2.83 2.83 291.53 191.52 2.83 36.90 2.56 202.64 2.56 51.27 
166PV F 54 61 160 23.82 677 81.32 53.94 154.52 2.26 2.53 214.56 2.26 403.29 241.94 2.26 38.37 2.05 259.09 2.05 94.63 
167PV F 53 59 165 21.67 575 158.18 3.38 161.76 2.66 2.98 2.66 2.66 451.12 230.65 2.66 32.99 2.41 312.80 2.41 104.81 
1MI M 27 72 165 26.40 476 20.39 20.39 17.99 16.09 53.97 16.09 16.09 675.31 442.45 32.18 29.11 29.11 558.02 29.11 1009.75 
2MI F 27 65 173 21.70 468 20.74 20.74 18.29 16.36 54.89 16.36 16.36 337.49 260.52 32.73 29.60 29.60 378.36 29.61 13.51 
3MI F 34 56 170 19.30 475 20.44 20.44 18.03 16.12 54.08 16.12 16.12 875.05 711.71 32.25 29.17 29.17 548.52 29.17 13.31 
4MI F 25 59 168 20.90 545 17.81 17.81 15.71 14.05 47.13 14.05 14.05 340.66 330.49 28.10 25.42 25.42 287.77 25.42 11.60 
5MI F 24 60 160 23.45 443 21.93 21.93 19.34 17.30 58.03 17.30 17.30 438.22 375.62 34.60 31.30 31.30 14.29 31.30 14.29 
6MI F 21 50 163 19.00 544 17.85 17.85 15.74 14.08 47.23 14.08 14.08 509.54 377.06 28.17 25.48 25.48 11.63 25.48 11.63 
7MI M 42 75 185 21.90 616 15.75 15.75 13.89 12.42 41.67 12.42 12.42 566.37 404.55 24.85 22.48 22.48 10.26 22.48 10.26 
8MI F 34 84 168 29.70 458 21.18 21.18 18.68 16.71 56.05 16.71 16.71 610.74 622.83 33.43 30.23 30.23 402.97 30.24 13.80 
9MI F 26 67 165 24.60 515 18.86 18.86 16.63 14.88 49.90 14.88 14.88 958.22 667.53 29.76 26.92 26.92 422.63 26.92 12.29 
10MI F 54 65 150 29.00 657 14.77 14.77 13.03 11.65 39.08 11.65 11.65 944.29 813.61 23.30 21.08 21.08 781.21 21.08 9.62 
11MI F 36 45 150 20.00 605 16.04 16.04 282.93 12.65 42.44 12.65 12.65 792.08 384.59 25.31 22.89 22.89 564.25 22.89 10.45 
12MI M 32 90 185 23.00 650 14.94 14.94 105.44 11.79 39.54 11.79 11.79 725.14 618.51 23.58 21.33 21.33 584.09 21.33 257.00 
13MI M 40 88 183 26.00 538 18.03 18.03 15.91 14.23 47.72 14.23 14.23 633.19 453.01 28.46 25.74 25.74 390.05 25.74 11.75 
15MI F 41 52 160 20.30 570 17.02 17.02 15.01 13.43 45.04 13.43 13.43 1749.12 1340.99 26.86 24.29 24.29 1029.01 24.29 390.31 
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PID Sex Age (years) 
Weigh 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) 
PCB 
31 
PCB 
28 
PCB 
52 
PCB 
101 
PCB 
77 
PCB 
118 
PCB 
105 
PCB 
153 
PCB 
138 
PCB 
126 
PCB 
156 
PCB 
128 
PCB 
180 
PCB 
169 
PCB 
170 
16MI F 49 78 172 26.36 572 16.98 16.98 323.59 13.40 44.94 13.40 13.40 1207.27 896.96 26.80 24.24 232.73 11.07 24.24 411.62 
17MI F 32 76 167 27.95 611 15.90 15.90 14.02 12.54 42.07 12.54 12.54 762.45 571.83 25.09 22.69 22.69 290.01 22.69 10.36 
18MI F 38 55 162 20.95 483 20.11 20.11 17.73 15.86 53.20 15.86 15.86 1256.96 941.28 31.73 28.70 28.70 518.71 28.70 398.20 
19MI F 38 86 164 31.96 526 18.46 18.46 16.28 14.56 48.84 14.56 14.56 995.81 642.80 29.12 26.34 26.34 452.12 26.35 12.02 
20MI F 38 46 150 20.40 471 20.63 20.63 829.77 16.28 54.59 16.28 16.28 1219.06 694.93 32.55 29.45 29.45 376.33 29.45 13.44 
21MI F 29 60 174 20.00 526 18.46 18.46 520.95 14.56 48.84 14.56 14.56 1001.08 532.15 29.12 26.34 26.34 432.88 26.35 12.02 
22MI F 26 70 175 23.00 498 19.48 19.48 17.18 15.37 51.56 15.37 15.37 628.48 244.72 30.74 27.81 27.81 345.25 27.81 12.69 
23MI F 46 47 151 20.60 627 15.49 15.49 13.66 12.22 40.98 12.22 12.22 654.29 380.19 24.44 22.10 22.10 746.61 22.11 10.09 
24MI F 34 53 160 20.70 499 19.44 19.44 17.15 15.34 51.45 15.34 15.34 532.86 516.21 30.68 27.75 27.75 354.69 27.75 12.67 
25MI M 43 83 170 28.70 544 17.85 17.85 15.74 14.08 47.23 14.08 14.08 540.09 484.05 28.16 25.48 25.48 460.48 25.48 11.63 
26MI F 36 55 172 18.70 351 27.68 27.68 283.22 21.84 73.25 21.84 21.84 2204.65 1612.00 43.68 39.51 505.73 1615.83 39.51 18.03 
27MI F 34 54 162 20.57 307 31.58 31.58 390.00 24.92 83.57 24.92 24.92 982.71 757.32 49.84 45.08 45.08 411.51 45.08 20.58 
28MI F 69 59 153 25.20 572 16.96 16.96 14.96 13.38 44.88 13.38 13.38 1573.55 1060.33 26.76 24.21 232.40 1069.61 24.21 375.69 
29MI F 34 55 163 20.70 483 20.12 20.12 17.74 15.87 53.23 15.87 15.87 867.15 941.81 31.74 28.71 28.71 629.09 28.72 13.11 
30MI F 44 58 160 22.60 516 18.80 18.80 16.58 14.83 49.75 14.83 14.83 13.42 13.42 29.67 26.84 26.84 12.25 26.84 12.25 
31MI F 33 55 163 20.70 476 20.41 20.41 18.01 16.11 54.02 16.11 16.11 472.01 477.84 32.21 29.14 29.14 542.60 29.14 13.30 
32MI F 21 53 163 19.90 376 25.84 25.84 273.51 20.39 68.38 20.39 20.39 759.80 531.12 40.78 36.88 36.88 148.15 36.89 16.84 
33MI F 44 63 173 21.00 474 20.48 20.48 18.07 16.16 54.20 16.16 16.16 1151.90 689.97 32.32 29.24 29.24 763.30 29.24 421.69 
34MI M 20 57 168 20.20 345 28.14 28.14 24.82 22.20 74.45 22.20 22.20 803.14 602.35 44.39 40.16 40.16 366.58 40.16 18.33 
35MI F 20 65 173 21.70 466 20.85 20.85 18.39 16.45 55.17 16.45 16.45 416.57 380.87 32.90 29.76 29.76 217.30 29.76 13.58 
36MI F 25 62 160 24.00 435 22.31 22.31 19.68 17.60 59.03 17.60 17.60 458.52 471.26 35.20 31.84 31.84 290.68 31.84 14.53 
37MI M 21 78 186 22.50 472 20.59 20.59 18.16 16.24 54.47 16.24 16.24 558.25 499.49 32.48 29.38 29.38 268.22 29.38 13.41 
38MI F 27 60 163 22.60 520 18.66 18.66 16.46 14.72 49.39 14.72 14.72 586.05 479.49 29.45 26.64 26.64 340.45 26.64 12.16 
39MI M 21 69 172 23.30 524 18.54 18.54 16.35 14.63 49.06 14.63 14.63 566.30 635.10 29.26 26.46 26.46 289.88 26.46 12.08 
40MI F 26 59 170 20.40 473 20.51 20.51 18.09 16.18 54.28 16.18 16.18 667.50 667.50 32.37 29.28 29.28 999.54 29.28 855.22 
41MI M 20 85 194 22.60 503 19.29 19.29 102.09 15.22 51.04 15.22 15.22 550.65 374.44 30.44 27.53 27.53 392.09 27.53 12.57 
42MI M 20 62 177 19.80 510 19.03 19.03 268.49 15.01 50.34 15.01 15.01 434.48 537.67 30.02 27.15 27.15 1586.50 27.16 12.39 
Abbreviations: PID, personal identification number; NF, Novafeltria; PV, Pavia; MI, Milan; F, female; M, male; BMI, body mass index; TL, total lipids; PCB, 
polychlorinated biphenyls. 
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Annex V: Individual personal characteristics of the study subjects and their computed results of PCB groupings measurements (expressed in 
pmol/g serum lipid). 
PID Sex Age (years) 
Weight 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs ∑DL–PCB ∑NDL–PCB ∑PCBs 
1NF M 44 76 183 22.69 526.9 15.60 6.50 39.10 446.96 278.54 64.55 722.15 786.70 
2NF M 45 74 180 22.84 488.4 65.49 7.01 67.99 349.06 235.55 103.28 621.82 725.10 
3NF M 57 78 174 25.76 480.4 8.08 7.13 79.14 777.10 553.81 114.63 1310.62 1425.26 
4NF F 52 58 157 23.53 780.8 13.62 4.39 92.59 649.60 262.05 125.81 896.43 1022.24 
5NF M 55 74 168 26.22 513.3 30.76 6.67 87.34 625.04 369.83 151.04 968.60 1119.65 
6NF M 44 101 175 32.98 601.1 13.01 5.70 55.32 338.19 158.33 70.29 500.26 570.55 
7NF M 47 81 180 25.00 513.8 12.31 6.67 78.97 539.66 282.47 108.08 812.00 920.08 
8NF M 54 71 168 25.16 594.8 12.67 5.76 72.08 559.67 374.79 111.71 913.27 1024.98 
10NF F 60 65 163 24.46 571.3 14.48 5.99 87.56 652.14 380.62 123.91 1016.88 1140.80 
11NF F 54 55 155 22.89 541.5 7.90 6.32 78.54 566.11 287.54 104.25 842.18 946.43 
12NF M 36 87 177 27.77 586.8 31.35 5.84 72.62 445.35 228.25 94.61 688.80 783.41 
13NF F 32 58 168 20.55 437.3 32.14 7.83 92.98 408.37 165.74 111.59 595.46 707.05 
14NF M 40 82 176 26.47 507.2 7.65 6.75 58.49 538.37 240.97 89.52 762.70 852.23 
15NF F 39 56 165 20.57 515.5 7.53 6.64 50.21 261.39 162.83 69.38 419.23 488.61 
16NF F 39 80 175 26.12 440.1 8.82 7.78 79.70 536.48 207.58 133.18 707.18 840.36 
17NF F 31 64 163 24.09 505.8 7.68 6.77 68.90 311.41 135.03 84.66 445.12 529.79 
18NF M 52 88 170 30.45 857.6 4.53 3.99 71.00 746.86 299.97 106.88 1019.47 1126.35 
19NF M 38 80 180 24.69 509.3 141.83 6.72 419.26 674.02 310.55 386.12 1166.26 1552.38 
20NF F 39 65 160 25.39 457.0 8.50 7.49 83.05 478.30 272.83 109.87 740.30 850.17 
21NF F 48 70 170 24.22 411.0 9.45 8.33 185.95 1029.76 438.71 248.57 1423.63 1672.20 
22NF M 43 73 170 25.26 648.4 19.81 5.28 46.37 248.81 177.94 65.66 432.55 498.21 
23NF F 57 69 168 24.45 741.3 5.24 4.62 102.85 1078.07 489.02 162.75 1517.03 1679.79 
24NF F 56 70 168 24.80 654.6 5.93 5.23 115.46 842.00 422.82 159.59 1231.86 1391.44 
25NF F 45 50 159 19.78 459.3 8.45 7.46 103.86 895.53 486.05 160.38 1340.98 1501.36 
26NF F 53 55 163 20.70 868.9 9.80 3.94 75.41 533.17 329.06 113.99 837.39 951.37 
27NF F 40 62 159 24.52 521.1 7.45 6.57 78.96 655.46 343.41 119.86 972.00 1091.86 
28NF M 38 97 191 26.59 550.0 12.28 6.23 63.35 371.70 215.46 82.13 586.90 669.02 
29NF M 40 78 180 24.07 640.8 19.92 5.34 35.13 196.74 111.81 50.93 318.03 368.96 
30NF F 55 59 157 23.94 430.8 9.01 7.95 147.09 1221.41 642.61 212.43 1815.64 2028.07 
31NF F 50 75 167 26.89 505.9 7.68 6.77 89.54 800.93 417.35 124.22 1198.04 1322.26 
32NF M 45 83 176 26.79 617.0 6.29 5.55 19.15 312.96 142.38 23.94 462.39 486.33 
33NF F 36 58 163 21.83 465.6 8.34 7.36 66.07 196.22 86.42 72.41 292.00 364.41 
34NF M 44 78 178 24.62 466.6 12.43 7.34 307.33 862.80 407.27 401.65 1195.52 1597.17 
35NF F 26 49 160 19.14 422.9 23.00 8.10 108.96 277.96 132.20 128.33 421.89 550.21 
36NF F 29 65 170 22.49 515.9 7.53 6.64 95.72 409.75 192.12 112.26 599.50 711.76 
37NF M 31 77 178 24.30 679.4 5.72 5.04 17.39 298.87 107.64 35.13 399.54 434.67 
38NF F 39 52 160 20.31 587.5 31.13 5.83 295.75 849.25 922.53 340.68 1763.82 2104.50 
39NF F 37 60 168 21.26 600.8 120.11 112.12 331.81 393.54 147.91 323.04 782.45 1105.50 
40NF F 30 65 158 26.04 422.9 9.18 8.10 72.33 242.52 123.80 79.31 376.62 455.93 
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PID Sex Age (years) 
Weight 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs ∑DL–PCB ∑NDL–PCB ∑PCBs 
41NF F 47 50 168 17.72 500.9 63.24 25.28 204.07 917.75 342.39 610.61 942.13 1552.74 
42NF F 34 64 168 22.68 518.6 7.49 6.60 59.87 299.30 174.46 84.40 463.32 547.72 
43NF M 50 82 173 27.40 598.7 30.45 5.72 51.72 278.76 162.48 70.22 458.90 529.13 
44NF F 48 68 157 27.59 598.7 6.49 5.72 66.25 395.58 224.92 88.91 610.04 698.96 
45NF F 28 63 160 24.61 462.0 8.40 7.41 47.91 157.39 82.50 61.85 241.76 303.61 
46NF F 43 58 164 21.56 511.9 7.59 6.69 63.86 380.76 240.70 84.11 615.49 699.60 
47NF F 46 62 155 25.81 616.0 6.30 14.59 56.38 467.95 267.14 89.17 723.20 812.37 
48NF M 46 92 172 31.10 657.1 12.10 5.21 78.77 625.61 284.66 105.72 900.64 1006.36 
49NF M 21 70 175 22.86 578.1 6.72 5.92 40.10 116.50 57.97 46.59 180.63 227.22 
50NF F 31 63 168 22.32 386.9 10.04 28.40 122.45 123.48 78.72 79.48 283.61 363.09 
51NF M 52 80 170 27.68 540.1 27.50 6.34 101.10 585.70 390.76 196.04 915.35 1111.40 
52NF M 48 80 174 26.42 525.0 7.40 6.52 64.18 729.18 435.36 97.89 1144.75 1242.64 
53NF M 43 75 172 25.35 1013.4 3.83 3.38 58.22 417.15 165.14 77.85 569.87 647.73 
54NF M 39 78 177 24.90 589.2 6.59 5.81 41.56 157.42 92.18 56.69 246.86 303.56 
55NF M 48 110 170 38.06 537.8 7.22 6.37 55.96 290.71 174.57 94.72 440.10 534.83 
56NF F 40 53 155 22.06 456.0 8.51 7.51 68.25 178.87 116.26 76.03 303.37 379.40 
57NF M 31 74 183 22.10 452.3 24.56 7.57 68.30 454.49 252.89 95.69 712.13 807.82 
58NF F 46 59 169 20.66 499.8 14.41 6.85 62.46 257.41 124.04 69.78 395.39 465.17 
59NF F 48 63 159 24.92 615.0 27.63 5.57 43.41 153.92 85.69 48.49 267.74 316.23 
60NF F 57 57 156 23.42 606.7 6.40 5.65 39.93 201.50 124.30 51.23 326.54 377.77 
61NF M 44 77 172 26.03 609.2 6.37 5.62 10.06 311.02 203.38 25.24 511.21 536.46 
62NF M 44 72 176 23.24 566.5 22.05 6.05 78.64 658.66 417.28 135.10 1047.57 1182.67 
63NF F 52 73 163 27.48 642.5 26.80 5.33 155.51 879.44 358.85 202.48 1223.46 1425.93 
64NF F 31 60 166 21.77 506.6 7.66 6.76 109.30 381.86 237.71 115.13 628.17 743.30 
65NF M 55 75 173 25.06 631.6 14.13 5.42 79.72 729.06 324.82 123.74 1029.42 1153.16 
66NF F 52 63 156 25.89 929.2 18.13 3.69 125.42 551.89 284.64 162.34 821.44 983.77 
67NF F 42 50 155 20.81 396.8 24.42 8.63 112.43 345.48 260.00 133.12 617.85 750.96 
68NF F 40 53 160 20.70 793.4 4.89 4.32 122.66 554.66 282.64 148.14 821.03 969.17 
69NF F 20 43 160 16.80 521.4 46.83 6.57 96.29 436.47 166.78 119.80 633.13 752.93 
70NF M 42 69 175 22.53 538.5 7.21 6.36 69.80 1591.34 773.69 168.36 2280.04 2448.40 
71NF F 44 60 152 25.97 418.5 9.28 8.18 763.42 1456.90 349.39 857.48 1729.68 2587.16 
72NF F 46 49 150 21.78 566.8 6.85 6.04 95.94 821.40 387.02 134.29 1182.96 1317.25 
73NF M 40 85 178 26.83 484.8 15.21 7.06 134.89 562.01 280.54 157.48 842.24 999.72 
74NF F 51 49 156 20.13 536.1 21.79 6.39 137.08 988.37 498.75 189.96 1462.43 1652.38 
75NF M 40 85 180 26.23 575.5 6.75 5.95 56.50 410.06 275.10 83.79 670.57 754.36 
76NF F 30 52 167 18.65 494.9 7.85 6.92 12.38 341.00 190.92 29.27 529.80 559.07 
77NF M 35 70 170 24.22 483.5 8.03 7.08 12.67 553.30 414.02 84.13 910.98 995.11 
78NF F 48 55 170 19.03 506.2 20.23 6.77 116.86 514.74 303.20 146.22 815.59 961.80 
79NF M 45 86 186 24.86 412.1 9.42 8.31 105.74 657.16 366.10 146.11 1000.62 1146.73 
80NF F 41 57 165 20.94 557.8 6.96 6.14 64.83 511.05 275.08 92.41 771.66 864.07 
81NF M 57 60 175 19.59 430.4 30.89 7.96 74.40 673.05 558.10 154.24 1190.16 1344.40 
82NF M 29 98 177 31.28 376.3 52.41 9.10 84.02 251.15 105.62 101.73 400.57 502.30 
83NF F 42 60 167 21.51 625.1 45.62 5.48 85.66 499.60 217.30 132.52 721.14 853.67 
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PID Sex Age (years) 
Weight 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs ∑DL–PCB ∑NDL–PCB ∑PCBs 
84NF M 56 69 172 23.32 899.2 15.35 3.81 55.94 780.75 435.09 110.28 1180.67 1290.95 
85NF M 59 78 171 26.67 338.6 26.02 10.11 678.65 1286.78 1234.06 762.60 2473.03 3235.63 
86NF F 38 52 162 19.81 639.6 57.48 5.35 91.17 525.89 246.45 115.44 810.90 926.34 
87NF M 38 60 173 20.05 499.3 34.45 6.86 47.27 334.54 287.24 63.09 647.27 710.36 
88NF M 46 85 186 24.57 401.3 24.76 8.53 166.52 1345.21 710.25 253.63 2001.63 2255.27 
89NF M 43 85 180 26.23 950.5 4.09 12.90 31.81 314.22 183.39 52.73 493.67 546.40 
90NF M 28 71 170 24.57 550.8 29.63 6.22 56.02 234.89 88.84 71.65 343.95 415.60 
91NF M 48 84 174 27.74 677.5 28.99 17.90 85.04 733.71 394.27 135.14 1124.77 1259.91 
92NF F 54 62 156 25.48 566.2 77.79 33.79 114.38 565.80 344.25 159.57 976.44 1136.01 
93NF M 44 90 180 27.78 598.6 6.49 5.72 99.63 350.67 177.75 120.07 520.19 640.26 
94NF M 41 60 167 21.51 514.1 7.55 6.66 62.16 374.00 214.65 85.55 579.48 665.03 
95NF F 26 55 168 19.49 601.2 50.16 23.50 99.54 293.73 126.58 117.18 476.32 593.51 
96NF F 48 52 167 18.65 520.5 22.18 6.58 91.77 620.86 397.13 138.00 1000.52 1138.52 
97NF M 48 53 164 19.71 556.5 70.21 156.17 116.47 605.99 315.38 191.05 1073.17 1264.22 
98NF M 21 75 180 23.15 409.4 9.48 8.37 14.96 221.10 101.08 43.54 311.45 354.99 
99NF M 21 92 185 26.88 406.0 23.53 8.44 15.09 113.75 37.70 22.36 176.14 198.51 
100NF M 28 87 186 25.15 376.7 10.31 64.54 16.26 226.56 92.85 24.10 386.43 410.53 
101NF F 42 55 164 20.45 614.1 31.25 9.86 89.39 322.28 188.78 94.20 547.38 641.57 
102NF M 58 92 187 26.31 446.3 34.13 7.67 55.34 615.22 528.26 61.95 1178.67 1240.62 
103NF M 19 76 174 25.10 330.6 11.75 10.36 18.53 495.85 239.78 27.46 748.80 776.27 
104NF F 53 59 158 23.63 525.4 22.33 6.52 91.53 731.86 302.76 117.68 1037.32 1155.00 
105NF F 37 48 160 18.75 578.4 9.95 5.92 47.14 277.50 202.94 63.17 480.27 543.44 
106NF F 28 53 167 19.00 567.9 17.63 6.03 61.21 307.60 141.11 83.36 450.22 533.58 
107NF M 48 72 168 25.51 806.5 17.69 4.25 69.03 495.15 288.94 98.89 776.16 875.05 
108NF M 55 65 170 22.49 554.7 20.00 6.17 60.18 524.94 302.92 95.95 818.27 914.22 
109NF F 29 68 155 28.30 471.5 38.13 7.26 161.17 539.17 214.50 170.84 789.39 960.23 
110NF F 19 45 170 15.57 362.5 14.70 9.45 16.90 227.13 124.83 25.04 367.97 393.01 
111NF M 50 84 164 31.23 765.4 5.80 6.97 102.03 767.60 468.52 252.53 1098.38 1350.91 
112NF M 54 90 175 29.39 612.6 7.77 5.59 88.42 619.75 365.81 125.24 962.11 1087.35 
113NF F 37 50 162 19.05 529.9 20.77 6.46 54.93 355.77 239.37 116.47 560.83 677.30 
114NF M 53 83 170 28.72 602.5 23.18 5.68 121.90 1167.66 600.49 177.97 1740.94 1918.91 
115NF M 35 63 168 22.32 538.3 10.37 6.36 98.54 517.25 238.82 124.94 746.41 871.35 
116NF F 33 48 160 18.75 527.1 15.60 6.50 76.78 382.76 234.18 106.12 609.69 715.81 
117NF F 40 50 155 20.81 594.1 15.54 5.77 57.81 480.07 315.04 84.33 789.90 874.23 
118NF F 34 72 160 28.13 518.2 7.49 6.61 127.16 287.12 115.76 142.63 401.50 544.14 
119NF M 28 80 173 26.73 596.3 6.51 5.74 50.81 271.34 138.27 55.76 416.92 472.69 
120NF F 28 57 162 21.72 411.0 51.46 8.33 89.44 273.29 148.09 109.41 461.19 570.60 
121NF F 59 69 155 28.72 699.7 7.09 4.89 57.41 548.99 295.63 86.76 827.27 914.02 
122NF M 48 93 178 29.35 504.2 7.70 6.79 51.10 561.36 353.75 82.16 898.55 980.71 
123NF F 19 51 165 18.73 505.9 20.87 6.77 12.11 111.74 85.25 17.94 218.79 236.74 
124NF F 44 68 169 23.81 434.6 8.94 7.88 108.75 675.28 338.75 140.34 999.25 1139.59 
125NF M 37 76 175 24.82 520.0 7.47 6.59 107.20 669.01 324.60 144.88 969.98 1114.86 
126NF F 33 63 162 24.01 412.7 9.41 8.30 110.30 280.33 126.59 117.45 417.47 534.93 
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127NF M 52 82 177 26.17 762.1 5.09 4.49 95.75 575.81 276.84 132.55 825.44 957.99 
128NF M 30 88 178 27.77 787.6 24.48 4.35 93.18 264.52 96.52 109.68 373.37 483.05 
129NF F 61 62 151 27.19 913.8 4.25 3.75 31.05 212.28 124.82 52.19 323.96 376.15 
130NF F 61 56 167 20.08 635.2 6.11 5.39 82.42 422.00 397.60 126.40 787.12 913.52 
131NF M 33 100 182 30.19 604.9 19.51 5.66 60.59 425.19 184.21 78.91 616.25 695.16 
132NF F 42 62 167 22.23 402.1 9.66 8.52 124.81 692.66 339.23 160.27 1014.61 1174.88 
133NF F 38 55 165 20.20 537.3 7.23 6.37 88.03 270.81 171.23 93.52 450.15 543.67 
134NF F 40 48 160 18.75 437.7 31.61 7.82 133.41 791.19 369.50 176.08 1157.45 1333.53 
135NF F 40 56 162 21.34 500.7 17.55 6.84 91.75 552.50 295.23 125.98 837.90 963.87 
136NF M 56 100 185 29.22 495.5 7.84 6.91 105.73 1353.11 872.99 173.21 2173.37 2346.57 
137NF F 43 66 172 22.31 479.3 8.10 7.15 104.55 656.55 339.31 139.14 976.52 1115.66 
138NF M 51 94 181 28.69 658.8 5.89 5.20 108.91 774.41 391.00 143.70 1141.70 1285.40 
139NF M 55 80 172 27.04 423.7 9.16 8.08 78.55 953.23 495.11 128.77 1415.36 1544.13 
140NF M 61 55 165 20.20 1001.6 13.17 3.42 110.38 805.97 428.51 151.18 1210.28 1361.45 
141NF M 38 83 164 30.86 539.6 30.89 6.35 82.64 404.89 182.11 88.11 618.76 706.87 
142NF F 38 49 156 20.13 593.0 6.55 5.78 72.79 491.83 253.35 98.75 731.54 830.29 
143NF M 39 74 166 26.85 525.3 18.15 6.52 103.94 530.69 257.25 137.10 779.44 916.54 
144NF M 45 76 174 25.10 567.5 16.23 6.03 102.26 677.01 310.41 136.51 975.43 1111.94 
145NF F 38 57 163 21.45 458.9 29.65 7.46 110.70 753.91 342.36 165.16 1078.92 1244.08 
146NF F 48 50 154 21.08 878.3 15.72 3.90 57.95 393.77 178.85 86.45 563.75 650.20 
147NF M 38 88 183 26.28 767.7 5.06 4.46 68.76 416.53 251.35 100.34 645.82 746.17 
148NF F 37 60 164 22.31 477.5 8.13 7.17 12.83 140.83 45.02 19.01 194.98 213.99 
149NF F 32 60 170 20.76 484.1 8.02 7.07 115.68 395.50 223.31 121.78 627.80 749.58 
150NF F 54 65 160 25.39 532.1 7.30 6.44 83.38 358.39 224.71 111.97 568.25 680.21 
151NF F 61 55 160 21.48 580.9 6.68 5.90 208.14 1429.16 586.05 288.99 1946.94 2235.93 
152NF M 33 93 181 28.39 638.4 35.91 5.36 54.69 363.56 179.48 59.32 579.69 639.01 
153NF M 47 78 170 26.99 711.0 5.46 4.82 85.98 351.36 177.53 90.13 535.02 625.15 
154NF M 35 91 181 27.78 654.2 23.61 5.24 9.37 315.28 145.18 13.88 484.79 498.67 
155NF M 27 63 172 21.30 453.6 8.56 7.55 13.51 213.11 120.33 20.01 343.05 363.06 
156NF M 26 54 158 21.63 473.1 24.68 7.24 12.95 342.21 183.26 48.44 521.91 570.35 
157NF F 53 80 156 32.87 647.1 6.00 5.29 114.05 765.09 291.09 157.40 1024.12 1181.52 
158NF M 59 75 173 25.06 786.9 22.70 4.35 46.83 454.06 331.38 82.68 776.64 859.32 
159NF M 27 74 179 23.10 566.2 18.81 6.05 10.82 228.54 105.54 16.03 353.72 369.76 
160NF M 35 75 176 24.21 574.0 6.76 5.97 10.67 566.92 302.77 61.01 832.09 893.10 
161NF F 50 79 160 30.86 466.5 8.32 7.34 157.59 610.51 262.72 163.91 882.56 1046.47 
162NF M 41 82 181 25.03 700.4 5.54 4.89 85.43 616.48 328.04 117.32 923.06 1040.39 
163NF M 53 84 173 28.07 490.5 7.92 6.98 12.49 561.11 306.01 18.51 876.00 894.50 
1PV M 32 68 175 22.20 417 9.31 35.19 14.69 682.89 368.42 24.17 1086.33 1110.50 
2PV M 35 69 169 24.16 468 12.65 18.97 13.08 514.97 220.10 24.87 754.90 779.77 
3PV F 32 46 152 19.91 740 5.24 24.23 8.27 308.46 119.77 18.19 447.79 465.99 
4PV F 27 59 155 24.56 487 7.97 7.03 12.58 303.83 108.12 18.64 420.90 439.54 
5PV M 51 98 179 30.58 586 6.63 25.49 10.46 828.59 556.19 47.92 1379.44 1427.36 
6PV M 40 78 174 25.76 498 7.80 15.20 12.31 1131.93 505.51 54.82 1617.92 1672.74 
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7PV F 27 45 155 18.73 588 6.61 12.71 10.43 292.05 96.23 15.45 402.58 418.03 
8PV M 48 73 174 24.11 405 9.59 22.02 731.73 1444.16 564.57 817.43 1954.64 2772.07 
9PV M 46 75 180 23.15 455 8.53 33.69 13.45 575.55 363.69 19.93 974.97 994.91 
10PV F 36 48 162 18.29 484 33.39 44.68 12.66 572.07 352.01 33.96 980.85 1014.81 
11PV M 23 68 170 23.53 478 8.12 29.50 12.81 369.60 121.28 20.45 520.86 541.30 
12PV M 40 104 182 31.40 347 11.20 29.93 17.67 1191.39 517.78 50.66 1717.29 1767.95 
13PV F 40 54 164 20.00 414 9.38 33.78 14.81 827.64 410.64 48.22 1248.04 1296.25 
14PV M 27 66 174 21.80 542 7.16 28.61 11.29 214.16 78.34 16.74 322.82 339.55 
15PV M 41 131 188 37.06 439 8.85 28.75 13.96 610.69 277.95 20.69 919.51 940.20 
16PV M 41 65 179 20.29 583 6.67 28.16 10.52 439.73 265.63 29.70 721.01 750.71 
17PV M 63 79 167 28.33 472 8.22 32.34 12.97 1824.90 967.71 87.16 2758.97 2846.13 
18PV M 71 85 176 27.44 346 71.62 44.71 1059.50 2997.27 1242.42 1126.69 4288.82 5415.51 
19PV F 56 74 154 31.20 502 62.63 40.27 416.06 2037.45 843.33 521.65 2878.08 3399.73 
20PV M 59 97 172 32.79 509 7.62 6.72 12.03 912.65 442.55 53.63 1327.95 1381.58 
21PV M 52 89 176 28.73 559 6.94 60.22 10.95 1252.46 424.99 56.18 1699.38 1755.56 
22PV M 40 83 182 25.05 535 7.25 43.26 11.45 608.29 139.70 16.96 792.99 809.95 
23PV M 45 68 165 24.98 608 6.39 23.98 10.08 1257.34 606.49 14.93 1889.34 1904.28 
24PV M 38 81 172 27.38 509 7.62 6.72 12.03 1378.78 624.65 61.61 1968.19 2029.80 
25PV M 52 77 168 27.28 475 8.18 18.54 12.91 1346.76 549.52 59.17 1876.74 1935.91 
26PV M 42 69 182 20.83 514 7.56 35.19 11.93 600.57 324.51 51.50 928.26 979.76 
27PV F 50 50 155 20.81 484 8.03 28.17 12.67 792.49 292.21 56.90 1076.67 1133.57 
28PV F 50 62 150 27.55 576 6.75 34.69 10.65 730.47 261.15 48.37 995.32 1043.69 
29PV M 40 80 173 26.73 542 7.16 63.80 11.30 591.24 242.38 43.53 872.35 915.88 
30PV M 40 118 175 38.53 649 5.99 19.16 9.45 475.05 87.23 14.00 582.89 596.89 
31PV M 35 85 185 24.83 524 7.41 32.11 11.70 534.91 153.15 17.33 721.95 739.28 
32PV M 58 89 175 29.06 422 9.21 27.70 14.53 950.78 429.95 80.23 1351.94 1432.17 
33PV M 56 88 178 27.77 502 7.74 6.83 12.21 1405.20 678.21 87.41 2022.78 2110.19 
34PV M 64 68 170 23.53 412 9.43 8.32 14.88 1275.88 825.75 113.40 2020.85 2134.25 
35PV M 31 87 187 24.88 466 8.33 7.34 13.14 436.70 150.95 19.46 596.99 616.46 
36PV M 34 72 175 23.51 485 8.00 7.05 12.62 563.61 208.97 36.33 763.92 800.25 
37PV M 64 68 165 24.97 557 6.97 37.04 10.99 1123.20 367.21 70.02 1475.39 1545.41 
38PV M 58 67 164 24.91 451 8.61 47.64 13.59 1230.93 470.33 50.27 1720.84 1771.11 
39PV F 34 48 154 20.24 615 6.31 5.56 9.95 529.67 182.26 23.30 710.46 733.76 
40PV F 39 59 156 24.24 306 12.71 11.21 20.05 950.37 283.77 58.18 1219.93 1278.11 
41PV F 42 50 155 20.81 494 7.86 27.68 12.40 812.03 278.22 30.35 1107.83 1138.18 
42PV M 53 60 167 21.51 507 7.66 47.58 12.09 994.90 512.91 79.80 1495.33 1575.13 
43PV M 37 70 175 22.86 531 7.31 36.40 11.53 349.85 101.61 17.68 489.02 506.70 
44PV M 25 65 173 21.72 581 6.69 23.34 10.55 309.34 110.67 26.36 434.22 460.58 
45PV M 39 79 168 28.00 788 4.93 17.52 7.78 369.14 135.63 11.52 523.47 534.99 
46PV M 48 85 163 31.99 612 6.34 38.82 10.01 1421.69 635.94 74.55 2038.25 2112.81 
47PV F 29 59 166 21.41 627 76.64 93.85 9.78 376.42 107.42 14.49 649.63 664.11 
48PV F 30 48 154 20.24 518 100.51 94.73 11.83 409.61 98.17 17.53 697.33 714.86 
49PV F 52 50 163 18.82 416 113.63 140.42 14.74 715.90 400.90 49.28 1336.32 1385.59 
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50PV F 25 48 165 17.63 566 100.37 92.05 10.83 520.83 85.23 75.63 733.68 809.31 
51PV M 53 70 165 30.80 626 6.20 27.81 9.79 487.63 170.59 31.55 670.47 702.02 
52PV M 39 78 177 24.89 474 8.19 33.76 12.92 561.76 241.95 19.14 839.42 858.56 
53PV M 33 89 187 25.45 541 7.18 31.14 11.33 456.73 78.04 74.62 509.78 584.41 
54PV M 45 64 167 22.94 728 5.34 44.78 8.42 504.73 187.74 17.56 733.45 751.01 
55PV M 44 100 169 35.00 637 6.10 5.38 9.62 1027.89 335.77 61.30 1323.46 1384.75 
56PV M 35 72 170 24.91 382 10.17 39.57 16.05 473.79 174.30 23.78 690.11 713.89 
57PV M 45 65 171 22.23 407 9.55 57.86 15.07 1024.10 480.12 43.90 1542.80 1586.70 
58PV M 34 87 172 29.41 309 12.58 66.89 19.84 1034.98 343.80 29.40 1448.68 1478.09 
59PV M 41 69 166 25.04 519 7.48 59.77 11.80 494.03 181.04 17.48 736.64 754.12 
60PV F 34 65 165 23.87 459 8.45 68.72 13.34 589.37 196.80 19.76 856.91 876.68 
61PV M 35 77 175 25.14 795 192.51 157.84 7.71 345.43 205.73 27.14 882.07 909.22 
62PV M 21 78 183 23.29 429 229.14 179.42 14.27 259.55 114.57 21.15 775.80 796.95 
63PV M 42 78 176 25.18 453 8.57 65.02 13.52 1333.11 779.74 101.34 2098.62 2199.95 
64PV M 32 83 185 24.25 465 327.48 283.73 13.18 486.58 210.10 29.11 1291.96 1321.07 
65PV M 54 80 175 26.12 466 365.73 288.16 13.15 448.85 572.62 60.14 1628.38 1688.52 
66PV F 27 60 167 21.51 456 590.96 377.73 13.43 784.01 368.61 47.82 2086.92 2134.74 
67PV F 23 52 164 19.33 356 472.62 414.09 17.23 497.65 181.98 29.42 1554.16 1583.58 
68PV M 37 87 168 30.82 485 456.71 377.11 193.34 1039.37 495.88 380.42 2181.98 2562.40 
69PV M 24 64 178 20.20 481 132.82 71.37 12.74 448.49 179.42 54.03 790.82 844.85 
70PV M 57 83 183 24.78 653 189.11 141.27 9.39 445.31 335.22 34.45 1085.84 1120.29 
71PV M 54 94 187 26.88 519 236.00 238.49 11.80 1308.48 1021.79 107.22 2709.34 2816.56 
72PV M 26 104 186 30.06 507 283.43 225.71 12.08 284.86 124.74 27.28 903.54 930.82 
73PV M 56 79 172 26.70 375 538.88 411.31 16.35 1956.61 1280.86 146.16 4057.83 4204.00 
74PV F 52 70 160 27.34 567 337.29 269.24 10.80 459.60 345.27 49.76 1372.44 1422.20 
76PV M 27 70 180 21.60 680 214.50 166.11 9.01 358.28 169.59 18.76 898.73 917.49 
77PV M 50 100 171 34.20 862 178.00 192.89 7.11 539.16 286.50 37.44 1166.21 1203.65 
78PV M 44 86 187 24.59 451 114.43 90.16 13.58 597.68 351.10 61.15 1105.80 1166.95 
79PV M 38 83 169 29.06 691 294.19 196.80 8.87 410.18 239.90 34.66 1115.28 1149.94 
80PV M 28 83 186 23.99 516 406.01 307.37 11.87 331.69 171.15 29.83 1198.27 1228.10 
81PV M 63 84 174 27.74 506 397.65 271.07 12.10 1883.00 1082.24 108.49 3537.58 3646.07 
82PV M 40 78 165 28.65 901 170.29 137.35 6.80 244.11 138.43 16.94 680.05 696.99 
83PV M 30 118 185 34.48 884 226.42 180.53 6.93 283.63 148.41 15.67 830.25 845.92 
84PV F 32 60 165 22.04 435 376.86 295.49 14.07 669.40 374.53 37.76 1692.60 1730.35 
85PV M 37 88 172 29.74 657 582.36 316.44 9.33 515.17 318.04 13.82 1727.52 1741.34 
86PV M 64 96 171 32.83 563 319.53 244.51 10.89 751.19 406.65 54.23 1678.53 1732.76 
87PV M 53 90 178 28.40 552 274.13 217.03 11.10 1595.15 916.84 79.58 2934.67 3014.25 
88PV M 21 74 189 20.72 722 224.56 176.59 8.49 199.65 77.08 14.02 672.34 686.36 
89PV F 46 55 160 21.48 602 288.47 209.43 10.18 576.66 390.15 49.62 1425.27 1474.89 
90PV M 67 72 181 21.97 412 458.87 334.49 14.88 2320.79 1628.31 148.09 4609.26 4757.34 
92PV F 53 64 163 24.08 485 362.86 294.28 12.63 1022.19 496.15 59.43 2128.69 2188.12 
93PV F 47 57 162 21.72 498 326.01 256.75 12.30 1222.66 877.61 108.74 2586.60 2695.34 
94PV M 43 69 164 25.65 3266 57.79 43.83 1.88 154.87 82.06 9.31 331.13 340.43 
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95PV F 23 68 179 21.22 750 236.09 195.84 8.17 321.90 125.86 24.13 863.75 887.88 
96PV F 32 61 165 22.40 777 272.38 212.90 7.88 660.25 306.82 35.74 1424.49 1460.23 
97PV M 53 83 172 28.05 761 304.80 219.05 8.05 781.29 676.39 66.65 1922.93 1989.58 
98PV M 44 54 164 20.07 742 239.57 103.80 8.26 450.31 348.45 36.39 1114.00 1150.39 
99PV M 30 83 181 25.33 686 251.90 182.92 8.93 383.23 223.62 41.54 1009.08 1050.62 
100PV M 33 76 181 23.20 524 122.37 151.19 11.69 250.60 150.03 19.72 666.16 685.88 
101PV F 44 53 158 21.23 704 225.36 241.58 8.71 418.52 224.33 21.64 1096.86 1118.49 
102PV M 44 118 188 33.39 774 99.60 99.13 7.92 577.41 249.00 37.53 995.52 1033.05 
103PV M 36 92 172 31.10 655 44.58 39.89 9.35 987.67 455.50 66.91 1470.08 1536.99 
104PV M 33 86 174 28.40 499 188.04 124.39 12.28 296.16 159.91 18.19 762.58 780.77 
105PV M 34 95 174 31.37 741 133.17 116.75 8.27 306.19 148.21 23.28 689.31 712.59 
106PV F 20 50 162 19.05 466 138.53 145.85 13.16 219.44 64.09 19.49 561.58 581.07 
107PV M 25 89 188 25.18 1297 10.52 11.53 4.72 241.50 97.93 19.71 346.50 366.22 
108PV M 69 64 162 24.38 687 21.36 29.22 229.90 1446.98 773.19 311.92 2188.73 2500.65 
109PV F 43 69 165 25.34 658 5.90 34.69 74.87 650.77 299.25 101.31 964.16 1065.47 
110PV F 41 69 158 27.64 828 26.72 19.97 75.23 560.61 253.06 105.18 830.41 935.60 
111PV F 49 61 170 21.10 522 61.84 46.26 11.74 989.31 462.33 58.68 1512.81 1571.49 
112PV M 33 72 182 21.73 402 9.67 49.06 98.33 897.11 411.48 143.61 1322.03 1465.64 
113PV M 60 90 173 30.07 439 8.84 51.16 13.95 1709.22 1320.74 143.11 2960.80 3103.91 
114PV M 56 87 183 25.98 492 25.38 28.09 199.54 1472.04 762.27 287.96 2199.35 2487.31 
115PV M 27 81 182 24.45 457 8.49 45.86 13.40 862.19 335.64 45.62 1219.96 1265.58 
116PV F 54 98 160 38.28 416 9.34 8.24 14.74 1365.40 594.80 78.61 1913.91 1992.52 
117PV M 58 81 178 25.56 467 21.39 31.75 13.13 2070.79 1227.61 132.42 3232.25 3364.67 
118PV M 59 93 170 32.18 481 33.36 29.08 12.75 1258.24 710.45 76.05 1967.83 2043.88 
119PV M 22 82 176 26.47 673 19.92 19.27 9.11 366.70 141.62 22.18 534.43 556.61 
120PV F 52 77 159 30.45 655 5.93 22.01 9.35 929.32 448.45 44.41 1370.66 1415.07 
121PV F 24 60 166 21.77 502 7.73 49.57 12.20 1078.55 448.18 52.84 1543.40 1596.24 
122PV M 67 98 178 30.93 436 78.92 52.37 14.06 2433.74 1209.20 157.44 3630.85 3788.29 
123PV F 44 43 150 19.11 389 9.98 37.05 15.75 1066.02 529.46 82.27 1576.00 1658.27 
124PV M 41 75 173 25.06 423 9.17 8.09 14.47 584.45 355.25 21.45 949.99 971.44 
125PV F 28 51 158 20.43 479 34.26 151.23 186.03 1231.36 533.64 265.39 1871.14 2136.53 
126PV F 29 59 167 21.15 588 23.06 31.72 10.42 763.99 310.68 45.51 1094.35 1139.86 
127PV F 30 53 164 19.70 426 9.12 8.04 14.39 707.45 333.35 21.32 1051.03 1072.35 
128PV F 44 75 176 24.21 403 9.64 48.71 15.21 2023.50 903.08 115.26 2884.87 3000.13 
129PV F 33 49 460 19.14 463 36.92 71.18 13.24 1978.54 943.10 107.59 2935.40 3042.98 
130PV F 37 66 168 23.38 436 8.91 58.25 14.06 1561.59 672.60 95.10 2220.30 2315.40 
131PV F 38 63 170 21.80 503 124.56 62.38 191.74 1328.84 654.69 250.67 2111.55 2362.22 
132PV F 28 77 165 28.28 382 46.63 53.11 173.99 1435.18 557.35 252.83 2013.42 2266.25 
133PV F 32 42 150 18.66 403 154.75 111.61 222.26 2124.05 958.64 369.13 3202.17 3571.30 
135PV M 46 83 179 25.90 469 162.86 76.90 208.34 1863.14 965.09 277.37 2998.96 3276.33 
136PV F 38 61 150 27.10 468 8.30 44.76 130.88 1071.31 514.13 182.03 1587.34 1769.37 
137PV F 28 50 148 22.82 583 6.66 49.04 90.34 746.86 238.43 127.50 1003.82 1131.33 
138PV F 21 62 162 23.62 614 6.33 30.89 131.42 843.62 315.30 167.96 1159.60 1327.55 
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PID Sex Age (years) 
Weight 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs ∑DL–PCB ∑NDL–PCB ∑PCBs 
139PV M 49 77 175 25.14 383 229.69 92.55 242.58 891.59 541.12 360.36 1637.17 1997.53 
140PV F 57 53 154 22.34 771 33.91 41.30 122.72 1118.41 627.19 180.41 1763.11 1943.52 
141PV M 68 75 167 26.89 660 5.88 42.98 235.47 1231.77 473.07 275.71 1713.46 1989.17 
142PV M 37 67 179 20.91 571 6.81 21.78 10.74 849.27 353.72 33.22 1209.09 1242.31 
143PV F 34 55 167 19.72 471 8.24 24.65 13.00 408.10 154.24 19.26 588.96 608.22 
144PV F 41 48 153 20.50 585 6.64 57.72 10.48 1339.98 562.25 72.15 1904.93 1977.08 
145PV F 34 53 155 22.06 551 7.04 91.64 11.12 1678.05 653.21 76.64 2364.42 2441.06 
146PV F 29 56 153 23.92 630 128.56 174.28 153.62 386.76 158.19 159.65 841.76 1001.41 
147PV F 39 52 165 19.10 578 165.25 45.24 10.61 568.64 326.93 15.72 1100.95 1116.66 
148PV F 46 71 154 29.93 738 5.26 147.04 116.60 619.55 236.62 136.27 988.81 1125.07 
149PV M 59 93 173 31.07 826 4.70 67.00 137.91 983.42 635.11 173.53 1654.61 1828.14 
150PV M 57 98 177 31.28 608 6.38 51.74 209.27 1368.11 543.61 284.75 1894.36 2179.11 
151PV F 50 58 160 22.65 614 6.33 43.53 204.00 1393.50 693.84 290.94 2050.25 2341.19 
152PV F 38 55 163 20.70 634 6.12 22.34 9.66 749.15 350.42 41.53 1096.18 1137.71 
153PV F 49 55 160 21.48 726 5.35 27.32 118.98 943.42 456.64 175.44 1376.27 1551.71 
154PV F 37 60 165 22.03 930 4.18 34.80 110.27 722.38 274.06 137.47 1008.22 1145.69 
155PV F 48 73 161 28.16 585 6.64 55.51 234.92 1480.43 589.40 291.96 2074.93 2366.89 
156PV F 52 69 161 26.61 676 5.75 44.68 181.07 1288.80 466.79 240.68 1746.41 1987.09 
157PV F 42 54 160 21.09 601 6.46 5.70 138.35 954.43 461.74 192.05 1374.64 1566.69 
158PV F 35 53 160 20.70 533 7.28 48.56 278.97 1575.08 634.50 347.95 2196.44 2544.39 
159PV F 32 66 170 22.83 614 6.33 45.60 229.58 1040.63 327.44 266.23 1383.35 1649.58 
160PV F 27 58 173 19.37 671 5.79 193.11 173.32 388.70 142.47 201.44 701.95 903.39 
161PV F 42 58 158 23.23 644 261.16 169.05 101.03 626.86 228.55 112.53 1274.12 1386.64 
162PV F 29 61 172 20.61 703 593.47 286.17 224.04 710.00 227.78 370.78 1670.69 2041.47 
163PV F 52 52 155 21.64 758 249.49 149.39 8.09 582.44 285.55 42.67 1232.30 1274.96 
164PV F 38 85 183 25.38 822 142.04 81.39 7.45 352.86 180.45 27.80 736.39 764.20 
165PV F 49 56 164 20.82 542 168.84 187.84 11.30 525.06 253.92 51.09 1095.88 1146.97 
166PV F 54 61 160 23.82 677 135.26 157.05 221.35 687.69 353.72 262.04 1293.03 1555.07 
167PV F 53 59 165 21.67 575 161.56 164.73 10.66 719.58 417.61 46.38 1427.76 1474.14 
1MI M 27 72 165 26.40 476 40.79 71.95 80.45 1205.08 1567.77 176.54 2789.50 2966.04 
2MI F 27 65 173 21.70 468 41.48 73.18 81.82 686.83 391.87 179.56 1095.64 1275.19 
3MI F 34 56 170 19.30 475 40.87 72.10 80.62 1674.27 561.84 176.91 2252.79 2429.70 
4MI F 25 59 168 20.90 545 35.62 62.84 70.26 747.41 299.37 154.19 1061.32 1215.51 
5MI F 24 60 160 23.45 443 43.86 77.37 86.51 907.74 28.57 189.85 954.22 1144.06 
6MI F 21 50 163 19.00 544 35.70 62.98 70.41 963.03 23.26 154.52 1000.86 1155.38 
7MI M 42 75 185 21.90 616 31.49 55.56 62.12 1038.35 20.52 136.31 1071.72 1208.03 
8MI F 34 84 168 29.70 458 42.37 74.74 83.56 1324.27 416.77 183.37 1758.33 1941.70 
9MI F 26 67 165 24.60 515 37.72 66.54 74.39 1706.50 434.91 163.25 2156.81 2320.06 
10MI F 54 65 150 29.00 657 29.54 52.10 58.26 1821.14 790.83 127.84 2624.02 2751.86 
11MI F 36 45 150 20.00 605 32.08 325.38 63.27 1245.35 574.70 138.84 2101.93 2240.77 
12MI M 32 90 185 23.00 650 29.89 144.98 58.95 1407.64 841.09 129.35 2353.18 2482.54 
13MI M 40 88 183 26.00 538 36.07 63.63 71.14 1163.42 401.80 156.11 1579.94 1736.05 
15MI F 41 52 160 20.30 570 34.04 60.05 67.14 3162.99 1419.32 147.34 4596.20 4743.54 
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PID Sex Age (years) 
Weight 
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) ∑Tri–CBs ∑Tetra–CBs ∑Penta–CBs ∑Hexa–CBs ∑Hepta–CBs ∑DL–PCB ∑NDL–PCB ∑PCBs 
16MI F 49 78 172 26.36 572 33.97 368.53 67.00 2385.44 422.69 147.03 3130.60 3277.63 
17MI F 32 76 167 27.95 611 31.80 56.09 62.72 1402.36 300.37 137.63 1715.70 1853.33 
18MI F 38 55 162 20.95 483 40.21 70.94 79.32 2284.33 916.91 174.05 3217.66 3391.71 
19MI F 38 86 164 31.96 526 36.92 65.12 72.81 1717.64 464.15 159.78 2196.86 2356.64 
20MI F 38 46 150 20.40 471 41.26 884.36 81.38 2002.33 389.77 178.59 3220.51 3399.10 
21MI F 29 60 174 20.00 526 36.92 569.80 72.81 1612.27 444.91 159.78 2576.92 2736.70 
22MI F 26 70 175 23.00 498 38.97 68.74 76.86 956.63 357.95 168.66 1330.48 1499.14 
23MI F 46 47 151 20.60 627 30.97 54.64 61.09 1100.79 756.70 134.06 1870.13 2004.20 
24MI F 34 53 160 20.70 499 38.89 68.60 76.71 1132.33 367.36 168.33 1515.57 1683.89 
25MI M 43 83 170 28.70 544 35.70 62.98 70.41 1100.57 472.11 154.52 1587.25 1741.77 
26MI F 36 55 172 18.70 351 55.36 356.47 109.20 4401.39 1633.87 239.63 6316.67 6556.30 
27MI F 34 54 162 20.57 307 63.17 473.57 124.59 1875.27 432.09 273.41 2695.28 2968.69 
28MI F 69 59 153 25.20 572 33.92 59.84 66.91 2914.69 1445.30 146.83 4373.84 4520.66 
29MI F 34 55 163 20.70 483 40.24 70.98 79.36 1895.11 642.20 174.15 2553.73 2727.88 
30MI F 44 58 160 22.60 516 37.60 66.33 74.17 107.34 24.50 162.76 147.19 309.94 
31MI F 33 55 163 20.70 476 40.83 72.02 80.53 1037.26 555.90 176.71 1609.82 1786.53 
32MI F 21 53 163 19.90 376 51.68 341.89 101.94 1401.57 164.98 223.70 1838.37 2062.08 
33MI F 44 63 173 21.00 474 40.97 72.27 80.80 1929.58 1184.99 177.32 3131.29 3308.61 
34MI M 20 57 168 20.20 345 56.27 99.26 110.99 1525.96 384.91 243.55 1933.84 2177.40 
35MI F 20 65 173 21.70 466 41.69 73.55 82.24 886.71 230.89 180.47 1134.61 1315.08 
36MI F 25 62 160 24.00 435 44.62 78.71 88.01 1025.30 305.21 193.12 1348.72 1541.85 
37MI M 21 78 186 22.50 472 41.17 72.63 81.21 1145.89 281.63 178.20 1444.32 1622.52 
38MI F 27 60 163 22.60 520 37.33 65.85 73.62 1145.46 352.61 161.56 1513.30 1674.86 
39MI M 21 69 172 23.30 524 37.08 65.41 73.14 1280.78 301.96 160.50 1597.88 1758.38 
40MI F 26 59 170 20.40 473 41.02 72.37 80.91 1422.82 1854.76 177.56 3294.32 3471.89 
41MI M 20 85 194 22.60 503 38.58 153.13 76.10 1007.69 404.66 166.99 1513.17 1680.16 
42MI M 20 62 177 19.80 510 38.05 318.84 75.05 1053.61 1598.90 164.70 2919.75 3084.45 
Keys: ∑PCB, ∑PCB 28, 31, 52, 77, 101, 105, 118, 126, 138, 153, 156, 167, 169, 180; ∑tri–CBs, ∑PCB 28, 31; ∑tetra–CBs ∑PCB 52, 77; ∑penta–CBs, ∑PCB 101, 105, 118, 
126; ∑hexa–CBs, ∑PCB 128, 138, 153, 156, 169) and ∑hepta–CBs, ∑PCB 170,180; ∑DL–PCBs, (∑77, 105, 118, 126, 156, 169); ∑NDL–PCB, ∑PCB 28, 31, 52, 101, 118, 
138, 153, 167, 180). 
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Annex VI: Individual personal characteristics of the examined subjects and results of measurements (All OCP measurements are reported in pmol/g 
serum lipid). 
PID Sex Age Weight (kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) β-HCH HCB p,p'-DDE o,p'-DDD p,p'-DDD o,p'-DDT ∑p,p'-DDX ∑o,p'-DDX ∑DDT ∑OCP 
1NF F 47 54 164 20.08 597 340 541 727 382 1021 704 1747 1086 2834 3714 
2NF M 45 85 180 26.23 729 35 72 272 266 13 925 285 1191 1475 1583 
3NF M 30 73 171 24.96 393 66 214 72 8 127 998 199 1006 1205 1485 
4NF M 50 76 185 22.21 410 75 231 169 183 198 3378 367 3561 3928 4235 
5NF M 43 61 173 20.38 482 756 153 33 6 920 2997 953 3003 3956 4865 
6NF F 53 75 173 25.06 455 552 1350 650 17 41 1674 691 1691 2382 4284 
7NF F 40 58 162 22.10 465 55 1050 277 34 161 1826 439 1860 2298 3403 
8NF F 44 56 165 20.57 543 47 220 168 12 1231 1086 1399 1097 2497 2764 
9NF M 53 85 173 28.40 908 28 131 339 21 79 1019 419 1040 1458 1618 
10NF M 48 70 170 24.22 575 45 18 405 5 33 20 437 25 462 525 
11NF M 59 70 168 24.80 576 45 189 306 22 542 274 848 296 1144 1378 
12NF M 40 70 170 24.22 454 57 240 332 83 48 112 381 194 575 872 
13NF F 53 80 160 31.25 483 441 2014 1081 26 453 520 1533 546 2079 4534 
14NF F 46 62 167 22.23 399 65 528 1348 63 901 106 2248 169 2417 3009 
15NF F 44 87 175 28.41 452 57 831 744 28 249 94 993 121 1114 2003 
16NF M 48 100 176 32.28 467 55 970 1212 348 120 6 1332 354 1686 2711 
17NF F 53 59 156 24.24 442 54 278 726 49 49 51 775 101 876 1208 
18NF M 49 90 173 30.07 473 80 282 492 7 7 54 499 60 559 921 
19NF F 44 51 155 21.23 552 355 64 177 28 57 608 233 636 870 1288 
20NF F 37 56 168 19.84 520 50 7 538 18 919 16 1457 34 1492 1548 
21NF F 22 47 158 18.83 427 60 8 52 22 15 59 66 81 148 216 
22NF M 34 68 171 23.26 437 59 209 317 21 7 607 324 628 952 1220 
23NF M 49 80 185 23.37 398 65 71 1177 149 31 617 1209 766 1974 2110 
24NF M 22 80 175 26.12 401 120 88 227 31 23 49 251 80 331 539 
25NF F 26 57 168 20.20 440 250 160 121 43 21 16 143 59 201 611 
26NF M 27 67 175 21.88 285 229 12 1556 22 33 25 1589 47 1635 1877 
27NF M 49 80 180 24.69 477 54 228 831 26 20 118 850 144 995 1277 
28NF F 52 52 168 18.42 570 380 209 695 16 11 59 706 76 782 1371 
29NF F 25 45 160 17.58 433 60 41 450 43 36 78 486 121 608 708 
30NF M 57 80 170 27.68 536 48 393 1320 15 15 395 1334 409 1744 2185 
31NF F 32 58 160 22.66 396 65 222 349 20 20 18 369 38 407 693 
32NF M 43 100 191 27.41 495 486 78 305 16 16 14 321 30 351 915 
33NF F 29 51 164 18.96 401 815 114 20 19 19 18 39 37 76 1005 
34NF F 37 52 168 18.42 352 73 140 545 22 22 20 567 42 609 822 
35NF M 45 80 176 25.83 457 56 254 647 17 17 15 664 33 696 1006 
36NF M 49 70 177 22.34 466 243 166 567 17 17 15 584 32 615 1025 
1PV M 32 68 175 22.20 417 511 84 196 349 229 460 425 809 1234 1829 
2PV M 35 69 169 24.16 468 632 105 138 180 130 380 268 560 828 1565 
3PV F 32 46 152 19.91 740 195 64 76 30 93 231 169 260 430 689 
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PID Sex Age Weight (kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) β-HCH HCB p,p'-DDE o,p'-DDD p,p'-DDD o,p'-DDT ∑p,p'-DDX ∑o,p'-DDX ∑DDT ∑OCP 
4PV F 27 59 155 24.56 487 413 101 100 80 183 330 283 410 693 1207 
5PV M 51 98 179 30.58 586 288 78 123 53 280 313 403 366 770 1135 
6PV M 40 78 174 25.76 498 839 92 259 78 144 212 403 291 694 1625 
7PV F 27 45 155 18.73 588 304 75 142 138 186 389 328 527 854 1233 
8PV M 48 73 174 24.11 405 471 104 105 108 401 1191 506 1299 1805 2380 
9PV M 46 75 180 23.15 455 264 112 124 72 220 350 344 422 767 1143 
10PV F 36 48 162 18.29 484 661 80 16 107 268 647 284 753 1038 1778 
11PV M 23 68 170 23.53 478 860 107 135 235 252 351 387 586 973 1939 
12PV M 40 104 182 31.40 347 708 187 199 104 329 976 528 1079 1607 2503 
13PV F 40 54 164 20.00 414 801 153 137 155 185 365 322 519 841 1795 
14PV M 27 66 174 21.80 542 676 81 116 95 167 284 283 379 662 1419 
15PV M 41 131 188 37.06 439 454 116 183 100 520 591 702 691 1393 1963 
16PV M 41 65 179 20.29 583 602 78 140 150 13 508 154 658 812 1492 
17PV M 63 79 167 28.33 472 561 100 523 17 278 377 801 393 1194 1855 
18PV M 71 85 176 27.44 346 790 406 1854 154 564 958 2418 1111 3530 4726 
19PV F 56 74 154 31.20 502 647 182 789 106 401 641 1191 746 1937 2766 
20PV M 59 97 172 32.79 509 811 121 507 71 239 490 746 561 1307 2238 
21PV M 52 89 176 28.73 559 154 101 298 87 14 194 312 281 593 847 
22PV M 40 83 182 25.05 535 125 95 94 64 50 134 144 199 342 563 
23PV M 45 68 165 24.98 608 249 72 140 54 59 264 199 318 517 838 
24PV M 38 81 172 27.38 509 331 100 71 15 15 47 86 62 149 580 
25PV M 52 77 168 27.28 475 485 126 420 62 66 330 486 392 878 1489 
26PV M 42 69 182 20.83 514 301 92 205 15 15 14 220 29 249 642 
27PV F 50 50 155 20.81 484 327 112 205 16 126 15 331 31 361 800 
28PV F 50 62 150 27.55 576 167 107 407 81 90 12 496 94 590 864 
29PV M 40 80 173 26.73 542 165 91 128 55 69 289 197 344 540 796 
30PV M 40 118 175 38.53 649 344 84 75 12 29 165 104 177 281 709 
31PV M 35 85 185 24.83 524 472 161 198 15 15 13 213 28 241 875 
32PV M 58 89 175 29.06 422 293 100 123 19 19 17 141 35 177 570 
33PV M 56 88 178 27.77 502 298 101 157 16 16 14 172 30 202 601 
34PV M 64 68 170 23.53 412 467 132 84 99 15 294 99 393 492 1092 
35PV M 31 87 187 24.88 466 454 79 132 80 205 336 336 416 753 1285 
36PV M 34 72 175 23.51 485 262 80 139 16 16 337 155 353 509 851 
37PV M 64 68 165 24.97 557 278 98 581 79 140 251 722 329 1051 1426 
38PV M 58 67 164 24.91 451 469 105 268 17 17 22 286 39 325 899 
39PV F 34 48 154 20.24 615 436 86 212 79 71 328 283 407 690 1212 
40PV F 39 59 156 24.24 306 1023 155 87 26 26 23 113 49 161 1339 
57PV M 45 65 171 22.23 407 190 116 282 123 184 697 466 819 1286 1592 
62PV M 21 78 183 23.29 429 305 106 198 135 127 677 325 812 1137 1548 
63PV M 42 78 176 25.18 453 228 143 163 17 17 243 180 260 440 812 
64PV M 32 83 185 24.25 465 362 143 433 101 91 601 523 701 1225 1731 
66PV F 27 60 167 21.51 456 388 127 293 99 116 560 410 659 1069 1584 
67PV F 23 52 164 19.33 356 386 158 283 149 219 1854 502 2003 2505 3050 
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PID Sex Age Weight (kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) β-HCH HCB p,p'-DDE o,p'-DDD p,p'-DDD o,p'-DDT ∑p,p'-DDX ∑o,p'-DDX ∑DDT ∑OCP 
68PV M 37 87 168 30.82 485 135 134 477 64 81 561 557 626 1183 1451 
70PV M 57 83 183 24.78 653 300 62 116 81 12 1274 128 1356 1483 1845 
71PV M 54 94 187 26.88 519 215 101 303 66 178 1343 481 1409 1889 2206 
72PV M 26 104 186 30.06 507 180 100 198 71 250 1174 448 1245 1693 1973 
74PV F 52 70 160 27.34 567 273 84 349 50 110 440 460 490 949 1306 
75PV M 43 75 170 26.01 595 246 91 217 92 53 261 269 353 622 959 
76PV M 27 70 180 21.60 680 243 67 190 69 76 442 265 511 776 1086 
80PV M 28 83 186 23.99 516 203 85 149 82 15 366 164 448 612 901 
91PV M 44 73 173 24.39 776 109 68 128 68 121 9 248 78 326 502 
95PV F 23 68 179 21.22 750 211 70 143 92 73 314 215 406 621 902 
138PV F 21 62 162 23.62 614 118 80 384 81 51 1181 435 1262 1697 1895 
140PV F 57 53 154 22.34 771 323 66 116 45 41 101 157 145 302 691 
166PV F 54 61 160 23.82 677 130 67 114 60 129 325 243 385 628 825 
1MI M 27 72 165 26.40 476 54 479 4380 16 16 2495 4396 2512 6908 7441 
2MI F 27 65 173 21.70 468 55 510 3292 17 17 15 3309 32 3341 3906 
3MI F 34 56 170 19.30 475 54 628 8539 16 16 15 8556 31 8587 9270 
4MI F 25 59 168 20.90 545 47 316 2885 14 14 13 2899 27 2926 3289 
5MI F 24 60 160 23.45 443 58 555 7104 18 18 16 7121 34 7155 7769 
6MI F 21 50 163 19.00 544 47 497 2417 14 14 13 2431 27 2459 3003 
7MI M 42 75 185 21.90 616 42 370 2805 13 13 11 2818 24 2842 3254 
8MI F 34 84 168 29.70 458 56 843 3637 17 17 15 3654 32 3686 4585 
9MI F 26 67 165 24.60 515 50 512 2138 15 15 14 2153 29 2182 2744 
10MI F 54 65 150 29.00 657 39 657 3588 12 12 11 3600 23 3622 4318 
11MI F 36 45 150 20.00 605 43 957 6250 13 13 12 6263 25 6287 7287 
12MI M 32 90 185 23.00 650 40 351 4840 12 12 11 4852 23 4875 5266 
13MI M 40 88 183 26.00 538 48 470 2629 15 15 13 2643 28 2671 3188 
14MI                                 
15MI F 41 52 160 20.30 570 45 979 6065 14 14 12 6078 26 6104 7128 
16MI F 49 78 172 26.36 572 45 571 6767 14 14 1747 6781 1761 8542 9158 
17MI F 32 76 167 27.95 611 42 713 4614 13 13 12 4627 24 4651 5407 
18MI F 38 55 162 20.95 483 53 560 14654 16 16 15 14670 31 14701 15314 
19MI F 38 86 164 31.96 526 49 888 3288 15 15 13 3303 28 3331 4268 
20MI F 38 46 150 20.40 471 55 746 5446 17 17 15 5463 32 5495 6296 
21MI F 29 60 174 20.00 526 49 774 3217 15 15 13 3231 28 3260 4083 
22MI F 26 70 175 23.00 498 52 627 2524 16 16 14 2540 30 2570 3249 
23MI F 46 47 151 20.60 627 41 482 6110 12 12 11 6123 24 6146 6669 
24MI F 34 53 160 20.70 499 52 225 2708 16 376 14 3084 30 3114 3390 
25MI M 43 83 170 28.70 544 47 323 2891 14 977 13 3868 27 3895 4265 
26MI F 36 55 172 18.70 351 74 1182 7962 22 22 20 7985 42 8027 9282 
27MI F 34 54 162 20.57 307 84 925 5514 25 315 23 5829 48 5878 6887 
28MI F 69 59 153 25.20 572 45 1215 17531 14 546 12 18077 26 18103 19363 
29MI F 34 55 163 20.70 483 53 488 5363 16 732 15 6095 31 6126 6667 
30MI F 44 58 160 22.60 516 50 17 15 15 15 14 30 29 59 126 
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PID Sex Age Weight (kg) 
Height 
(cm) 
BMI 
(kg/m2) 
TL 
(mg/dL) β-HCH HCB p,p'-DDE o,p'-DDD p,p'-DDD o,p'-DDT ∑p,p'-DDX ∑o,p'-DDX ∑DDT ∑OCP 
31MI F 33 55 163 20.70 476 54 495 3306 16 493 15 3799 31 3830 4379 
32MI F 21 53 163 19.90 376 69 523 5859 21 624 19 6483 40 6523 7115 
33MI F 44 63 173 21.00 474 54 585 7962 16 527 15 8489 31 8521 9161 
34MI M 20 57 168 20.20 345 75 834 8339 23 23 20 8361 43 8405 9314 
35MI F 20 65 173 21.70 466 55 324 5726 17 17 15 5743 32 5775 6155 
36MI F 25 62 160 24.00 435 59 896 5781 18 18 16 5799 34 5833 6788 
37MI M 21 78 186 22.50 472 55 633 4208 17 17 15 4224 32 4256 4943 
38MI F 27 60 163 22.60 520 50 1060 4691 15 15 14 4706 29 4735 5844 
39MI M 21 69 172 23.30 524 49 637 3904 15 465 216 4369 230 4600 5286 
40MI F 26 59 170 20.40 473 54 660 3654 17 17 15 3671 31 3702 4417 
41MI M 20 85 194 22.60 503 51 474 2499 16 16 14 2515 30 2544 3070 
42MI M 20 62 177 19.80 510 51 406 1233 15 15 14 1248 29 1277 1734 
Abbreviations: BMI, body mass index; TL, total lipids; β-HCH, beta-hexacyclohexane; HCB, hexachlorobenzene; o,p'-DDE, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-
chlorophenyl)ethylene; p,p'-DDE, 1,1-dichloro-2,2-bis-(p-chlorophenyl)-ethylene; o,p'-DDD, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; p,p'-DDD, 1,1-
dichloro-2, 2-bis (4-chlorophenyl)ethane; o,p'-DDT, 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p chlorophenyl)-ethane; p,p'-DDT, 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane; 
∑p,p'-DDX = (p,p'-DDE + p,p'-DDD); ∑o,p'-DDX = (o,p'-DDD + o,p'-DDT); ∑DDT = (∑p,p'-DDX + ∑o,p'-DDX); ∑OCP = (β-HCH  + HCB  + ∑DDT). 
 
